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In-vitro Modelling of Stromal and Immune Cell Interactions Following Surgical Bone
Marrow Stimulation
Sophie Louise Frankham-Wells
Osteoarthritis (OA) results in degeneration of cartilage and bone within a joint, leading to pain and loss-
of-function. While effective treatments exist for end-stage OA, earlier disease stages lack treatment
options. Micro-fracture and micro-drilling, often termed bone marrow stimulation techniques, offer an
early-stage repair and regenerative strategy. These techniques result in the formation of a haematoma
containing Bone Marrow Stomal Cell (BMSC) and immune cells at the joint surface, leading to repair.
However, the quality of repair after marrow stimulation is, at present, sub-optimal. BMSC are known
to interact with immune subpopulations during repair, although the consequences of these interactions
for repair outcomes are not fully understood. This thesis aims to further the current understanding of
how interactions between immune subpopulations and BMSCs in the environment of a haematoma
may influence repair outcomes following surgical bone marrow stimulation techniques.
In order to understand the influence of hypoxia on BMSC, strains of Human Bone Marrow Stromal
Cells (hBMSCs) were isolated and cultured under normoxic (18.9 % oxygen) and hypoxic (3.0 %
oxygen) conditions. Characterisation demonstrated that hypoxic culture had functional consequences
on BMSC phenotype and behaviour. To explore the effect of BMSC-immune cell interactions on
BMSC migration, immuno-regulation, and cell phenotypes, parallel experiments were performed
under normoxic and hypoxic conditions. A unique approach was taken to identify an immune subpop-
ulation resulting in BMSC migration, which was used as an indicator of potential co-localisation and
interaction. BMSC were exposed to paired enriched and depleted populations of peripheral blood
mononuclear cells, which had been sequentially fractionated using specific markers. The migration
stimulated in the BMSC by the enriched and depleted fractions was compared. A Natural Killer
(NK) cell population was found to have induced the greatest BMSC migration relative to its paired
fraction. Co-cultures indicated that the influence of NK cells on BMSC, particularly NK cell-mediated
cytotoxicity, were heavily dependent on culture conditions, including NK cell number and oxygen
vi
levels. In a further study, co-cultures of BMSC and monocytes, which interact with BMSC and have a
potential role in fibrosis, were co-cultured under normoxic and hypoxic conditions. A pro-angiogenic,
immunomodulatory phenotype developed in normoxic co-cultures, which was significantly reduced
in hypoxic co-cultures.
In conclusion, these data suggest that BMSC and immune subpopulations have diverse interactions
which are strongly influenced by the local oxygen tension and cellular environment. These findings
demonstrate the importance of the microenvironment formed by bone marrow stimulation techniques
on cellular interactions, with potential consequences for the outcome of the repair. Furthermore, this
work indicates that manipulation of the haematoma and surrounding environment following bone
marrow stimulation could improve repair and regenerative outcomes.
For all those who asked me, ’when?’,
I hope one day to answer, ’now’.
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Lay Summary
Osteoarthritis is an extremely common joint condition, affecting many people around the world.
During osteoarthritis, the smooth cartilage covering the bone ends in the joint is damaged or lost,
leading to stiffness and pain. Osteoarthritis can affect any moving joint, such as the knee, hip,
wrist, and spine. Although many sufferers of osteoarthritis are elderly, it does not exclusively affect
older people. The chances of developing osteoarthritis can be increased by injury, infection, obesity,
smoking, and inherited disease. For example, cruciate ligament injuries, which are very common
amongst football players, increase the odds of getting knee osteoarthritis. At the moment, the best
treatment for knee osteoarthritis is a knee replacement. However, this is only done once the joint is
completely worn-out, which means that people must live with increasingly painful, stiff knees for
many years.
Some facts about osteoarthritis:
In the UK. 33 % of people
over 45 have visited their
GP about osteoarthritis
In the UK, 18 % of people
over 45 have knee
osteoarthritis
85 000 knee replacements
are performed by the NHS
every year
This body of work looks at a new group of treatments for knee osteoarthritis, sometimes called bone
marrow stimulation techniques. These can be used in the early stages of osteoarthritis to halt the
damage to the cartilage, therefore preventing the knee wearing out. There are multiple ways of
stimulating the bone marrow to repair the cartilage. For example, during the bone marrow stimulation
technique called micro-drilling, a surgeon drills tiny holes between the bone end (where the damaged
cartilage is) and the bone marrow, while during micro-fracture an awl is used to create the holes.
Bone marrow contains cells with regenerative potential, which means they can repair damage, while
cartilage does not contain these cells, so it cannot heal itself. The drill holes allow the bone marrow
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cells to reach the cartilage and help it to heal. However, instead of making smooth, strong cartilage, a
scar forms, which is rough and weak and does not protect the knee joint. If we understand why the
scar forms, we can improve these techniques to make healthy cartilage.
One suggestion as to why these techniques fail is that immune cells from the blood also reach
the cartilage and interfere with the regenerative cells, perhaps by killing them or blocking their
contributions so that instead of healing, a scar forms. During my research, I studied how different
immune cells and the regenerative bone marrow cells interact in different conditions, and how this
could influence the healing process. I did this by isolating the regenerative cells from bone marrow
samples donated by patients having knee replacement surgery, and immune cells from the waste
product produced during platelet donations. These cells were mixed together to form in vitro co-
cultures, meaning that the cells were grown with each other in the lab and act as a model of what
is happening in the body. By varying the conditions I grew the co-cultures in, I was able to study
how these cells interact, and what the consequences of these interactions might be. One condition I
was interested in was the level of oxygen present. Most experiments are done at atmospheric oxygen,
the normal level in the air, or normoxia. However, after bone marrow stimulation techniques are
performed, there is no blood supply to the treated area, meaning that there is very little oxygen present,
which is called hypoxia. While other people have studied similar interactions before, the work has
been done in normoxia. I believed that the low oxygen level, or hypoxia, would have an influence on
how these cells interact.
What I found is that the interactions between regenerative bone marrow cells and immune cells are
affected by oxygen level. I looked at two types of immune cells: Natural Killer Cells, and Monocytes.
These cells are both attracted to wounds, such as bone marrow stimulation, where they have roles in
repairing the damage. As the name suggests, Natural Killer Cells kill unhealthy cells, for example
tumour cells or cells infected with bacteria. Monocytes have many roles, including phagocytosis
where they engulf and digest debris, waste, and bacteria to clear up infections or wounds. In normal
oxygen conditions, Natural Killer Cells attract the regenerative cells, which move towards them and
are then killed by the Natural Killer Cells. However, under low oxygen conditions, the Natural Killer
Cells are less good at attracting the regenerative cells, and are only able to kill them if they are given
a signal. Like the Natural Killer Cells, the Monocytes attracted the regenerative bone marrow cells
more strongly in normal rather than low oxygen conditions. Instead of then killing the regenerative
cells, in normal oxygen levels the two different cell types worked together to increase the growth of
blood vessels and reduce inflammation. By contrast, low oxygen levels prevented this.
This means that both the oxygen level and the type of immune cells present can influence the behaviour
of the regenerative bone marrow cells, which might influence how well bone marrow stimulation
works. Future studies could take this further and look at how this information could be applied to
improve bone marrow stimulation techniques for treating osteoarthritis. Eventually, this could lead to
improved techniques to treat OA.
Ethical Statement Regarding Use of Human Tissues
All experiments were carried out in strict accordance with local procedures and national ethical
regulation.
Bone marrow
Human bone marrow was obtained from patients undergoing total knee replacement as treatment for
osteoarthritis with full ethical consent in writing in accordance with the Human Tissue Act 2004 and
approved by the local Research Ethics Committee (Cambridge Local Research Ethics Committee No.
06/Q0108/213).
Leukocyte Reduction System Cones
Leukocyte reduction system cones, from platelet donations by healthy donors, were supplied by NHS
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Chapter 1
Introduction
Osteoarthritis (OA) is a chronic, degenerative condition affecting articulated joints that results in pain
and loss of function. The Global Burden of Disease Study 2013 ranked OA 13th on a global scale of
Years Lost to Disability (YLD), an increase of 3 places since 1990 with around 250 million or 3 %
of the global population now affected (Vos et al. 2015). Furthermore, musculoskeletal conditions
including OA were ranked fourth behind neoplasms, cardiovascular disease, and mental health
disorders in global causes of mortality. Although OA itself is not directly fatal, the restricted mobility
and motility resulting from pain and loss of joint function can contribute to other co-morbidities
such as obesity, mental health issues, cardiovascular disease, or diabetes. While all forms of OA are
showing increasing global prevalence, cases of knee OA in particular are increasing rapidly. In the
United Kingdom, 8.75 million people have consulted a doctor regarding OA, and 18 % of over 45 year
olds have been diagnosed with knee OA (ARUK 2013).
Therapies for early-stage OA and focal cartilage lesions, such as Autologous Cartilage Implantation
(ACI) or scaffolds, provide a level of regeneration but do not currently represent a definitive, long-term
solution. At present, the sole therapy offering a significant period of restored joint function and
associated pain reduction is arthroplasty in the end-stage of OA. Therefore, effective, long-term
interventions are required for early-stage OA where cartilage deterioration is focal and disability
could therefore be minimised.
One such family of interventions are bone marrow stimulation techniques, which introduce bone
marrow to the joint surface through abrasion, drilling, or fracturing of the subchondral bone. As
a result, a bone marrow clot forms at the defect site. While cartilage has very weak regenerative
potential, the bone marrow contains cells capable of regeneration with the potential to differentiate
into chondrocytes, called Bone Marrow Stomal Cell (BMSC) (Jiang and Tuan 2015). The identity
and role of these cells in repair and regeneration will be discussed later in section 1.5. By introducing
the bone marrow to the joint surface in the form of a clot, the BMSC are able to regenerate the lost
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cartilage and damaged subchondral bone, and restore functionality to the joint. Furthermore, the
presence of the haematoma introduces nutrients, immune cells, and oxygen to the defect site enabling
repair.
In practice, bone marrow stimulation techniques have potential to regenerate the osteochondral defects
seen in OA, but require significant development. The ideal clinical outcome is regeneration of healthy
hyaline cartilage with the requisite biomechanical properties, clearly defined tidemark (the interface
between calcified and non-calcified cartilage), and correct extracellular matrix composition. However,
studies have shown that while the defects treated with bone marrow stimulating techniques have
some infill with hyaline cartilage, the majority of the repair tissue is fibrocartilage (Saw 2011, 2013;
Saw et al. 2009). Although this does cover the exposed surface of the bone and restore a level of
functionality, fibrocartilage is more prone to abrasion and therefore the repair lacks longevity. Studies
have shown that alteration of the cellular environment within the clot formed following bone marrow
stimulation resulted in improved clinical outcomes (Broyles 2017b; L. Gao et al. 2017; K. Lee et al.
2007; Murphy et al. 2018; Saw 2013). The interventions used included administration of autologous
BMSC, Peripheral Blood Mononuclear Cell (PBMC), bone marrow aspirate, or immunomodulatory
compounds such as Hyaluronic Acid (HA). These findings indicate the importance of both BMSC
and immune populations during repair. In order to identify methods of improving bone marrow
stimulation outcomes, it is important to understand which immune subpopulations present within the
haematoma interact with BMSC, and how these interactions may influence the clinical outcome of the
repair.
1.1 Osteoarthritis: past and present knowledge
OA is an ancient condition, dating back perhaps 125 million years, and has been described as ‘imper-
vious to evolution’ (Massicotte 2011). The section below will present a brief history of some of the
milestones in OA treatment and research, culminating in the Charnley Hip Replacement and the first
successful total knee replacement in the 20th Century.
1.1.1 Osteoarthritis in prehistory
Researchers claim to have found evidence of OA in 30 % of Caudipteryx fossils, an oviraptor from
the Aptian Age of the Early Cretaceous Period, dating from around 125 million years ago, and also
in an Iguanodon ankle joint dating from 85 million years ago in the Late Cretaceous Period (Farlow
and Brett-Surman 1999; Paul 2016; Rothschild et al. 2012). This last is compelling as osteophyte
development is clear on the joint periphery. However, diagnosis of OA from fossilised remains is
contentious, being based solely on presence of osteophytes, changes in bone density, and presence of
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Fig. 1.1 Atlatl and spear
Sketch showing a modern atlatl and spear based on designs from Mesoamerican artefacts. The atlatl, which
pre-dates the bow and arrow, acted as an extension of the arm, increasing the leverage and therefore the speed
and power of the thrown spear. Original work based on drawing from life.
bone cysts due to the lack of soft tissue, and therefore risks some confusion with other degenerative
joint conditions (Farlow and Brett-Surman 1999).
The earliest evidence of OA in hominid species comes from Homo neanderthalis remains dated to
around 30 000 years ago, while that in modern humans (Homo sapiens sapiens) dates to 4500 B.C. in
Native American remains found in modern-day Tennessee and Kansas (Bridges 1992). OA in humans
appears to have been relatively common in the Neolithic period, affecting the elbows of adults males
so often that the condition has been termed ’atlatl elbow’ by one paleopathologist, a reference to
the atlatl or spear-thrower, depicted in fig. 1.1, which was in widespread use among hunter-gatherer
communities at the time and the extensive use of which has been postulated to cause OA (Bridges
1992).
Perhaps the most famous Neolithic sufferer of OA was Ötzi, the Iceman, who died around 3000
B.C. Osteoarthritic changes, namely subchondral sclerosis and joint space narrowing, can be seen in
X-rays of his right hip joint (Kean et al. 2013). Due to the excellent preservation of Ötzi’s soft tissue,
diagnosis of OA can be made with confidence. Further examination of his body may indicate some of
the earliest treatment methods for OA in Europe: medicinal tattooing. At the time of his death, Ötzi
had 61 tattoos whose locations appear to correspond to regions of his body showing signs of damage
or wear, including one tattoo on his right, lower lumbar region which may have corresponded to the
perceived location of pain from his advanced hip OA (Samadelli et al. 2015).
References to joint pain and popular treatments thereof begin to appear in the literature in about 2500
B.C. around 500 years after the death of Ötzi. At this point, OA, Rheumatoid Arthritis (RA), septic
arthritis, and gout were all treated and referred to as the same condition, termed arthritis deformans,
a state of affairs which would continue until the 19th century. However, it is clear that joint pain
was a common condition, particularly among the elderly. One of the Ptahhotep Maxims, attributed
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to the Egyptian vizier Ptahhotep in 2400 B.C. , reads ‘old age descendeth. . . The bones are painful
throughout the body; good turneth into evil’ indicating an awareness of increasing joint degeneration
with age (Ptahhotep translated by (Kagemna and Ptahhotep 2009)). Indeed, mummified remains from
Egypt show that OA was very common among the elite classes, particularly in the spine (Fritsch et al.
2015).
The earliest written record of proposed therapy for joint pain appears to be the ‘Nei Ching’, or
‘The Yellow Emperor’s Classic of Internal Medicine’, rumoured to date to 2500 B.C. , suggesting a
combination of acupuncture, and tea made from poplar and willow bark, which was also prescribed
for joint pain in a Sumerian tablet dating from 2000 B.C. (Ni 1995). The famous Egyptian medical
scroll, the Papyrus Ebers, attributed to the scribe Imhotep in 1550 B.C. , suggested application of a
topical ointment made from fat, honey, herbs, and bone marrow to ease painful joints (Halioua and
Ziskind 2005). Joint pain and OA appear to have been relatively neglected by the Greek physicians;
Hippocrates makes very little mention of either in his Aphorisms dating to 400 B.C. , with only
two alluding to the subject. These are the 31st Aphorism of Section III listing the diseases of the
elderly, which include vertigo, cataracts, and pains in the joints, and the 25th Aphorism of Section V,
where the application of cold water was suggested to soothe painful joints (Hippocrates, translated
by (Adams and Hippocrates 2000)). In the first century A.D. , Dioscorides proposed the use of ivy
berries for joint pain, a practice which continued to be popular into 19th Century England, where it is
proposed in John Hill’s ‘The Family Herbal’ (Hill 1812).
1.1.2 Key stages in the understanding and treatment of osteoarthritis
In 1741, the anatomist Morgagni was the first to produce a written description of osteoarthritic
cartilage (Benedek 2006). William Heberden then initiated the process of distinguishing OA from
rheumatoid arthritis when in 1782 he described digitorum nodi, ‘hard little knobs, about the size
of a small pea’, on the hands of OA sufferers (Heberden 1818). Nowadays, these are referred to
as Heberden’s Nodes and, along with Bouchard’s Nodes, described by Charles Bouchard in 1887,
allow clear discrimination between OA and rheumatoid arthritis of the hand, due to their strong
association with OA and relative scarcity in rheumatoid arthritis (Alexander 1999; Tan Ai Lyn et al.
2005). The further differentiation of OA from gout was performed by William Garrod in the early
1850s, although use of the name ‘Osteoarthritis’ wasn’t recorded until 1886 when it was first used by
Dr John Kent Spender, an English physician (Garrod 1859; Spender 1888). In this paper, Spender
wrote eloquently of the lack of knowledge surrounding the condition, saying that ‘Few things are so
apt to cause a feeling of drowsy despair. . . as the prospect of an academic discussion on the aetiology
of osteoarthritis’. The combination of lack of knowledge about OA and lack of effective treatment
ultimately led to the formation of the Empire Rheumatism Council in 1936, which eventually became
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Arthritis Research United Kingdom (ARUK) (ARUK 2017). ARUK and Arthritis Care merged in
2017 to form Versus Arthritis (Versus Arthritis 2017).
A hugely significant step in the treatment of OA occurred in 1961, when John Charnley perfected
the low-friction arthroplasty for OA which represented the first effective treatment for the condition
(Charnley 1961). Although arthroplasty had been performed prior to this date, with the earliest
recorded procedure performed by Anthony White in 1822, the Charnley method represented the
first successful, long-term, reproducible procedure and, with some modification, remains the best
solution for end-stage OA (Charnley 1961; Trebše and Mihelič 2012). The first successful total knee
arthroplasty, for knee OA, was performed 13 years later in 1974 (Trebše and Mihelič 2012).
1.2 Current understanding of osteoarthritis
1.2.1 Anatomy of the knee
To understand the disease process and treatment methods involved in OA, it is important to first
understand the anatomy of the affected tissue. This thesis is primarily concerned with the knee, so
this section will discuss key points of relevant anatomy within the knee. Hyaline, derived from the
Greek for crystal or transparent (ὑάλινος or ὕαλος), describes cartilage with a smooth, glassy, bluish
appearance most commonly found on the articulating surfaces of joints (Martin 2015). In the knee,
these surfaces are the patellofemoral, between patella and femur, and lateral and medial tibiofemoral,
between the tibia and the lateral or medial condyles of the femur respectively, as shown in fig. 1.2.
Articular hyaline cartilage lubricates and provides shock protection to the articulating joint surfaces.
Additional protection of the joint is provided by the menisci, articular discs of fibrocartilage, and
the bursae, synovial membranous sacs containing synovial fluid. The menisci are located between
the tibia and femur, and prevent rubbing of the bone ends as well as providing shock absorption and
deepening the tibial sockets. Synovial fluid is a viscous, non-Newtonian, transcellular liquid formed
by weeping lubrication from the intracellular fluid of articular cartilage during movement, as well as
secretion by the synovial membrane. Synovial fluid contains hyaluronan and lubricin, and provides
both lubricant and some shock absorption in the joint, as well as transfer of nutrients, waste, and gas
exchange for the cartilage (Gray and Lewis 1918; Margo et al. 2010).
Hyaline cartilage itself is avascular, aneural and alymphatic with very low cellularity, around 2 %
chondrocytes by volume, being mainly composed of a highly ordered collagen-proteoglycan matrix
(Fox et al. 2009). These components contribute to the macromolecular structure of the cartilage, and
the chondrocytes embedded within this matrix are responsible for its maintenance. This matrix has
a zonal organisation, made up of the superficial, middle, and deep zones fig. 1.3. Each zone has a
distinct organisation of matrix fibre composition and orientation, and chondrocyte location and shape
6 Introduction
Fig. 1.2 The knee joint
Anatomical drawing of the human knee joint, with key structures labelled. Derivative work by SLFW based on
Gray’s Anatomy Original Edition (Gray and Lewis 1918).
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Fig. 1.3 Structure of articular hyaline cartilage
Diagram showing the zonal composition of articular hyaline cartilage in terms of both cellular (fig. 1.3a) and
matrix (fig. 1.3b) composition. Original work.
with correspondingly different biomechanical properties (Fox et al. 2009). Below the deep zone of
cartilage lies a calcified tidemark zone formed of hypertrophic chondrocytes, marking the transition
from cartilage to subchondral bone. This subchondral region is around 10 times more deformable
than cortical bone, with a critical role in reducing peak loading and distributing force across the joint
surface (Millis 2014).
Damage to the cartilage can occur as a result of congenital abnormality, biomechanical instability and
misalignment, trauma, or disease processes including infection and diabetes (Abramson and Attur
2009). In many mammalian species, such as mice, rabbits, sheep, pigs, and goats, articular hyaline
cartilage lesions below a critical threshold in size heal completely, but in humans, articular hyaline
cartilage has low self-repair potential, making it vulnerable to damage and degradation which may
then progress into OA (Chu et al. 2010).
1.2.2 Current understanding of disease processes within osteoarthritis
OA is characterised by damage to, and loss of, articular cartilage, along with meniscal damage, joint
space narrowing, proliferation of the synovium (synovitis), osteophytic growth, subchondral sclerosis
and bone marrow lesions, indicating that OA is not solely a condition of the cartilage, but the whole
joint (Abramson and Attur 2009; Brandt et al. 2006). Originally, lack of inflammation was thought to
be a key distinguishing feature between OA and RA or gout, but recent studies have demonstrated
8 Introduction
that inflammatory processes may in fact play a role in OA (Goldring and Otero 2011). OA lacks
a standard disease progression, so stages of the disease with commonly associated symptoms are
grouped together, as outlined in the figure below (fig. 1.4f). The Kellgren-Lawrence scale, first
developed in the 1940s, is commonly used to categorise the disease progression, although other
grading schemes do exist (Beck et al. 2005; Konan et al. 2011).
1.2.3 Diagnosis of osteoarthritis
Diagnosis of OA is usually made through a combination of reported symptoms, examination, and
radiographic evidence, although blood tests and Magnetic Resonance Imaging (MRI) may be used to
rule out other conditions such as septic arthritis or damage to soft tissues supporting the knee (ARUK
2013; NICE 2014). Pain correlates poorly to disease progression in OA, and so is used to determine
treatment requirements for individual patients rather than as an indicator for disease stage (Pritzker
et al. 2006). OA can be either primary, or secondary in cause. Primary or idiopathic OA has in the
past commonly been associated with ageing and therefore was termed “wear-and-tear OA”. However,
while age is a strong risk factor, OA is not necessarily an intrinsic feature of the ageing process,
making this term obsolete. Genetic predisposition, sex, lifestyle factors (including occupation and
smoking), obesity, and co-morbidites (including diabetes) are also all key risk factors for development
of OA, although the impact of each depends on the joint in question: obesity is a key predisposing
factor for knee OA, while hip OA is more strongly linked to genetic factors (Abramson and Attur 2009;
Buckwalter 2003; Magnusson et al. 2017; Sellam and Berenbaum 2013; Zengini et al. 2018; Zhai et al.
2007). Secondary OA results from a clearly identifiable cause, which may be the aforementioned
cartilage trauma, joint infection, inflammatory arthritis, biomechanical and misalignment issues or
congenital disease. However, cartilage trauma does not necessarily progress to OA: a retrospective
analysis of 4121 knee arthroscopies demonstrated that there was no difference in progression or
severity of OA between those with large cartilage defects and those without, indicating that the disease
processes are more complex than simple degradation due to cartilage damage (Widuchowski et al.
2011).
Nevertheless, cartilage defects and progressive erosion are a unifying feature of OA and can advance
to the point where the exposed subchondral bone is itself eroded, leading to progressively worsening
joint misalignment, and disability. Understanding the biology of articular hyaline cartilage can aid
understanding of both the disease process and the inherent difficulties faced when considering repair
and regenerative strategies for OA.





(b) Very early OA: loss of
superficial zone of cartlage
(c) Early OA: zonal
structure of cartilage lost









(f) End stage OA: full loss




Fig. 1.4 Stages in the development of Osteoarthritis
In the healthy joint, hyaline cartilage has a highly ordered zonal stucture overlying the subchondral bone
(fig. 1.4a). During the initial stages of the disease, the superficial layer of cartilage is lost (fig. 1.4b). As disease
progresses, there is further loss of cartilage accompanied by subchondral sclerosis, disorganisation in the
cellular structure of the remaining cartilage and development of bone marrow lesions and osteophytes
(figs. 1.4c to 1.4e). In the end stage, all cartilage is lost from the joint surface leading to eburnation and erosion
of the subchondral bone (fig. 1.4f). Original work based on descriptions of disease progression and histological
slide examination.
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1.3 Treatment strategies for osteoarthritis
1.3.1 Current techniques
Non-surgical techniques
Non-surgical techniques are employed in the early stages of OA where no definitive cause can be
identified and disease has not yet progressed to result in significant impact on a patient’s quality
of life. These methods are also used in conjunction with surgical techniques in later stages of OA
to improve treatment outcomes, and can be classed into symptomatic management techniques, and
physiotherapy. Symptomatic management includes the use of painkillers, ranging from over-the-
counter medications such as paracetamol through to steroid injections or opioids in more severe
cases. Lifestyle modifications, such as weight loss to reduce joint loading, are also covered by this
term. Physiotherapy may be employed to improve biomechanical alignment, also achieved through
orthotics, or to strengthen the supporting muscles and ligaments to protect the joint from insult, or to
assist in recovery from surgical procedures.
Surgical techniques
Resolving underlying biomechanical issues by repairing damaged supporting tissues such as anterior
cruciate ligament or meniscus, or by correcting joint misalignment can significantly delay the progres-
sion of OA, preventing deterioration. Misalignment can be corrected through use of orthotics and
physiotherapy for mild cases, but in severe cases or congenital malformation of the joint, surgical
intervention such as wedge osteotomy can be used. Wedge osteotomy is also commonly used in
conjunction with techniques to repair the cartilage defect, such as mosaicplasty, Autologous Cartilage
Implantation (ACI) or Matrix-induced Autologous Chondrocyte Implantation (MACI). These tech-
niques aim to repair defects by infilling with healthy cartilage or cells taken from non-load-bearing
sites (Brittberg et al. 1994). Although the specifics of the techniques vary between the different
therapies, the underlying principle is similar: autologous tissue from non-load-bearing regions is
taken and used to infill the defect and promote repair, either as intact osteochondral or cartilage plugs
(mosaicplasty, sometimes called Osteochondral Autograft Transfer System (OATS)), embedded in a
gel (MACI), or sealed under a patch (ACI) (Bartlett et al. 2005; Ebert et al. 2017; NICE 2018). All of
these techniques result in damage to the harvest site, are only suitable for defects below a critical size,
result in fibrocartilage infill, and delay, rather than prevent, disease progression. For example, ACI
showed high engraftment in only 35 % of cases after one year, and success was heavily dependent
on site and size of defect. However, use of ACI has been approved by National Institute of Clinical
Excellence (NICE) in the UK as the sole effective therapy for individuals with early-stage OA of the
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knee and cartilage defects greater than 2 cm2 in size where symptomatic management has failed, but
joint replacement is not indicated (NICE 2017).
Instead of using autologous explants or cells, scaffolds made from biocompatible materials can be
implanted into the defect to provide a structure for cellular regeneration. These scaffolds can be made
from ceramics, composites or alloys, and advances in biomimetic material design, 3-dimensional
printing, and laser sintering have enabled more complex scaffold design . For example, biphasic
scaffolds with a hydroxyapatite base and gel top to mimic the biomechanical properties of bone
and cartilage respectively are under development (Rodrigues et al. 2016). Other strategies showing
promise include embedding scaffolds with regenerative factors such as Bone Morphogenic Protein 2
(BMP-2), stem cells, or chondrocytes (Quinlan et al. 2015; Shimomura et al. 2017). However, the
success of these scaffolds is very mixed with poor scaffold-tissue integration, defect collapse, and
problems with implantation being seen.
As a result, current and even developing treatment strategies ultimately delay disease progression.
However, once the disease has reached end-stage, there are highly effective treatments available:
arthrodesis and arthroplasty. Arthrodesis, where the joint is fixed to prevent rubbing, is used in
non-replaceable joints such as the vertebral, ankle, manubriosternal, and carpometacarpal joints
(Al-Dahiri and Pallister 2006; Hartigan et al. 2001; Takakura et al. 1999). While this does prevent
further pain, joint functionality is removed. Arthroplasty, common in large joints such as the hip, knee,
or shoulder, replaces the damaged joint with a prosthetic and is considered the gold-standard treatment
for end-stage OA in these joints. This treatment prevents pain and restores functionality to the joint,
improving both mobility and motility, albeit with some limitations. The surgery occurs in end-stage,
when the patient has experienced multiple years of increasing pain and disability with associated
personal and economic impacts. Additionally, the prosthetics have limited lifespans; around 20 years
for a knee replacement is considered optimal, but many require replacement after fewer than 5 years
due to infection, loosening or mechanical wear, resulting in revision surgeries in increasingly elderly
patients or, in severe cases, amputation of the affected limb or even, in rare cases, death (Labek et al.
2011; Son et al. 2017; Tay et al. 2013). Furthermore, prosthetic lifespan is influenced by the age
of the recipient, with those implanted in more elderly patients showing much greater lifespans than
those implanted in younger recipients (Boulos and Jolles-Haeberli 2008). As a result, while an elderly
patient may require a single revision procedure, a younger patient may require multiple revisions with
the associated increased risks of adverse effects and disability. Therefore, although joint replacement
offers an effective solution to end-stage OA in the elderly, it is less ideal in younger patients where an
earlier intervention with greater longevity is required.
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1.3.2 Potential therapy: Bone marrow stimulation
In OA, the hyaline cartilage covering the articular surface is damaged or lost, along with other
pathological changes. Focal cartilage defects, which may progress to OA, also involve loss of hyaline
cartilage. Current treatments for early-stage OA either manage the disease, or result in low-level
regeneration of the damaged tissue. A more ideal strategy would be a regenerative technique resulting
in the re-coverage of the joint surface with hyaline cartilage, complete with the correct zonal structure
and biomechanical properties. Such a strategy requires a cell population within the defect site which
is capable chondrogenesis and producing articular hyaline cartilage to replace that which was lost.
Human articular hyaline cartilage has low instrinsic repair potential, unlike that found in many other
mammalian species (Chu et al. 2010). As a result, any damage sustained by articular hyaline cartilage
in humans will resolve poorly, if at all (Widuchowski et al. 2011). The extent and type of repair
tissue formed following trauma depends in part on the severity of the injury. A partial-thickness
defect, which does not penetrate to the subchondral bone, shows a different level of repair to a full-
thickness defect which penetrates to, and may involve damage to, the subchondral bone itself (Fellows
et al. 2016). A partial-thickness defect shows little to no cellular recruitment, meaning that cellular
involvement is restricted to chondrocytes, which show low and transient proliferation in response to
the damage (Hunziker 1999; Hunziker and Rosenberg 1996). By contrast, greater cellular recruitment
is seen in the case of full-thickness defects, especially with subchondral involvement, and the cellular
response is comprised of cells with higher proliferative and regenerative potential such as bone marrow
stromal cells or macrophages (Kreuz et al. 2006). Infill tissue is produced in both defect types, but
the nature of this tissue varies with the extent of the cellular response. Partial-thickness defects show
infill with an acellular fibrous tissue, while the infill tissue in a full-thickness defect is comparatively
more robust, being an unstructured mix of hyaline cartilage and fibrocartilage (Hunziker 1999; Kreuz
et al. 2006; L. Zhang et al. 2009). However both repair tissues are considerably less biomechanically
stable than healthy articular hyaline cartilage and are highly prone to degradation. In either case, infill
of the defect is partial at best leaving an uneven depression in the coverage at the joint surface.
As a result, intrinsic repair processes are insufficient to fully resolve cartilage defects. The repair tissue
formed is transient, providing temporary infill but not restoring functionality. Indeed, the uneven joint
surface resulting from the partial infill can lead to further degradation of the surrounding cartilage;
the rim of a cartilage defect experiences high levels of shear forces, leading to decreases in matrix
proteins and cells in surrounding tissue, propagating the trauma and increasing the risk of secondary
OA developing (Zevenbergen et al. 2018). The relatively superior repair seen in full-thickness defects
with subchondral involvement indicates that there is at the least the potential for formation of articular
hyaline cartilage as the infill tissue. The mixed hyaline and fibrocartilage repair tissue is presumably a
result of the presence of cells from the bone marrow with higher regenerative potential in the defect in
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combination with a fibrin clot. These cells are capable of regenerating hyaline cartilage, but are unable
to fully recapitulate the developmental pathways resulting in healthy articular hyaline cartilage.
Articular hyaline cartilage development is a process which begins in utero and finishes post-natally,
although it is not yet fully understood. In the earliest stage, joint formation begins with interzone
condensation of flattened Collagen 2-positive mesenchymal progenitor cells at presumptive joint
sites within the cartilage anlage under the control of Gdf5, Wnt family genes and Erg, among others
(Decker, Koyama, et al. 2015; Decker, Um, et al. 2017). Cavitation follows interzone condensation,
with the development of the joint space, although the exact mechanism is unknown (Bari et al. 2010;
Chijimatsu and Saito 2019). The synergistic effects of multiple transcription factors, including but not
limited to bone morphogenic proteins, growth / differentiation factors, Sox and Wnt family members,
induce secondary joint structure development which in turn leads to chondrogenic commitment and
differentiation at the articular surface (Bari et al. 2010). At this point, the articular cartilage is matrix-
poor, highly cellular and isotropic, unlike the matrix-rich, low cellularity and strict zonal organisation
of mature cartilage as shown in fig. 1.3 (Decker, Um, et al. 2017). Final development and maturation
of the cartilage occurs post-natally, under control of Prg (coding for Lubricin), transforming growth
factors, fibroblast growth factors and parathyroid hormone-related peptide, as well as biomechanical
forces (Caldwell and J. Wang 2015; Chijimatsu and Saito 2019). Matrix secretion increases leading
to increased thickness of the articular cartilage and a corresponding decrease in cellularity. As the
cartilage matures, zonal organisation occurs, in part under control of the canonical Wnt pathway.
While full recapitulation of the cartilage developmental pathway to regenerate damaged cartilage
is currently out of reach, elements could be manipulated to encourage repair and regeneration. In
the context of these thesis the most pertinent is the presence of precursor cells with chondrogenic
potential at the joint surface. During cartilage development these cells initiate joint formation in the
condensation phase and subsequently differentiate to form the various cell types found within a joint,
including chondrocytes as discussed above. However, they are not present in mature articular hyaline
cartilage. Adult BMSC are thought to be descendents of these mesenchymal precursor cells and are
capable of expressing similar factors, such as Col-2, as well as replicating some of their behaviours,
such as chondrogenesis (Caplan 1991; Pittenger et al. 1999; Sheng 2015). In addition, the presence
of some hyaline cartilage within the repair tissue formed after cartilage damage with subchondral
involvement indicates that they are capable of forming hyaline cartilage in the adult. Therefore,
introducing bone marrow cells to the joint surface in a controlled manner could stimulate intrinsic
pathways leading to formation of superior repair tissue at sites of cartilage trauma. Furthermore,
studies have shown that decreasing immune involvement in regions of trauma may favour a more
complete regenerative reponse, possibly closer to tissue formation or fetal repair (Julier et al. 2017;
Shi et al. 1997; Toben et al. 2011).
Bone marrow stimulation techniques, which exploit the intrinsic regenerative potential of bone marrow
(as shown in fig. 1.5) have been proposed as therapies for osteochondral repair for many years (Pridie
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and G. Gordon 1959). During bone marrow stimulation, bone marrow is introduced to the defect
site through various techniques, such as abrasion, Micro-Drilling (MD), or Micro-Fracture (MF)
of the bone surface exposed by cartilage loss. This marrow forms a marrow clot which contains
cells with regenerative potential: hyaline articular cartilage itself is believed to have very few cells
with regenerative potential and hence has weak intrinsic repair potential (Jiang and Tuan 2015).
These regenerative cells may directly contribute to infill of the defect by undergoing chondrogenic
differentiation and producing hyaline cartilage themselves, or may recruit or support other cell types
to undergo the same process. Furthermore, articular hyaline cartilage is avascular and hence has low
nutrient and oxygen levels and restricted waste exchange, but it is suggested that repair has a greater
metabolic requirement than that typically provided at the joint surface (Abramson and Attur 2009).
The surgically induced trauma at the defect site increases nutrient, gas, and waste exchange which
supports the repair and regeneration, including angiogenesis, occurring during the healing cascade, as
well as recruitment of cells with regenerative potential responding to the trauma.
These therapies have shown promise in treating focal cartilage loss and early-stage OA, but this
has never been fully realised. This may be due to incomplete understanding of the mechanisms
underlying the technique, preventing optimisation. As a result, although there is partial re-covering of
the joint surface and infill of defect sites following treatment with bone marrow stimulation techniques,
much of the regenerated tissue is fibrocartilage, which is an improvement, but not as desirable or
long-lived an outcome as hyaline cartilage (Bae et al. 2006). Therefore, although chondrogenesis
can be stimulated using this technique, and some hyaline cartilage is produced, the type and extent
of the chondrogenic response is currently sub-optimal. Understanding how the early interactions
between cell types within the marrow clot influence chondrogenesis and eventual resolution of the
repair could enable the techniques to be improved, resulting in a repair tissue comprised entirely of
hyaline cartilage.
1.3.3 Techniques used in bone marrow stimulation
Abrasion arthroplasty
During abrasion arthroplasty, damaged cartilage and subchondral bone is debrided. No direct large
diameter conduits between the joint surface and marrow cavity are formed and so the clot forms
through bleeding from damaged blood vessels within the subchondral bone. This technique is
generally considered palliative and will not be considered in further detail here.
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(a) Left side: damaged
cartilage. Right side:
Damaged cartilage is
debrided to expose the
subchondral bone. At this
stage, the debrided region
can be left to repair
(Abrasion arthroplasty) or
further treatments can be
applied
(b) Channels are created
between the debrided
defect site and bone
marrow by drilling (MD,
left side) or fracturing with
an awl (MF, right side)
(c) Following creation of
the channels, a marrow clot
forms within the defect site
Fig. 1.5 Bone marrow stimulation techniques




Micro-drilling (MD) was first introduced by Pridie in 1959 (Pridie and G. Gordon 1959). During MD,
damaged cartilage is debrided to the level of the subchondral bone, and a drill is used to bore through
the subchondral bone to the marrow cavity. Marrow and blood from the marrow cavity are extruded
into the defect site by hydraulic pressures to form a marrow clot. Modern MD techniques use irrigation
to prevent heat necrosis. Micro-fracture (MF) was originally introduced by Steadman in the late 1990s
(Steadman et al. 1997). In principle, MF is similar to MD, although the holes between marrow cavity
and joint surface are created using an awl, rather than a drill. This procedure often leads to bone
compaction and potentially increased osteocyte necrosis around the holes. MD/MF have potential as a
therapy for focal cartilage defects, with multiple long-term studies showing that the techniques reduce
development of OA in over 50 % of cases with greater success in non-smoking, younger patients with
normal Body Mass Index (BMI), smaller, early-stage defects, and good biomechanical alignment
(Gracitelli et al. 2016; Knutsen et al. 2016; Ulstein et al. 2014). Furthermore, the combination of
MD/MF with wedge osteotomy or Anterior Cruciate Ligament (ACL) repair (if required) to correct
alignment is highly recommended and indeed shows significantly improved results compared to
MD/MF alone. The ideal outcome of MD is regeneration of healthy hyaline cartilage with correct
zonal structure of the tissue, clearly defined tidemark, correct Extracellular Matrix (ECM) composition
and requisite biomechanical properties. However, in those patients where the treatment fails, this
occurs within 2 to 5 years of surgery. Regardless of the eventual outcome, in the majority of cases the
regenerated tissue is composed mainly of fibrocartilage and lacks the highly organised structure and
biomechanical properties of healthy hyaline articular cartilage, leaving the repair tissue vulnerable
to erosion as shown in fig. 1.6 (Steadman et al. 1997). Studies have shown that defects treated with
MD/MF have some infill with hyaline cartilage, although the proportions within the repair tissue
vary (Bae et al. 2006; K. B. L. Lee et al. 2012; Saw 2013). Furthermore, the infill of the defects is
often partial or incomplete, leaving a clear indentation on the cartilage surface, which risks collapse
of the edges of the defect leading to further erosion. While this does protect the bone from being
further damaged by abrasion and provides a level of coverage/joint lubrication the poor biomechanical
properties of fibrocartilage means that this acts more as a stop-gap than a true repair. In addition, over-
debridement of the calcified cartilage within the defect can lead to bone overgrowth, increasing failure
rate (Mithoefer et al. 2016). However, delaying the age of joint replacement through achieving best
functional repair is beneficial in younger patients by preventing the need for earlier joint replacement
surgery, and potentially multiple revisions. It has been suggested that the influence of MD on the
subchondral bone is responsible, at least in part, for the success of the technique, perhaps by creating
an environment more conducive to hyaline cartilage formation (de Vries–van Melle et al. 2014).
More recent studies have examined various ways of manipulating MD to improve repair outcomes.
These include exogenous administration of Bone Marrow Aspirate Concentrate (BMAC), isolated
autologous bone marrow progenitors, or Platelet-Rich Plasma (PRP) and HA (Broyles 2017a,b; K.










tidemark and with an
uneven surface
Fig. 1.6 Comparison of the desired and actual outcomes of bone marrow stimulation techniques for
cartilage repair. Original work
Diagram showing the desired outcome of bone marrow stimulation techniques and an example of the outcome
seen in reality.
Lee et al. 2007; Saw 2011). Outcomes were improved compared to MD alone, suggesting that the
positive effects of the treatment are due to the presence of bone marrow progenitors combined with
HA, which has immuno-modulatory properties, or PRP, which is thought to have immuno-modulatory
and chondroprotective properties through enhancing autophagy and supressing inflammation and
apoptosis (Moussa et al. 2017).
However, the patients within these studies were exposed to multiple intra-articular procedures; in one
study, patients required 12 separate bone marrow aspiration procedures and intra-articular injections of
BMAC, PRP, and HA over a twelve-month period to achieve measurable benefit (Broyles 2017a). This
represents a huge burden on the patient and health provider, as well as significant risk of adverse events
and patient drop-out. Therefore, since the positive effects of many of these therapies are believed to
be mediated through innate immune system effects a greater understanding of the BMSC-immune
interactions within the MD clot may yield points of intervention which could be therapeutically
exploited using, for example, small molecule therapies administered in less invasive ways. Greater
understanding could also indicate the optimum timepoint for interventions such as exogenous cell
administration based on the progression of the repair and inflammatory response. This thesis aims to
explore some of the interactions between BMSC and immune cells to further this understanding and
support development of future interventions.
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1.4 Wound healing and fracture repair
1.4.1 Differences between fracture repair and MF / MD
Fracture repair in bone will be considered as a model for the repair occurring following MD therapy,
to provide context and insight into the cell biology that underpins these events. It must be noted that
the repair occurring following bone fracture and MD is not identical, nor are the desired outcomes.
The best outcome in bone repair is one where the cartilage produced within the fracture callus has
been fully mineralised and remodelled to restore biomechanical strength. However, following MD the
desired outcome is a stratified repair with subchondral bone covered by a highly organised layer of
hyaline cartilage. After the currently employed bone marrow stimulation procedure, there is a level of
cartilage regeneration which covers the bone end but this is mainly comprised of fibrocartilage with a
small amount of hyaline-like cartilage (Bae et al. 2006). In fact, this repair tissue bears similarities to
that seen within a pseudarthrosis where the non-union fracture forms a false joint which is lined with
a mixture of fibrocartilage and hyaline-like cartilage (Milgram 1991; Panteli et al. 2015; Urist et al.
2017). This would suggest that the healing in a MD/MF repair could be considered a disordered or
disrupted version of fracture repair. The MD/MF repair is also small in size compared to a fracture,
which may alter the microenvironment and biodynamics within the repair. The repair will also have
some contribution from the cartilage and synovium which may produce factors, such as cytokines or
proteoglycans which alter repair pathways. The synovium may additionally contribute inflammatory
or fibroblastic cell populations, while the contribution of the remaining cartilage within the joint to
the repair is less clear cut. There is growing consensus that hyaline cartilage does contain progenitors,
but their activity and contribution to repair is currently unknown (Jiang and Tuan 2015). That being
said, the same cell types will be present in both scenarios, with contributions from the blood, bone
marrow, bone and periosteum of immune cells and stem / progenitor populations. This assessment
only considers repair in the context of sterile repair and assumes no infectious component. Presence
of infection within repair significantly alters both the physical and cellular environment as well as
pathways involved and has profound consequences for the resolution of the injury. This section will
consider the descriptive steps in early fracture repair; specific cellular conditions will be considered
separately.
1.4.2 Key stages of fracture repair
Fracture repair can be considered a developmental process occurring post-natally, comprising the same
pathways and features as skeletal development (Gerstenfeld et al. 2003). Bone is one of the few tissues
in the adult body capable of scarless injury resolution. Fracture sites can be nigh indistinguishable from
the original bone following complete resolution, with repair tissue displaying the same biomechanical
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properties, cellular composition, and organisation as the undamaged tissue (Einhorn and Gerstenfeld
2015). There are five key stages in fracture repair: haemostasis, inflammation, soft callus, hard callus
(in general wound repair these are jointly referred to as proliferation), and maturation or remodelling.
These phases are not discrete and may overlap temporally with other phases, although they are
characterised by specific events, as indicated in fig. 1.7.
1.4.3 Early fracture repair
Formation of the haematoma
My work is primarily concerned with interactions between cells occurring during haemostasis and the
first seven days of repair. During haemostasis, a haematoma forms to stop the bleeding from damaged
blood vessels and to provide a matrix for the repair. The haematoma is a dynamic environment and
has a crucial role in the outcome of the repair: removal of the early haematoma delays repair, increases
inflammation and compromises the resolution of the repair (Hoff, Maschmeyer, et al. 2013; Kolar
et al. 2011). My work does not consider the role of biomechanical forces, but perturbation of the
repair by biomechanical instability also negatively influences repair outcomes. This stage begins
with the traumatic insult and continues for the first hours following damage. Platelets degranulate in
response to the damage, initiating the clotting cascade and resulting in the production of a haematoma,
or clot. The haematoma is a hydrogel, containing fibrin polypeptide chains formed by proteolytic
cleavage of terminal glycine residues from fibrinogen by thrombin (Bailey et al. 1951; Doolittle 2010).
Thrombin also activates Factor XIII which crosslinks fibrin protofibrils, formed from the polypeptide
chains, into a matrix (Doolittle 2010). This matrix is stabilised by platelets which influence both the
structure and the mechanical properties of the haematoma (Tocantins 1936). Contained within this
matrix are cells from the peripheral blood and bone marrow. Following haemostasis, the release of
Damage Associated Molecular Patterns (DAMPs) and cytokines results in infiltration by immune and
other cell types, which initiate the inflammatory phase and start clearing debris and remodelling the
matrix to form the soft callus.
Physical environment of early fracture
Following haemostasis, the haematoma has no regular blood supply until neovascularisation occurs
at around day 5 post-fracture so, during this time, nutrient, waste, and gas exchange is achieved
by diffusion from surrounding tissues. In a sheep fracture model, oxygen content was elevated
immediately after fracture due to the influx of oxygenated blood prior to haemostasis, followed by a
rapid decline as a result of increased metabolic activity in the damaged region consuming residual
oxygen (Epari et al. 2008). The haematoma is profoundly hypoxic, with a measured partial pressure
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Fig. 1.7 Stages of fracture repair
Diagram showing outline of stages during fracture repair. Original work based on (Einhorn and Gerstenfeld
2015).
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of oxygen below 1 %, compared to the usual physiological level of 5 to 12.5 % (physoxia) (Hirao
et al. 2006). However, this is similar to the environment found within bone marrow: direct in vivo
measurements in mice have shown a gradient in oxygen levels within the bone marrow, ranging from
2.8 % in endosteal regions down to 0.6 % in peri-sinusoidal regions (Spencer et al. 2014).
Accompanying the changes in oxygen tension within the haematoma are changes in potential of hydro-
gen (pH). Following injury, acidification occurs resulting in a decrease in pH relative to physiological
conditions (pH 7.35 to 7.45). This acidification has been recorded as lowering haematoma pH to as
low as pH 4.7, although is more commonly found to be around 7.2 (Chakkalakal et al. 1994; Newman
et al. 1987; Steen, Kay H. et al. 1995). Acidification is followed by alkalinisation, an increase in
pH relative to physiological conditions, which peaks 20 days post-fracture. Acidification coincides
with the start of the inflammatory response as a result of increased lactic acid concentration within
the haematoma due to secretion from infiltrating neutrophils through anaerobic respiration, while
alkalisation corresponds to calcification (Lardner 2001; Newman et al. 1987; Swenson and Claff
1946). Disruption of these pH changes has deleterious effects on repair outcomes.
The local temperature of the haematoma also rises as part of the inflammatory response. In a sheep
fracture study, knee intra-articular temperature was found to increase from 34.8 ◦C pre-fracture,
to 38.5 ◦C 4 days post fracture, comparable to sheep core temperature of 38 to 40 ◦C (Epari et al.
2008). Although studies have not measured the thermal profile of a human haematoma, qualitative
observation indicates that local tissue temperature increases following fracture. Human knee intra-
articular temperature at rest is 31 to 33 ◦C, lower than core temperature of 37 ◦C and similar to the
difference between sheep lower limb and core temperature, although temperature changes during
exercise do occur (Becher et al. 2008; Harris and McCroskery 1974).
Therefore, in the early stage of repair, the haematoma has a low oxygen tension and pH, high lactate,
and a disorganised 3D structure (Kolar et al. 2011; Schmidt-Bleek et al. 2011). This environment
is strongly pro-inflammatory, resulting in the recruitment and infiltration of immune cells from the
peripheral blood and surrounding tissues. This inflammatory phase peaks 24 hours post-fracture
and continues for 5 to 10 days post-fracture when resolution occurs (Einhorn and Gerstenfeld 2015;
Mountziaris and Mikos 2008; Pence and Woods 2014).
Biochemical environment of early fracture
During haemostasis and inflammation, cytokines are major biochemical components of the response.
Morphogens, proteases and pro-angiogenic factors are secreted by several different cell types later
in healing (Gerstenfeld et al. 2003). In early inflammation, the profile is dominated by Interleukin 6
(IL-6), Interleukin 8 (IL-8), Interferon Gamma (IFNγ), and Tumour Necrosis Factor Alpha (TNFα)
from the damaged bone and surrounding soft tissue. Interleukin 1 beta (IL-1β) is also increased in the
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haematoma, and appears to have a role in controlling endochondral ossification. In response to the pro-
inflammatory cytokines, anti-inflammatory cytokine production occurs, characterised by production
of Interleukin 1 Receptor Antagonist (IL-1RA), Interleukin 4 (IL-4) and Interleukin 10 (IL-10) and
represents a counter-regulatory response (Hoff, Gaber, et al. 2016). Receptor Activator of Nuclear
factor κ B Ligand (RANKL) and Osteoprotegerin (OPG), whose relative levels are important in the
regulation of bone resorption and formation, are also upregulated at this point (Gerstenfeld et al. 2003).
The overall balance of all of these cytokines and growth factors is critical to the success of the healing.
For example, both over and under-expression of IFNγ and TNFα have profound consequences for
resolution (H. Schell et al. 2017). IL-6, IL-8, IFNγ and TNFα are potent chemokines for neutrophils,
the first cells recruited to the haematoma, which rapidly infiltrate the site of trauma within an hour
of injury and peak at around 24 hours post-trauma (Edderkaoui 2017; Loi et al. 2016). Neutrophils
secrete chemokines such as C-C Motif Chemokine Ligand 2 (CCL2) and C-X-C motif chemokine
Ligand 8 (CXCL8) which initiate neoangiogenesis and recruit monocytes to the site of damage
(Edderkaoui 2017). Bone marrow cells and Haematopoietic Stem and Progenitor Cells (HSPCs) are
recruited during this phase from surrounding bone marrow, muscle tissue and blood, in addition to
those captured within the clot during haemostasis (Gerstenfeld et al. 2003; Hoff, Maschmeyer, et al.
2013; Schmidt-Bleek et al. 2011). As a result, the cytokine and cellular profile of the haematoma is
dynamic, highly complex and has a significant impact on the eventual repair outcome.
The inflammatory response in fracture repair
A balanced inflammatory response is extremely important to successful repair; the strength and
duration of this inflammatory phase is critical to the outcome of the repair, hence the impor-
tance of immunoregulatory pathways during the anti-inflammatory phase are clear. The initial
pro-inflammatory response appears to have a detrimental effect on healing which is later countered
by the anti-inflammatory response, shown in the improved healing seen in immune-deficient mice
(Claes et al. 2012; Toben et al. 2011). Further evidence for the important of a correctly regulated
pro-inflammatory phase comes from studies on fracture healing in human patients with immune
disorders such as Systemic Lupus Erythematosus (SLE) or diabetes mellitus. These patients develop
chronic inflammation which prolongs the repair and results in compromised outcomes (Claes et al.
2012).
There is some evidence that lack of an inflammatory response can improve healing where highly
organised repair with minimal scarring is required. In a study on wound regeneration after lens surgery
in the eye, an immune privileged site, it was found that careful creation of a small incision to minimise
inflammatory infiltrate resulted in complete regeneration of the lens (Haotian Lin et al. 2016). The
lens has a highly organised cellular and matrix structure, broadly similar to hyaline cartilage, and
is able to functionally regenerate in the absence of immune cells. By contrast, when inflammation
1.5 Bone Marrow Stromal Cells 23
occurs the cellular organisation of the lens is disrupted resulting in sub-optimal repair. A similar result
was seen when comparing repair in dermal and oral wounding. Oral wounds have lower infiltration
of immune cells such as neutrophils, macrophages and T-cells, and show improved healing with
decreased scarring compared to dermal wounds (Szpaderska et al. 2003).
1.5 Bone Marrow Stromal Cells
1.5.1 Discovery of Bone Marrow Stromal Cells
In his 1867 paper ‘Ueber entzündung und eiterung’ (On Sepsis and Inflammation) Julius Friedrich
Cohnheim observed dyed cells with a fibroblastic appearance migrating to regions of tissue dam-
age from the bone marrow (as described in Rodríguez-Merchán and Liddle 2016). A year later,
L’Academie de France in Paris awarded Emile Goujon a prize of 500 Francs for his work showing that
bone marrow transplantation into muscle caused ectopic ossification in chickens and rabbits (Goujon
1869) as summarised in (Bolontrade and García 2016). Despite these early advances, nearly one
century would pass before Tavassoli and Crosby enlarged on this work and demonstrated that bone
marrow has inherent osteogenic potential (Tavassoli and Crosby 1968). This early work paved the way
for the seminal work by Friedenstein and Owen, who first defined an adherent subpopulation of the
bone marrow, with a fibroblastic appearance, trilineage potential (osteo-, adipo- and chondro-genic),
and colony forming behaviour (Friedenstein, Chailakhjan, et al. 1970; Friedenstein, Chailakhyan, and
Gerasimov 1987; Friedenstein, Chailakhyan, Latsinik, et al. 1974). In 1991, Caplan denominated
this population the ‘Mesenchymal Stem Cell’ or ‘MSC’ (Caplan 1991). Later work by Pittenger
demonstrated trilineage potential after clonogenic expansion, as well as the importance of ‘MSC’
in supporting haematopoiesis (Pittenger et al. 1999). These discoveries showed that these cells had
potential applications in the nascent field of regenerative medicine. Since that time, the field has
grown immensely. Moreover, analogues of these cells with similar properties have been extracted
from multiple tissues within the human, such as adipose, umbilical cord, pancreas, and menstrual
blood as well as from diverse mammalian species, including mouse, dog, sheep, whale, and pig
(Bornes et al. 2015; Hoogduijn et al. 2013; K. Lee et al. 2007; Russell et al. 2016). These cells appear
to be ubiquitous within the body in mammalian species, being distributed throughout the tissues,
although the influence of tissue source on cell properties is incompletely understood.
1.5.2 Nomenclature
Throughout this thesis, these cells will be referred to as Bone Marrow Stromal Cells, or BMSCs. As
can be seen from fig. 1.8, the nomenclature of these cells is complex, with a range of interpretations in
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Fig. 1.8 Distribution of ‘MSC’ acronym usage within US clinical trials
The various interpretations of the ‘MSC’ acronym were assessed in a sample of clinical trials from the US in
July 2018 and are presented here as a chart (ClinicalTrials.Gov 2018).
use. In this section, I will discuss other terms and explain why these cells will be referred to as BMSC
throughout my thesis. An exception will be made when discussing research using cell analogues
derived from other tissues.
Mesenchymal stem cell
This is the most commonly used term, and was championed by Caplan in his 1991 paper (Caplan 1991).
However, the implication of the term ‘stem’ is that of a self-renewing population, and while BMSC
are capable of differentiating to other cell types, they are not capable of indefinite self-propagation
(DiMarino et al. 2013). Additionally, ‘stem’ is used in an imprecise manner, covering cells ranging
from the totipotent blastocyst, to multipotent tissue-specific cell types, and implies a homogeneous,
well-characterised population (Tajbakhsh 2009). Indeed, in recent years, Caplan himself has argued
against the use of this term, such as at the 2017 International Cartilage Research Society conference.
Mesenchymal stromal cell
This second interpretation avoids the controversy of the word ‘stem’ by replacing it with ‘stromal’.
While this is an improvement, the term itself is somewhat of a tautology. ‘Stromal’ refers to the cells
supporting the parenchyma, such as blood vessels or connective tissues, which do not have an organ-
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or tissue- specific function. In the adult, ‘mesenchymal’ refers to cells derived from the embryonic
mesodermal lineage. This is a very broad term, encompassing the soft, connective tissues derived
from the mesenchyme, which provide structure and support to organs. Additionally, this term does not
make any distinction between cells derived from different tissue sources; it implies that tissue source
is irrelevant. This is clearly not the case, as there are clear differences between MSC from adipose
tissue and from bone marrow (Sung et al. 2008). A common practice now is to add an indicator of
tissue of origin to the acronym, for example A-MSC for Adipose-derived Mesenchymal Stem/Stromal
Cell. This term does acknowledge the heterogeneity of the population, which is an improvement over
mesenchymal stem cell (DiMarino et al. 2013).
Medicinal signalling cell
This term is the newest and has been proposed by Caplan as replacement for Mesenchymal Stem Cell
(Caplan 2017). The logic is that MSC contribute to regeneration more through immunomodulation
than through differentiation. There is also no use of the terms ‘mesenchymal’ or ‘stromal’ since
Caplan claims that MSC are in fact pericytes (Caplan and Correa 2011). The term is slightly awkward,
since the idea of the ‘MSC’ is well known, and it was believed that changing the acronym would
simply be confusing. Further, it is a clinical term, suggesting the cells should be considered as a drug
or delivery system, rather than intrinsic components of a biological system and, once again, does not
identify tissue of origin or heterogeneity.
Bone Marrow stromal cell
This final term avoids the tautology of mesenchymal stromal cell, and is specific about the tissue of
origin. The term BMSC may also be used to further distinguish the tissue of origin and avoid the
confusion of the ‘MSC’ acronym. This term has recently been challenged based on the existence of
a marrow stroma: Caplan argues that there is no stroma in bone marrow, and therefore referring to
these cells as marrow stromal cells is incorrect (Caplan 2017). However, if the previously discussed
definition of stroma (cells which do not perform the specific function of the organ or tissue) is used,
then this argument is questionable. The function of the bone marrow is haematopoiesis, which is
performed by the resident HSPC within the tissue. The BMSC do not perform haematopoiesis, but
instead form part of the HSPC niche in a supportive, or stromal, role. Therefore, in my opinion, the
term Bone Marrow Stromal Cell (BMSC) provides the optimal balance between acknowledgement of
tissue of origin, cellular function within the niche, population heterogeneity, and cellular identity and
will be used throughout this thesis. The acronym is also similar to the well-established ‘MSC’, and
the modified ‘B-MSC’ used to denote tissue origin, allowing the work to be considered in the broader
context of the field while minimising confusion over nomenclature.
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1.5.3 In vitro isolation and characterisation of Bone Marrow Stromal Cells
Given the confusion surrounding the nomenclature of the BMSC, it should be of no surprise that
the scientific definition is equally contentious. While some basic attributes of the BMSC are widely
agreed upon, there is no definitive consensus on phenotyping criteria. This means that when the term
‘MSC’ or ‘BMSC’ is found in a study, it is always necessary to identify how the individual research
groups have defined the population. The basic definition of a Human Bone Marrow Stromal Cell
(hBMSC) is based on the work by Friedenstein and Owens, Caplan, and Pittenger as described above
and was proposed by the International Society for Cell Therapy (ISCT) in 2006 (Dominici et al. 2006).
Their criteria were:
1. The population must be plastic adherent under standard tissue culture conditions
2. The population must have the expression of surface markers defined in table 1.1, as determined
by single stain flow cytometry (see table A.1 in Appendix A for a description of markers used)
3. The population must be capable of tri-lineage differentiation. In the context of BMSC /
mesenchymal stromal cell (MSC) this refers to osteogenic, adipogenic, and chondrogenic
differentiation (see section 1.5.4).
Table 1.1 Surface Marker Expression of hBMSC
Positive (≥95 % expression) Negative (≤2 % expression)
Cluster of differentiation (CD)
CD73, CD90, CD105
CD45, CD34, CD14 (or CD11b),
CD79α (or CD19),
Human Leukocyte Antigen – D Related (HLA-DR)
It is immediately clear that cell populations isolated and characterised using these conditions will be
highly heterogeneous, due to the looseness of the guidelines. This is acknowledged by the ISCT, and
in the paper, they discuss how these guidelines represent the bare minimum to define a BMSC. To
further complicate the definition, a ‘Skeletal Stem Cell’ which expresses similar markers to BMSC,
but does not undergo adipogenic differentiation has been described (Chan et al. 2015; Worthley
et al. 2015). Multicolour analysis, additional markers and more stringent thresholds are suggested
to improve characterisation of the BMSC (Dominici et al. 2006). The underlying heterogeneity of
the population is especially highlighted by work from the Genever group (James et al. 2015). This
group has created four human telomerase reverse transcriptase (hTERT) immortalised lines of BMSC,
each derived from a single cell and all isolated from the same donor sample, named Y101, Y102,
Y201, and Y202. Characterisation of these lines by flow cytometry has shown similar expression of
ISCT markers (Positive: CD105, CD90, CD73, and negative: CD34 and CD45), along with extra
markers identified by the group (CD29, CD44 and CD166). However, characterisation by tripotential
differentiation, proliferation and migratory phenotype demonstrated that the lines can be split into two
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groups with starkly differing phenotypes. Critically, while the Y101 and Y201 lines were tripotent, the
Y102 and Y202 lines had weak differentiation abilities (with possible immunomodulatory behaviour)
despite all having similar marker expression profiles (James et al. 2015). This suggests that BMSC
have heterogeneous behaviours despite similar marker profiles. This could be due to a spectrum of
behaviour, determined spatially or temporally in vivo, which has been fixed by the immortalisation
process. Either way, only two of these lines would be considered BMSC by the ISCT, despite their
markers and population of origin. A consideration of 9 papers published since the ISCT guidelines
were proposed, although a small subset of the available literature, firstly show that none of these
papers used these exact criteria as stated, nor were any of the characterisation methods used the same
between papers (Adesida et al. 2012; W. Chen et al. 2018; James et al. 2015; J. Kim and Hematti
2009; Poggi et al. 2005; Prasanna et al. 2010; Sacchetti et al. 2007; Sotiropoulou et al. 2006; Wagegg
et al. 2012). The use of plastic adherence was the sole consistent criteria in all methods, as shown in
fig. 1.9.
Fig. 1.9 Differentiation ability criteria used for hBMSC identification
Assessment of in vitro differentiation ability used to characterise hBMSC in a subsection of published papers
(Adesida et al. 2012; W. Chen et al. 2018; James et al. 2015; J. Kim and Hematti 2009; Poggi et al. 2005;
Prasanna et al. 2010; Sacchetti et al. 2007; Sotiropoulou et al. 2006; Wagegg et al. 2012).
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In terms of both differentiation potential and cell surface marker expression, it is clear that while
the ISCT guidelines act as inspiration, and were even referenced as the characterisation method for
the study, individual research groups have developed their own methods of characterising BMSC
(fig. 1.9 fig. 1.10). CD44 in particular is commonly used, possibly due to its upregulation on cells
during in vitro culture although its expression is of questionable relevance in vivo (Le Blanc and
Davies 2018). Further, the expression of these markers is not unique to BMSC: fibroblasts also
express many of these markers at similar levels. The divergence in thought is clear if the age of
the ISCT guidelines are considered: these have not been updated since 2006, which is most likely
due to lack of consensus among key researchers. As a result, comparisons between BMSC / MSC
studies are challenging. In my study, the basic ISCT guidelines will be adopted and used for hBMSC
characterisation. While other markers are proposed, such as CD44, the guidelines provide a baseline
which is widely acknowledged, if not universally accepted, and provide a useful entry-point when
developing hBMSC research.
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(a) Number of uses of ISCT proposed hBMSC
positive cell surface markers
(b) Number of uses of ISCT proposed hBMSC
negative cell surface markers
(c) Number of uses of non-ISCT proposed
hBMSC positive cell surface markers
(d) Number of uses of non-ISCT proposed
hBMSC negative cell surface markers
Fig. 1.10 Cell surface markers used for hBMSC identification by flow cytometry
Cell surface markers used for the flow cytometric characterisation of hBMSC in papers published since
announcement of the ISCT guidelines. (Adesida et al. 2012; W. Chen et al. 2018; James et al. 2015; J. Kim and
Hematti 2009; Poggi et al. 2005; Prasanna et al. 2010; Sacchetti et al. 2007; Sotiropoulou et al. 2006; Wagegg
et al. 2012).
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1.5.4 Pathways and culture conditions for in vitro tri-lineage differentiation of BMSCs
During this thesis, the terms ’osteogenesis’, ’chondrogenesis’, and ’adipogenesis’ will be used to refer
to specific BMSC differentiation pathways. To clarify exactly what is meant by these terms, there
follows a brief discussion of the differentiation pathways and associated culture conditions each refers
to.
Fig. 1.11 Adipogenic, chondrogenic, and osteogenic differentiation pathways
Outline of differentiation pathways induced by in-vitro stimulation of BMSC (Bateman et al. 2016; Green et al.
2015; Karahuseyinoglu et al. 2008).
Chondrogenic differentiation
During chondrogenic differentiation, BMSC become chondrocytes, matrix-secreting cells responsible
for the production of cartilage, as shown in fig. 1.11. In the context of osteochondral repair, chondro-
cytes are a highly desirable cell type at the joint surface, where, ideally, they would produce articular
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hyaline cartilage to contribute to the infill of chondral defects. Chondrogenic differentiation of BMSC
takes around 14 days.
Chondrogenic differentiation in-vitro is stimulated by the addition of proline, Transforming Growth
Factor β1 (TGFβ1), Ascorbic Acid Phosphatase Ascorbic Acid Phosphate (AAP), ITS supplement,
and dexamethasone to serum-free medium. The key component of the supplement which initiates
the chondrogenic response is the TGFβ1. TGFβ1 stimulates the MAP kinase and Wnt pathways
through upregulation of p38, ERK-1, and JNK, resulting in the modulation of N-Cadherin and N-
CAM (Franceschi and Iyer 1992; Xiao et al. 2009). N-Cadherin initiates, and N-CAM stabilises, the
condensation of BMSC which begins the commitment of the cells to the chondrogenic lineage (Tavella
et al. 1994). TGFβ1 also increases expression of chondrocyte-related genes, particularly collagen II
and aggrecan, and its effects on chondrogenesis are potentiated by the addition of the glucocorticoid
dexamethasone to the medium (Shintani and Hunziker 2011; W. Wang et al. 2014). The amino
acid proline is added due to its necessity for collagen synthesis, since proline and hydroxyproline
account for around 23 % of collagen by mass; AAP is crucial for the hydroxylation of proline to
form hydroxyproline, without which the correct helical structure of the collagen strand cannot form
(Barbul 2008; Franceschi and Iyer 1992). ITS supplement contains Insulin, Transferrin, and Sodium
Selenite, and is a common supplement in differentiation media, which has been shown to have effects
on chondrogenic differentiation through interaction with p38, ERK-1, and JNK /glsWatanabe2001.
In addition to the biochemical environment, the physical cellular environment is also important
for chondrogenic differentiation. Low oxygen tension, or hypoxic, conditions have been shown to
enhance chondrogenesis as a result of increased proliferation, inhibition of osteogenesis, and greater
upregulation of chondrogenic genes such as Collagen II (Sheehy et al. 2012). Furthermore, a 3D
culture environment, such as pellet cultures, is required for chondrogenesis to ensure that the BMSC
develop and maintain the rounded morphology which is a key feature of condensation during early
chondrogenic lineage commitment (Johnstone et al. 1998).
Osteogenic differentiation
Bone is a dynamic tissue which is remodelled through finely balanced anabolic and catabolic cell
activities. In a highly simplified model, osteoclasts, break down the bone matrix, while osteoblasts
secrete the calcified matrix. Unlike osteoclasts, which are derived from myeloid progenitor cells,
cells of the osteoblastic lineage, including osteoblasts and osteocytes, are derived from osteochondral
progenitor cells: BMSC (fig. 1.11). Due to this shared heritage with chondrocytes, there are similarities
in the media used for differentiation. Indeed, hypertrophic chondrocytes are capable of differentiating
into osteogenic lineage cells (Bateman et al. 2016).
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During osteochondral repair following MF/MD, osteogenic differentiation is not desirable at the joint
surface. However, the subchondral bone is perforated during the surgery, and this must be repaired
to provide a stable base for the regenerated cartilage. Indeed, it has been suggested that some of
the success of MF/MD is due to the stimulation of repair processes within the subchondral bone
(de Vries–van Melle et al. 2014).
In-vitro, osteogenic differentiation is stimulated using medium supplemented with dexamethasone,
AAP, and β-glycerophosphate, and takes around 21 days. dexamethasone contributes to positive
regulation of Runt-related Transcription Factor 2 (RUNX-2), a transcription factor widely regarded
as a master regulator of function, gene expression, and differentiation in osteoblasts (Bruderer et al.
2014). This regulation is accomplished through increased transcription of FHL2, TAZ and MKP1
(Langenbach and Handschel 2013; Thiagarajan et al. 2017). FHL2 stimulates translocation of β-
catenin to the nucleus, leading to increased transcription of RUNX-2, TAZ regulates the activity of
RUNX-2 while also inhibiting adipogenesis, and MKP1 regulates RUNX-2 phosphorylation. AAP
and β-glycerophosphate also enhance RUNX-2 activity through activation and phosphorylation of
ERK1/2, which translocates to the nucleus, binds RUNX-2 and leads to upregulation of osteogenic
gene expression, such as BMP-2 via the cyclic-AMP / protein kinase A pathway (Tada et al. 2011;
Xiao et al. 2009). β-glycerophosphate also acts as a source of phosphates for mineralisation, although
the concentration in the differentiation medium must be carefully optimised to avoid dystrophic
mineralisation (Langenbach and Handschel 2013; Tada et al. 2011). Similar to the chondrogenic
medium, AAP has a role in supporting collagen production, although during osteogenesis this is
collagen I, since the presence of collagen I in the extra-cellular matrix is essential for osteoblast
differentiation (Xiao et al. 2009).
Unlike chondrogenic differentiation, osteogenic differentiation is typically performed on monolayers
of cells. In addition, normoxic conditions are considered optimal for osteogenic differentiation
(Wagegg et al. 2012).
Adipogenic differentiation
Adipogenic differentiation stands apart from both chondrogenic and osteogenic differentiation. While
the latter two pathways are related and there is some level of cross-talk between them, adipogenic
differentiation is more distinct. This is fortunate in the context of osteochondral repair, since formation
of adipocytes within the joint is highly undesirable. The adipogenic differentiation pathway leads to
the formation of adipocytes, lipid-storing cells which are the primary cell type found in adipose tissue,
as outlined in fig. 1.11.
The distinction of the adipogenic pathway extends to the medium used in-vitro for BMSC differen-
tiation. Similar to osteogenic differentiation, adipogenic differentiation is performed in monolayer
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cultures, but instead takes around 14 days. Due to the number of components required, their identities
and functions are summarised in table 1.2.
Table 1.2 Medium supplements used during adipogenic differentiation
A summary of the supplements and functions thereof in adipogenic differentiation medium (Kuri-
Harcuch et al. 1978; Obregon 2008; Styner et al. 2010; XingYun Wang et al. 2018; Xu et al. 2009).
Supplement Function
Biotin
Co-enzyme for lipoprotein lipase and glycerophosphate
dehydrogenase, the primary adipogenic enzyme
dexamethasone
Similar to in chondro- / osteogenic media, potentiates
adipogenesis, increases cyclic-AMP and lipolysis
Indomethacin
Suppresses Cox-2, and increases PPAR-γ
and C/EBPβ expression in a prostaglandin-independent manner
Insulin
Hormone influencing pro-adipogenic transcription factor
expression, including PPARγ and FABP4
Isobutyl methylxanthine
Stimulates the cyclic-AMP-dependent protein kinase
pathway, leading to upregulation of C/EBPβ
Pantothenic acid
B vitamin, similar to Biotin, which supports
differentiation and increases lipid accumulation
Transferrin As for pantothenic acid
Triiodothyronine
Increases expression of UCP-1 and PPAR-γ,
enhancing differentiation and adipogenic metabolic activity
1.5.5 Use of hBMSC in cellular therapy
Due to their proposed regenerative properties and ability to home to sites of damage, BMSC have
been used in therapies for conditions as disparate as cardiovascular disease, spinal lesions, diabetic
nephropathy, acute respiratory distress syndrome, and sepsis (see fig. 1.12), and have shown moderate-
to-good results in terms of outcomes in studies ranging from animal models through to Phase I and II
clinical trials in humans (Espinoza et al. 2016; Khalilpourfarshbafi et al. 2017; Y.-C. Kim et al. 2016;
Lalu et al. 2016; Quevedo et al. 2009). How BMSC (or similar cells from other tissues) contribute
to repair and regeneration is not completely understood. Two key models of contribution have been
suggested: cell replacement and cell empowerment, which can alternately be termed cell autonomous /
direct and cell non-autonomous / indirect respectively (Ying Wang et al. 2014). In the cell replacement
model, the progenitor cells differentiate into the cell types found within the damaged tissue and
restore its structure and function. In the cell empowerment model, the same progenitors do not engraft
into the tissue, but instead modulate the growth environment to enable and support intrinsic repair
processes, for example through recruitment or immunomodulation.
In many studies, the influence of BMSC on repair does appear to be through cell empowerment
or paracrine mechanisms. For example, a review of seven studies using BMSC to treat diabetic
nephropathy showed the BMSC homed to the site of damage and resulted in improved repair outcomes
(Khalilpourfarshbafi et al. 2017). However, examination of the mechanisms by which the BMSC
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Fig. 1.12 Use of hBMSC in cellular therapies
Distribution of clinical trials using hBMSC as a treatment for various conditions. Based on data from Wei et al.
2013
contributed to repair showed that the majority of effects were mediated through paracrine mechanisms,
such as through hepatocyte growth factor secretion, downregulation of Glucose Transporter 1 (GLUT1)
membrane localisation, or upregulation of Vascular Endothelial Growth Factor (VEGF) and B-cell
lymphoma 2 (Bcl-2) genes. A recent systematic review by Phinney and Pittenger examined 35 papers
using cell free therapies based on BMSC exosomes, small extracellular vesicles released by BMSC
which contain Ribonucleic Acid (RNA) and/or proteins that have paracrine effects on cells (Phinney
and Pittenger 2018). The exosomes were used to treat a range of diseases including myocardial
infarction, liver fibrosis, pulmonary hypertension and skin wounding: significant improvements in
repair were seen in all of these models. While the study of exosomes is in its infancy, this provides
strong evidence that BMSC are able to support repair through cell empowerment.
With regards to hBMSC contribution to repair through cell replacement, engraftment and differentia-
tion of BMSC correlate to improved repair outcomes: studies into BMSC therapy in cardiomyopathy
have found that BMSC engraftment is strongly correlated to improved repair outcomes, and that
the BMSC contribute to the repair by differentiating into relevant cell types (Quevedo et al. 2009).
This provides evidence that BMSC are involved with repair through cell replacement. Furthermore,
a spinal lesion study showed that BMSC introduced into a spinal lesion with a scaffold showed
higher engraftment and differentiation into neuronal cell types, indicating that BMSC are capable of
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direct contribution to repair in multiple tissues (Y.-C. Kim et al. 2016). However, the BMSC were
also secreting neurotropic factors and thereby supporting other cell types to effect the repair and
regeneration. It is most likely that BMSC have a combinatorial influence on repair and regeneration,
both contributing directly and supporting cell types. The relative contributions from the direct and
indirect mechanisms are not currently known and may be heavily context dependent.
1.6 Cellular contributions to fracture repair
1.6.1 Bone Marrow Stromal Cells in fracture repair
The role of BMSC in fracture repair has been a long-term focus of study in the field of regenerative
medicine. The success of therapuetic BMSC administration for example following myocardial
infarction, has demonstrated their repair and regenerative potential (N. F. Huang et al. 2009; Lipinksi
and Epstein 2016; Quevedo et al. 2009). Furthermore, the osteogenic properties of bone marrow have
been known since the mid-19th century due to the work of Goujon (Goujon 1869) as described in
(Bolontrade and García 2016) (see section 1.5.1). In addition, the work of Goujon’s contemporary,
Cohneim showed that fibroblastic cells, now known to be BMSC, migrate to sites of damage from the
bone marrow (Rodríguez-Merchán and Liddle 2016). More recent studies have shown that BMSC
have key roles in fracture repair, not only related to their differentiation potential, but also their
secretory and immuno-modulatory roles as well as their ability to home to sites of damage for targeted
drug-delivery purposes.
The importance of BMSC in fracture repair has been demonstrated in various ways. In a murine
fracture model it was found that ovariectomy resulted in delayed and impaired bone repair (Pang et al.
2015). The study showed that the ovariectomy resulted in significantly lower BMSC numbers in both
the peripheral blood and the bone marrow in the early stages of fracture (up to 72 hours post-injury),
indicating both decreased BMSC numbers and mobilisation. The impaired repair was attributed in
part to the decreased BMSC numbers, in addition to the hormonal perturbation resulting from the
ovariectomy. In addition, exogenous administration of BMSC can lead to improved repair of large
segmental bone defects in both animal models and human trials, compared to scaffolds alone, or
segmental bone transplantation (Y. Chen et al. 2017; Dupont et al. 2010; Petri et al. 2013). Fluorescent
tracking of administered BMSC labelled with fluorescent quantum nanocrystals (Q-dots) showed
fluorescence could be detected at the defect site up to 12 weeks after administration, although the
animals used in the tracking study did not show any bridging in the segmental defect and many Q-dots
were found to be associated with macrophages.
Another piece of evidence for the importance of BMSC in fracture repair is the mobilisation and
recruitment of the cells to the region of fractured bone. A fracture-repair study in mice using Green
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Fluorescent Protein labelled Mesenchymal Stromal Cell (GFP-MSC) injected into the tail vein showed
that GFP-MSC could be detected within the fracture site three days after injection (Granero-Moltó
et al. 2009). Homing appeared to be mediated by the C-X-C motif chemokine Ligand 12 (CXCL12)
(also Stromal Cell-Derived Factor 1 (SDF-1)) - C-X-C Motif Chemokine Receptor Type 4 (CXCR4)
axis (CXCL12-CXCR4 axis), although only a subset of GFP-MSC homed to the damage site; most of
the injected GFP-MSC were trapped in the lungs. The GFP-MSC which were recruited to the site
of damage could then be detected in a quiescent state within a tissue-specific stem cell niche for six
months after injection, although they were not detected within the callus itself, suggesting that the
BMSC were providing trophic support to the repair (Granero-Moltó et al. 2009).
The osteogenic properties of bone marrow suggest that a key role of BMSC might be migrating
to the site of damage and differentiating into osteoblasts which then produce mineralised matrix.
However, the aforementioned tracing studies show that labelled BMSC are not found, or found at
low numbers, within the callus long-term, indicating that cell replacement is unlikely to be the sole
mechanism through which BMSC contribute to repair. This means that BMSC also contribute through
cell empowerment, supporting other cell types to repair the damage. Further evidence for this can
be found in a study characterising the exosomes released from hBMSC which showed evidence for
both cell empowerment and replacement occurring simultaneously (Xiaoqin Wang et al. 2018). This
study found that as the BMSC differentiated down the osteogenic lineage, they released exosomes
which themselves stimulated osteogenic differentiation relative to the differentiation stage of the
BMSC from which the exosomes were derived. In the early stages of osteogenic differentiation, the
exosomes were able to induce osteogenic commitment, but only late-stage exosomes could induce
mineralisation. This demonstrates how BMSC are able to contribute directly to repair, while also
supporting repair by other cell types in a stage- and time-dependent trophic manner.
Evidence for this empowerment paradigm also comes from studies looking at cell-free therapies based
on BMSC products to improve fracture repair. For example, an osteotomy model in hypothyroid rats
showed that treatment of the defect site, with medium preconditioned by culture with BMSC, enhanced
the bone repair at the osteotomy site by reducing healing time and improving the biomechanical
properties of the repaired bone (Sefati et al. 2018). The CXCR4 recruitment study, which could
not localise BMSC to the fracture repair site, found that instead the BMSC contributed to repair
by secretion of BMP-2 (Granero-Moltó et al. 2009). In addition, another group examined how
BMSC-derived exosomes influenced murine fracture repair in a Complement component C9 precursor
knockout (C9-/-) mouse (Furuta et al. 2016). These mice have reduced exosome release and bone union
rate following fracture is also significantly decreased compared to wild-type. However, treatment
of fractures in the C9-/- mouse with exosomes isolated from wild-type BMSC conditioned medium
rescued the phenotype, restored C9-/- mouse fracture repair to that seen in the wild-type. Although a
brief snapshot, these studies demonstrate the multiple pathways through which BMSC provide trophic
support to the regenerative process through paracrine signalling. In summary, BMSC interact with
1.6 Cellular contributions to fracture repair 37
Fig. 1.13 Schematic showing division of immune cells into adaptive, intermediate, and innate cell
types. Original work.
components of the immune system during repair and this results in altered contributions to the repair
by both the immune cells and BMSC, and some of these specific interactions are explored in more
detail in section 1.6.2.
1.6.2 Immune cell contributions to fracture repair
The immune system has a critical role in fracture repair. Severely immunocompromised mice show
significantly impaired fracture repair, especially in the remodelling phase (Rapp et al. 2016). However,
the individual immune cell subtypes have more nuanced roles in fracture repair. At first glance, the
adaptive immune response appears to be detrimental to fracture repair. Recombination Activating
Gene 1 knockout (RAG-1 -/-) mice, which lack an adaptive immune system, show more rapid fracture
repair (Toben et al. 2011). However, this model removes all components of the adaptive immune
system, obscuring the subtleties in how these cells contribute to fracture repair. The innate immune
system has key roles in fracture repair, through a range of roles such as phagocytosis and cytokine
release (Charles and Nakamura 2014). fig. 1.13.
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Adaptive immune system: B-cells and T-cells
Following fracture, B and T cells infiltrate the injury in a two-wave process: there is an initial peak
after 4 hours post-fracture, and then another peak after 21 days during re-vascularisation, with B-cells
outnumbering T-cells at this point (Könnecke et al. 2014).
T-cells Studies in mice have shown that T-cells control the speed of endochondral ossification
through manipulating the mineralisation of osteogenic cell types (Serra et al. 2012). CD4-positive
T-helper cells, along with macrophages, are the dominant cell type in the haematoma 2 days post-
fracture, despite CD8-positive cytotoxic T-cells being more prevalent in the bone marrow, indicating
an enrichment for T-helper cells in the haematoma (Könnecke et al. 2014). In murine studies,
CD8-positive cytotoxic T-cell enrichment in the haematoma which skews the CD8:CD4 ratio results
in impaired regeneration, while depletion of CD8-positive cytotoxic T-cells enhanced repair in an
osteotomy model (Reinke et al. 2013; Toben et al. 2011).
T-cells have bi-directional interactions with BMSC in fracture repair. Preconditioned medium
from T-helper cells induces an osteogenic phenotype in BMSC by upregulating RUNX-2, osteo-
calcin and Bone Sialoprotein (BSP) production, possibly via TNFα secretion, while TGFβ1 from
T-regulatory cells increase BMSC proliferation (El-Jawhari et al. 2016). Conversely, BMSC along
with macrophages act to suppress the maturation of T-helper cells into Th1 / Th17 subtypes (Kovach
et al. 2015). In a study looking at fibrosis following injury in mouse livers it was found that Bagg
Albino inbred mouse strain c (BALBc) mice have a more severe fibrotic response than C57 black
6 inbred mouse strain (C57BL6) mice after trauma, attributed to the T Helper type 2 (Th2) skewed
response in BALBc and T Helper type 1 (Th1) skewed in C57BL6 (Shi et al. 1997).
B-cells B-cells peak in numbers within the haematoma after around 4 hours post-fracture and are
more numerous than T-cells in the haematoma during the remodelling phase (Könnecke et al. 2014).
B-cells secrete both RANKL and OPG, being responsible for 64 % of total bone marrow OPG
production in mice and are therefore key mediators of the OPG/Receptor Activator of Nuclear factor
κ B (RANK)/RANKL axis (Y. Li et al. 2007). RANK/RANKL binding increases bone resorption by
stimulating osteoclastogenesis, while OPG/RANKL binding blocks this and permits bone deposition
(Boyce and Xing 2007). As a result, B-cells may have an important role in balancing bone deposition
and resorption during the proliferative and remodelling phase of bone repair via their interaction
with mature and precursor osteoclasts within the fracture callus (Schlundt, Hanna Schell, et al. 2013).
Manipulation of fracture repair using B-cell therapy has not been performed although the manipulation
of the OPG/RANK/RANKL pathway using monoclonal antibodies to reduce osteoporotic fractures
and bone mineral density loss has improved health outcomes (Lacey et al. 2012). A study in skin
lesions showed that application of naïve B-cells accelerated wound healing due to increased fibroblast
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proliferation and anti-inflammatory effects, suggesting that B-cells may have other contributions to
repair (Sîrbulescu et al. 2017).
Currently it is not known how B-cells might interact with BMSCs during fracture repair ((El-Jawhari
et al. 2016). Studies have shown that BMSCs inhibit B-cell proliferation and activation, but functional
consequences and bi-directional interactions have not been demonstrated (Kovach et al. 2015).
Intermediate immune system: T-cell subtypes
T-cell subtypes have been described which are considered intermediary between the innate and
adaptive immune system: gamma-delta T-Cells (γδ T-Cells) and Natural Killer T-cells (NKT-cells).
Evidence regarding the role of γδ T-Cells in fracture repair is mixed. On the one hand, murine studies
have shown γδ T-Cell deficient mice have improved fracture repair due to increased mineralised
matrix production, although one study shows increased cartilage deposition while other work shows
decreased tissue repair (Colburn et al. 2009). Conversely T-Cell Receptor δ Chain knockout (Tcrd-/-)
mice which are also γδ T-Cell deficient show delayed fracture repair due to decreased progenitor
proliferation (Jameson et al. 2002; Ono and Takayanagi 2017). γδ T-Cells may interact with hBMSC
through their role as major producers of Interleukin 17a (IL-17a), a mediator of osteoclastogenesis:
Interleukin 17a knockout (IL-17a-/-) mice show impaired fracture repair as a result of low osteoblast
numbers, which suggests that IL-17a has an apparent role in BMSC differentiation and proliferation
(Ono, Okamoto, et al. 2016).
The role of NKT-cells in fracture repair is relatively unexplored, although work has been done in
other tissues. In the skin, NKT-cell depletion accelerated wound closure and increased collagen
deposition, possibly via TGFβ1 regulation, without influencing immune cell, specifically neutrophil
and monocyte / macrophage, infiltration(Schneider et al. 2011). In the liver, NKT-cells have opposing
effects on fibrosis through production of pro-fibrotic factors, such as IL-4, Interleukin-13 (IL-13)
and osteopontin, and anti-fibrotic factors, such as IFNγ (B. Gao and Radaeva 2013). BMSC appear
to negatively regulate NKT-cell numbers in liver injury, reducing the number of NKT-cells and
preventing NKT-cell mediated hepatotoxicity (Milosavljevic et al. 2017).
Innate immune system
Mast cells and basophils Following fracture, mast cell numbers increase within the callus and
appear to concentrate in the convex side, indicating a possible role in bone resorption during callus
remodelling (Taniguchi 1990). In early repair, mast cells appeared to have a pro-inflammatory role:
mast cell deficient mice showed decreased pro-inflammatory cytokines and bone remodelling and
increased stiffness of regenerated bone compared to wild type mice (Kroner, Kovtun, Messmann,
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et al. 2016). In a c-Kit independent mouse fracture model, mast cells induced both local and
systemic immune response following trauma as well as increasing osteoclastogenesis and activation
via histamine, leading to bone absorption (Kroner, Kovtun, Kemmler, et al. 2017). Excessive numbers
of mast cells, or mastocytosis, results in osteopenia and is a feature of osteoporosis; mast cell numbers
inversely correlate to bone density (Cundy et al. 1987; Frame and Nixon 1968). There is some
indication that mast cells may have an important role in regulating BMSC differentiation during
fracture repair (Ramirez-GarciaLuna et al. 2017). By comparison, very little is known about basophil
contribution to fracture repair: they have striking similarities to mast cells, and so the contributions
may also be similar.
Monocytes and macrophages Monocyte and macrophage infiltration peaks 48 hours post-fracture,
followed by peak lymphocyte infiltration at 72 hours (Pence and Woods 2014). Along with neutrophils,
macrophages are very important in repair pathways, and together with T-helper cells, are one of the
dominant cell types in the haematoma 2 days after formation (Könnecke et al. 2014). Monocytes
and macrophages are primarily circulating phagocytic cells which migrate to sites of damage or
infection where they are involved with cytokine release, immuno-modulation, and debris clearance,
although some macrophages are tissue resident (Geissmann et al. 2010). In addition, monocytes are
able to differentiate into effector cell types during repair, primarily macrophages but also dendritic
cells. Macrophages are arguably the most important cell type derived from monocytes in terms
of fracture repair. They are a highly heterogeneous population of cytokine-producing phagocytic
cells with multiple polarisation subtypes. Aside from their ability to differentiate into macrophages,
monocytes have important roles in fracture repair. During fracture repair, monocytes appear to have
multiple bi-directional interactions with BMSC. In the first place, monocytes are able to recruit BMSC
to fracture sites through Monocyte Chemoattractant Protein 1 (MCP-1) / C-C Motif Chemokine
Receptor 2 (CCR2) signalling (Ishikawa et al. 2014). Following BMSC recruitment, monocytes
appear to contribute to osteogenic differentiation of BMSC within the callus, regulating BMSC
matrix mineralisation, and osteoblast differentiation through Signal Transducer and Activator of
Transcription 3 (STAT3) signalling (Guihard et al. 2018; Nicolaidou et al. 2012). Evidence for
bi-directional interactions in fracture repair comes from the observation that BMSC induce monocytes
to differentiation into macrophages with a reparative and pro-angiogenic M2 phenotype (Guihard
et al. 2018).
Macrophages Macrophage deficient mice show delayed cartilage resorption, poor revascularisation
and lowered endochondral ossification during development (Schlundt, El Khassawna, et al. 2018).
However, local macrophage depletion did not show an effect on early soft callus formation or repair but
instead was more critical in the hard callus (Y. Y. Yu et al. 2012). In addition, the various macrophage
subtypes appear to contribute in different ways to repair. Following fracture, circulating monocytes
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infiltrate, differentiate and polarise into macrophages, which can be broadly grouped into two major
subtypes, each of which can be further subdivided: proinflammatory M1 and immuno-modulatory M2
(Wu et al. 2013). The ratio of M1 : M2 macrophages appears to modulate fracture repair. Macrophages
naturally skew towards the M2 phenotype in fracture repair: if this is enhanced, bone formation is
increased, while M1 enrichment compromises the repair outcome (Schlundt, El Khassawna, et al.
2018).
Similar to monocytes, both M1 and M2 polarised macrophages have been implicated in BMSC
osteoblast differentiation via secretion of BMP-2 and Oncostatin M, as well as recruitment of BMSC
to the injury site through secretion of factors such as CCL2, CXCL8 and SDF-1 (Gu et al. 2017;
Lu et al. 2017; Pajarinen et al. 2018). Both monocytes and macrophages appear to have important
regulatory roles in fracture repair, including controlling BMSC contribution to repair through a variety
of mechanisms.
Dendritic cells Dendritic Cell (DC) contribution to fracture repair appears to be through production
of trophic factors, particularly Dendritic Cell Specific Transmembrane Protein (DC-STAMP) which is
elevated in humans following fracture (Chiu and Ritchlin 2016; Chiu, Sheu, et al. 2015). DC-STAMP
modulates interactions between osteoclasts and osteoblasts, as well as osteoclast differentiation
thereby regulating bone resorption (Chiu, Schwarz, et al. 2017). In a murine fracture model, mice
with a DC-STAMP knock out showed delayed bone repair (Chiu and Ritchlin 2016). Studies in
mice have shown that DCs can differentiate into osteoclasts after interaction with CD4-positive T
helper cells, suggesting a more active role in remodelling (Alnaeeli et al. 2006; Wakkach et al. 2008).
DC-BMSC interactions are less described. DC are known to secrete Interleukin 2 (IL-2) leading to
Th1 differentiation in T cells. This is prevented by IL-10 secretion from BMSC, indicating a potential
regulatory interaction (Kovach et al. 2015).
Neutrophils Neutrophils are the most rapidly recruited cell type following fracture, arriving within
6 hours of fracture (Pence and Woods 2014). On arrival at the site of sterile trauma, they phagocytose
debris and dying cells, and contribute to the initiation of the inflammatory phase (El-Jawhari et al.
2016). Treatment of fracture with TNFα recruits further neutrophils and macrophages, improving
repair (Chan et al. 2015). Further, local depletion of neutrophils prior to fracture in mice resulted
in increased cytokine production and macrophage recruitment leading to decreased bone deposition
and callus strength after 21 days (Kovtun et al. 2016). However, chronic stimulation of trauma with
damage associated molecular patterns resulted in increased scarring due to increased recruitment of
neutrophils and persistent inflammation (Qian et al. 2016). This indicates a critical role for neutrophils
in modulating the inflammatory environment in the early callus and the critical time-dependent nature
of the repair process. Neutrophils also appear to have a physical contribution to fracture repair. A
study in human patients indicated that fibronectin extracellular matrix was synthesised by neutrophils
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in the 48 hours following initial trauma. (Bastian et al. 2016).There is little evidence for direct
neutrophil-BMSC interaction during fracture repair. However, neutrophils may be important in the
recruitment of BMSC; neutrophils secrete CCL2 and CXCL8 in response to fracture environments,
which recruit monocytes and BMSC to the site of damage (Edderkaoui 2017).
Eosinophils Eosinophils are recruited to the fracture by the Th2 response and appear to be involved
with the remodelling phase of bone repair (Chaplin 2010). Along with neutrophils and basophils,
eosinophils express Complement 5a Receptor 1 (C5aR1), the complement 5 receptor. This is a key
stimulator of bone resorption via osteoclastogenesis through the OPG/RANK/RANKL pathway;
upregulation of this receptor impaired fracture healing in a murine model (Bergdolt et al. 2017).
Further, Complement 5 knockout (C5-/-) mice have smaller callus formation and decreased mechanical
strength compared to wild type (Ono and Takayanagi 2017). Eosinophils may contribute to fracture
repair through this pathway. Other than generalised immunomodulatory functions, there is very little
information on the interaction between BMSC and eosinophils during fracture repair.
Natural killer cells The exact contributions of Natural Killer (NK) cells to bone repair are still
not clear; their contribution to fracture repair does not seem to be through their cytotoxic ability,
although they do appear to have a trophic influence. NK cells do appear to have an involvement
with osteoclastogenesis from monocytes through production of RANKL and Macrophage Colony
Stimulating Factor (M-CSF) (Söderström et al. 2010). They are also potent producers of IFNγ and
TNFα, already discussed as important in fracture repair (Chan et al. 2015; Toben et al. 2011). NK
cells have roles in recruiting BMSC to sites of injury, and also prime the BMSC for repair through
their IFNγ production (El-Jawhari et al. 2016). Studies on the direct interactions between BMSC
and NK cells have shown mixed results. On the one hand, some studies have shown that NK cells
have a cytotoxic effect on BMSC ((El-Jawhari et al. 2016), while others suggest that NK cells either
do not lyse or display minimal cytotoxic behaviour towards BMSC (Almeida et al. 2012). Inversely,
BMSC appear to suppress the proliferation, cytotoxic behaviour and cytokine production of NK cells
(Sotiropoulou et al. 2006). This would indicate that BMSC-NK cell interactions are immunoregulatory
and bidirectional, but their exact contributions to fracture are still incompletely understood.
1.6.3 Haematopoietic stem and progenitor cells in fracture repair
Haematopoietic stem and progenitor cells (HSPC) are known to have complex interactions with
BMSC: within the bone marrow niche, interactions between the populations maintain quiescence and
support haematopoiesis (Greenbaum et al. 2013; Méndez-Ferrer et al. 2010; Morrison and Scadden
2014; Walenda et al. 2010). A small pool of HSPC is present in the peripheral blood, with this number
increasing following fracture, indicating a mobilisation response to trauma (Mehrotra et al. 2013)).
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Fracture callus size and bone mineral density was improved in mice injected with AMD3100 (a
CXCR4 antagonist), which mobilises stem and progenitor populations, including endothelial stem
cells, BMSC and HSPC into the blood via the CXCR4 axis (Toupadakis et al. 2013). Once in the blood,
these cell types migrate to sites of damage and may contribute to the improved fracture repair seen in
the mice. At sites of injury, interactions between BMSC and HSPC appear to improve vasculogenesis:
in a co-transplantation study, a gel containing a mix of HSPC and BMSC, or the cells alone, was
implanted subcutaneously into a mouse (Moioli et al. 2008). Gels containing the mixture showed
improved angiogenesis when compared to the single population gels. This would suggest that BMSC
and HSPC have synergistic roles within fracture repair, although the mechanism is not fully known.
1.7 Summary
To summarise, OA is a large and growing health problem, which requires novel repair and regenerative
strategies targeting the early stages of the disease. A group of possible candidate therapies are bone
marrow stimulation techniques, which have been shown to have potential for treating early stage OA
and cartilage defects, but result in repair tissue with suboptimal biomechanical properties and clinical
performance. As a result, while the therapy has promise, greater understanding of the biology of the
repair and regeneration occurring is needed to enable optimisation.
Bone marrow stimulation is based on the intrinsic regenerative properties of BMSC, which are
introduced to the joint surface in a marrow clot during the therapy and assist in the repair and
regeneration of the damaged region. Other therapies are already successfully using BMSC to treat
a diverse range of conditions. BMSC are known to have key roles in fracture repair, although
whether this is through indirect or direct contributions is currently not completely understood. At
any rate, the BMSC within the marrow clot are certain to interact with populations of cells from
the peripheral blood, primarily immune cells, which are trapped within or attracted to the region
of damage. Drawing from research into immune involvement in fracture repair, it is clear that the
interactions, both paracrine and cell-to-cell, between BMSC and peripheral blood / immune cells have
consequences for the outcome of repair, although the knowledge in this area is by no means complete.
Greater understanding of these interactions within the environment of the marrow clot could indicate
targets which could be exploited by therapeutic intervention to improve repair outcomes. This body
of work aimed to increase the understanding of BMSC-peripheral blood cell interactions within the
environment of a marrow clot for osteochondral repair.
The aims of this work were:
1. To isolate robust, well-characterised populations of hBMSCs from human sources under
normoxic and hypoxic culture conditions.
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2. To identify a subpopulation of cells within the peripheral blood inducing significant migration
in hBMSC in hypoxic and/or normoxic conditions
3. To characterise the interactions between NK cells and hBMSCs under normoxic and hypoxic
conditions.




A list of equipment and reagents used may be found in Supplementary data (table A.2,table A.3).
2.1 Cell culture
2.1.1 Human Umbilical Vein Endothelial Cells
Human Umbilical Vein Endothelial Cells (HUVECs) were obtained from Lonza. For basic mainte-
nance, cells were grown in complete HUVEC culture medium (Medium 199 4-(2-Hydroxyethyl)-
piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) (HEPES)
modification, 20 % volume per volume (v/v) Fetal Bovine Serum (FBS), 2 mmol L-Glutamax, 5 µg/ml
Gentamicin, 1.5 µg/ml Amphotericin B, 50 ng/ml Endothelial Cell Growth Supplement (ECGS),
100 ng/ml Heparin) in T-75 flasks coated with 1% v/v Gelatine in Phosphate Buffered Saline (PBS),
pH 7.4, under normoxic culture conditions (Normoxia / normoxic culture conditions: humidified
tissue culture incubator at 37 degrees Celsius (◦C), 5 % carbon dioxide (CO2), 18.6 % oxygen (O2)
(ambient within normoxic incubator)). Initial seeding density was at 2500 cells per square centimetre
(cm2). Cells were passaged at between 80 to 90 % confluence as described in section 2.1.3, unless
cells were at more than 50 % confluence prior to a 72 hour interval between feeds when cells were
passaged at a lower confluence. During feeding or passaging, supernatants were centrifuged at 300
Relative Centrifugal Force (RCF), 5 minutes, room temperature to pellet suspension cells that were
reintroduced to the culture. Excess cells were cryopreserved as described in section 2.1.3 using
HUVEC culture medium with 5 % Dimethyl Sulfoxide (DMSO) instead of Cryopreservation Medium
(FBS, 10 % v/v DMSO).
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2.1.2 Isolation and culture of human primary adherent bone marrow cells
Bone marrow was obtained from total knee replacements from patients aged between 64 to 87
(Average 75.2±9.7 years), both male and female, with consent. The marrow originated in the
medullary cavity and was removed following femoral cuts during prosthetic sizing by the surgical
team. Immediately after extraction, marrow was placed into a tube containing 5 ml of 400 µg/ml
heparin sulphate solution.
Marrow was manually dissociated through 70 µm filters into 50 ml Falcons using a 5 ml syringe
plunger, rinsing with Flow cytometry buffer (PBS with 3 % v/v FBS, and 5 mmol Ethylenediaminete-
traacetic Acid (EDTA)) until no residual pink colouration could be seen. The cells were centrifuged at
300 RCF, 10 minutes, room temperature (spin-washed) and the fat and supernatants discarded. Pellets
were pooled in a fresh 50 ml Falcon tube in Flow cytometry buffer and centrifuged at 300 RCF, 5
minutes, room temperature. This transfer and spin-wash was repeated twice more. Cells were then
counted as described in section 2.1.3 at an appropriate dilution.
Cells were centrifuged at 300 RCF, 5 minutes, room temperature, resuspended in Complete Medium
B (αMEM without nucleosides with 10 % v/v FBS, 2 mmol L-GlutaMAX, 5 µg/ml Gentamicin, and
1.5 µg/ml Amphotericin B, 10 ng/ml Fibroblast Growth Factor 2, and 14 µg/ml L-Ascorbic Acid
Phosphate) and seeded into tissue culture flasks at 1×107 cells/cm2. Flask size and number was
determined by the cell yield. Flasks were maintained under either Normoxic or Hypoxic culture
conditions for 72 hours. The flasks were washed with PBS and complete Medium B was added.
Suspension cells were discarded. This wash step was repeated again after 96 hours. Cultures were
maintained as in section 2.1.3.
2.1.3 Basic cell culture and maintenance
Cells were maintained as follows, unless specified within the relevant subsection.
Full medium changes were performed every 2 to 3 days into the appropriate culture medium. Cells
were grown to between 70 to 80 % confluence before passaging. The flasks were rinsed with PBS and
incubated with 5 ml 1x TrypLE Express for five minutes under either normoxic or hypoxic culture
conditions. Flasks were gently agitated, and culture medium was added and triturated between 5 to 8
times, ensuring that the flask base was thoroughly rinsed. The cell suspension was transferred to a
50 ml Falcon tube and centrifuged at 300 RCF for 5 minutes at room temperature, resuspended in
culture medium and quantified using a disposable haemocytometer, at an appropriate dilution. Three
large squares were counted for each sample, and the average taken. This was accepted only if all
counted values lay within 10 % of the mean, otherwise the count was repeated using a fresh sample.
Calculations were performed as follows:
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cells/ml = cellsaverage ×dilution×104
cellstotal = cells/ml×volumetotal
The same procedure was followed to harvest cells for assays. Cells for assays were taken from all
cultures between passage 2 to 4.
Following counting, an aliquot containing an appropriate number of cells, determined by the seeding
density of the specific cell type as well as the required size of flask was resuspended in an appropriate
volume of culture medium. 6 ml of medium was added to T-25 flasks, 15 ml to T-75 flasks, and 25 ml
to T-175 flasks. Primary adherent bone marrow cells / bone marrow stromal cells were seeded at
2300 cells/cm2 for human culture. Seeding density for other cells are recorded in the relevant section.
Expanded populations were cryopreserved after counting by centrifuging at 300 RCF, 5 minutes, room
temperature and resuspending in Cryopreservation Medium (FBS with 10 % DMSO v/v). Aliquots
were placed into labelled cryovials and frozen between −70 to −80 ◦C (departmental practices changed
the temperature of the freezer from −80 to −70 ◦C during the study) in a CoolCell. After 24 to 48 hours,
cells were transferred to long-term storage either within the −70 to −80 ◦C freezer, or within a liquid
nitrogen storage system at −196 ◦C.
Cells were thawed by immersing the cryovial into a water bath at 37 ◦C until a small piece of ice
remained. 1 ml of culture medium was added to the vial and the contents transferred to a 50 ml Falcon
tube. 8 ml of culture medium was added to the cells over a period of 2 minutes, then 6 ml over a
period of 1 minute. Cultures were centrifuged at 300 RCF, 5 minutes, room temperature and seeded
as previously described within this section for culture.
2.2 Cell characterisation
Cells at 70 to 80 % were used between Passage 1 to 3. Cells were detached and counted as in
section 2.1.3. Images were captured using a standard digital camera, or Leica light microscope at
100x magnification.
2.2.1 Osteogenic differentiation
Osteogenic differentiation in vitro drives bone marrow stromal cells down the osteogenic lineage,
and may lead to osteocyte formation. Regions of mineralisation are commonly identified in vitro
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by Alizarin Red staining; the stain reacts with calcium to form a crimson-red chelation complex.
(Puchtler et al. 1969).
Cells were seeded into T-25 flasks or twelve well plates at 5×103 cells/cm2 in culture medium and
incubated for 2 hours under either normoxic or hypoxic culture conditions. The monolayers were
rinsed with PBS, culture medium was added to control wells, and Osteogenic Medium (DMEM with
high glucose and GlutaMAX with 10 % v/v FBS, 50 µg/ml L-Ascorbic Acid Phosphate Sesquimagnes,
10 mmol β-glycerol phosphate, 10 nmol dexamethasone) was added to test wells. Cultures were
returned to the appropriate incubator and maintained for 21 days, with 50 % medium changes every 2
to 3 days.
After 21 days, cultures were rinsed with PBS and fixed with 10 % weight per volume (w/v) formalin
for 30 minutes. Monolayers were rinsed twice with distilled water and stained with 2 % Alizarin Red
(pH 4.2, w/v, pre-made) for 2 to 3 minutes. The monolayers were rinsed 3 times with distilled water
and imaged.
2.2.2 Chondrogenic differentiation
Chondrogenic differentiation in vitro drives BMSC down the chondrogenic lineage, leading them to
form chondrocytes that produce proteoglycan-rich matrix (Johnstone et al. 1998). Alcian blue staining
binds to glycosaminoglycans resulting in a distinctive blue stain. The name ‘Alcian blue’ refers to a
family of dyes, but generally refers to Alcian Blue 8G and is a polyvalent basic dye based on copper
phthalocyanine (Hayat 1993)
Cells were centrifuged at 300 RCF, 5 minutes, room temperature and resuspended at 1×107 cells/ml.
Five 10 µl droplets of the cell suspension (each containing 1×105 cells) were placed into the wells
of a 12 well plate. Droplets were left for 2 hours under normoxic or hypoxic culture conditions.
In-house Chondrogenesis Medium (DMEM, 100 µg/ml Sodium Pyruvate, 40 µg/ml Proline, 50 mg/ml
ITS+ premix, 5 µg/ml Gentamicin, 1.5 µg/ml Amphotericin B, 10 ng/ml TGFβ1, 0.1 mmol AAP,
100 mmol dexamethasone) was added to test wells, and culture medium to control wells. Cultures
were maintained for 14 days at under normoxic or hypoxic culture conditions, with 50 % medium
changes every 2 to 3 days.
After 14 days, cultures were rinsed with PBS and fixed with 10 % w/v formalin for 30 minutes.
Following fixation, wells were rinsed with PBS and stained overnight with 1 % w/v Alcian Blue in
hydrochloric acid. The following day, wells were rinsed 3 times with 0.1 normality (N) hydrochloric
acid, neutralised with distilled water, and imaged.
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2.2.3 Adipogenic differentiation
Adipogenic differentiation assays push BMSC to differentiate into adipocytes containing lipid droplets
(Scott et al. 2011). Differentiated cells are identified by Oil Red O staining. Oil Red O is a
lysochromic dye related to the diazo Sudan family of dyes (Histopathologic Techniques 2006). The
dye accumulates within lipid droplets in cells, allowing differentiated adipocytes to be visualised.
Cells were then centrifuged at 300 RCF for 5 minutes at room temperature and resuspended in culture
medium. Cells were seeded at 1×105 cells/cm2 (1×104 cells per well) into the wells of a 12 well
plate. Cells were left to attach for 2 hours at 37 ◦C, 5 % CO2 under either normoxic or hypoxic culture
conditions. Stempro Adipogenesis Medium (StemPro Adipocyte Differentiation Basal Medium with
10 % v/v StemPro Adipocyte Differentiation Supplement, 5 µg/ml Gentamicin) was added to test wells,
and culture medium to control wells. Cultures were maintained for 14 days under either normoxic or
hypoxic culture conditions with 50 % medium changes every 2 to 3 days.
After 14 days cultures were rinsed with PBS and fixed with 10 % w/v formalin for 30 minutes. Wells
were rinsed with PBS and incubated for 5 minutes with 60 % v/v Isopropanol in water. Wells were
stained with Oil Red O for 5 minutes. Following staining, wells were rinsed 3 times with distilled
water and imaged.
2.2.4 Colony forming unit fibroblast assay
The Colony Forming Unit (CFU) assay is a method of quantifying the proliferative potential of a cell
population. The ratio of colonies formed per cell seeded is an indication of the proliferation potential
of the cell population.
Cells were centrifuged at 300 RCF for 5 minutes at room temperature, resuspended in culture medium
and seeded at 250 cells per well into six well plate in triplicate. Cells were cultured under normoxic
conditions for 10 days. Following this incubation, cells were stained for histological analysis. Wells
were rinsed twice with PBS and fixed for 20 minutes in 10 % w/v formalin, rinsed twice with PBS and
stained for 30 minutes with 1 % w/v Crystal Violet. Wells were then washed three times with PBS
and imaged. The number of colonies over 2 mm in diameter (approximately 50 cells) was quantified
by visual assessment. CFUs were calculated per thousand cells.
2.2.5 Flow cytometry
Flow cytometry is a method for both counting and categorising cells. Cells were passed through a
flow chamber one at a time, and lasers shone through the cells. The light signals produced were then
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captured by photomultipliers and interpreted to give measurements. Cells were categorised by their
forward and side scatter (that can be equivocated to their respective size and internal granularity)
or by their marker expression that was identified using distinct fluorescently conjugated antibodies.
Multiple fluorescently conjugated antibodies were used simultaneously to phenotype cell populations.
A list of markers used within this thesis and their supposed functions may be found the the Supple-
mentary material (table A.1).
Controls used for flow cytometry were:
• Single stain controls: experimental cells stained with a single fluorophore. One made for each
fluorophore in the panel (see tables 2.1 to 2.5). Used to set up initial experiment voltages the
first time the experiment was run.
• Unstained or negative control: experimental cells with no antibody staining. One made for each
sample. Used to check for auto-fluorescence in the cell population in all experiments.
• Isotype control: experimental cells stained with the isotype control for each fluorophore used
in the experiment: may be individual for single colour, or full panel for multiparametric (see
tables 2.1 to 2.5). One made for each sample and fluorophore (single colour), or sample
(multiparametric). Used to check for non-specific binding within the cell population in all
experiments.
• Compensation controls: beads stained with a single fluorophore. One made for each fluorophore
within the panel (See tables 2.1 to 2.5). Used to correct for spectral overlap within the panel
(see tables 2.1 to 2.5). Used only in multiparametric experiments.
• Fluorescence Minus One controls: experimental cells stained with the full panel of fluorophores
(see tables 2.1 to 2.5) minus one fluorophore. One made for each fluorophore within the panel
(See tables 2.1 to 2.5). Used for correct localisation of positive and negative gating. Used only
in multiparametric experiments as described in tables 2.2 to 2.5.
Cells were detached and counted as outlined in section 2.1.3. A minimum of 5×104 cells were
taken for each sample and centrifuged at 300 RCF for 5 minutes at room temperature. Cells were
resuspended in Flow cytometry buffer. A sample of the cells was put aside for the unstained
control. See tables 2.1 to 2.5 for details of the individual flow panel used. For Panels 3, 4, 5, and
6 (tables 2.2 to 2.5 respectively), excess cells were pooled for Fluorescence Minus One (FMO)
controls. All subsequent steps were performed cold and in the dark to prevent non-specific staining or
bleaching. Centrifugation occurred at room temperature due to equipment restrictions. Stainings and
quantifications were performed in 5 ml polystyrene flow tubes.
FMO controls were also stained with 1 % Zombie Aqua, excepting the Zombie Aqua FMO. Cells
were then centrifuged at 300 RCF for 5 minutes at room temperature in Flow cytometry buffer. As
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Table 2.1 Human characterisation flow cytometry panel
Antibody / fluorochrome Channel / Filter λ (nm)
HLA-DR FITC Blue 530/30
CD73 PerCP EFluor710 Blue 695/40
CD317 PE Yellow 585/15
CD19 Pe-Cy5 Yellow 670/14
CD271 PE-Cy7 Yellow 780/60
CD146 BV421 Violet 450/50
Zombie Aqua Violet 525/50
CD34 BV605 Violet 610/20
CD105 BV650 Violet 660/20
CD45 BV785 Violet 780/60
CD14 APC Red 660/20
CD90 AlexaFluor700 Red 730/45
much supernatant as possible was removed without disturbing the pellet. The pellet was resuspended
in this minimal residual medium and 4 µl Forward Chain Receptor (FCR) block was added to all
samples. Cells were incubated for 10 minutes at 2 to 8 ◦C and Flow cytometry buffer was added to
give a final volume of 100 µl.
Master mixes for each panel were prepared as below using volumes of antibodies determined by titra-
tion. Antibody titration was performed by creating a dilution series based on the initial manufacturer’s
concentration suggestion. For example, a range of 0, 0.5, 1, 2.5, 5, 7.5 and 10 µl antibody per test
was used if the initial suggestion was 5 µl per test. A standardised number of cells was stained for
each concentration in the same method as described above and quantified on the flow cytometer. The
concentration giving the best separation between positive and negative populations was selected. This
was performed for each new batch of antibody, hence concentrations are not given in tables 2.1 to 2.5.
The antibody and isotype master mixes as specified in tables 2.1 to 2.5 were divided equally between
polystyrene flow tubes and the cell samples split equally between them. Where FMO controls were
prepared (tables 2.2 to 2.5), all the antibodies or isotypes were added individually at the volumes
specified, excepting the one corresponding to the control.
Cells were stained for 40 minutes at 2 to 8 ◦C and all samples (including unstained) were centrifuged
at 300 RCF for 5 minutes at room temperature, resuspended in Flow cytometry buffer and filtered
using a CellTrix 70 µm filter. Compensation controls were prepared using Compensation Beads in
PBS with each fluorophore at the volume determined by titration. Samples were transported in the
dark, on ice to the National Institute for Health Research Biomedical Research Centre (NIHR BRC)
Cambridge Phenotyping Hub where quantification was performed using a modified Becton Dickinson
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Table 2.2 Subpopulation screening flow cytometry panel
Antibody / fluorochrome Channel / Filter λ (nm)
CD68 FITC Blue 530/30
CD73 PerCP EFluor710 Blue 695/40
CD133 PE Yellow 585/15
CD16 Pe-Cy5 Yellow 670/14
CD309 PE-Cy7 Yellow 780/60
CD146 BV421 Violet 450/50
Zombie Aqua Violet 525/50
CD34 BV605 Violet 610/20
CD105 BV650 Violet 660/20
CD45 BV785 Violet 780/60
CD14 APC Red 660/20
CD31 AlexaFluor700 Red 730/45
Table 2.3 Monocyte characterisation flow cytometry panel
Antibody / fluorochrome Channel / Filter λ (nm)
HLA-DR FITC Blue 530/30
CD56 PE Yellow 585/15
CD16 Pe-Cy5 Yellow 670/14
CD19 PE-Cy7 Yellow 780/60
CD3 Pacific Blue Violet 450/50
Zombie Aqua Violet 525/50
CD45 BV785 Violet 780/60
CD14 APC Red 660/20
CD31 AlexaFluor700 Red 730/45
Table 2.4 hBMSC – NK cell co-culture phenotyping flow cytometry panel
Antibody / fluorochrome Channel / Filter λ(nm)
HLA-DR FITC Blue 530/30
CD73 PerCP EFluor710 Blue 695/40
CD56 PE Yellow 585/15
CD16 Pe-Cy5 Yellow 670/14
CD19 PE-Cy7 Yellow 780/60
CD3 Pacific Blue Violet 450/50
Zombie Aqua Violet 525/50
CD34 BV605 Violet 610/20
CD105 BV650 Violet 660/20
CD45 BV785 Violet 780/60
CD14 APC Red 660/20
CD90 AlexaFluor700 Red 730/45
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Table 2.5 Monocyte differentiation phenotyping flow cytometry panel
Antibody / fluorochrome Channel / Filter λ (nm)
CD200R FITC Blue 530/30
CD163 PerCp Cy5.5 Blue 695/40
Tie2 PE Yellow 585/15
CD16 Pe-Cy5 Yellow 670/14
CD64 PE-Cy7 Yellow 780/60
CD209 BV421 Violet 450/50
Zombie Aqua Violet 525/50
CD11b BV605 Violet 610/20
CD80 BV650 Violet 660/20
CD45 BV785 Violet 780/60
CD14 APC Red 660/20
CD31 AlexaFluor700 Red 730/45
(BD) Fortessa flow cytometer using the channels specified in the tables above on the FACSDiva
software. Data were analysed using Kaluza v1.2. Graphs were plotted in GraphPad Prism.
A note on nomenclature regarding populations characterised by flow cytometry Throughout
this body of work, populations characterised as positive will be labelled ‘+’ while negative populations
will be labelled ‘−’. Therefore, a population labelled ‘CD56+’ contains cells staining positive for
CD56 and a population labelled ‘CD14−’ contains cells staining negative for CD14, as determined by
gating. The same holds true for populations characterised by multiparametric analysis. A population
labelled ‘CD105+ CD90+ CD45− CD34−’ is positive for both CD105 and CD90, and negative
for CD45 and CD34. This will have been determined by sequential gating so every cell within that
population has that exact marker phenotype. This nomenclature has been chosen to prevent confusion
with cell populations isolated by magnetic activated cell sorting, that are labelled as described in
section 2.3.2.
2.3 Peripheral blood mononuclear cell isolation from peripheral blood
2.3.1 Density gradient centrifugation
Density gradient centrifugation is a technique used to separate mononuclear cells and granulocytes
/ erythrocytes from blood and bone marrow. Fresh, whole blood has a specific gravity of between
1.0590 or 1.0650 g/ml (Trudnowski and Rico 1974). In order of increasing density, the components
of whole blood are plasma, platelets, leukocytes, granulocytes and erythrocytes. By layering diluted
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blood over a density gradient centrifugation medium, here Lymphoprep, and centrifuging the blood
components were separated based on density.
Leukocyte Reduction System (LRS) cones were procured from NHS Blood and Transplant. The
conditions of supply stipulate that LRS cones for research can only be received the day after isolation
from the donor. The contents of the LRS cone were transferred into 150 ml bottles and diluted 10 -fold
in Flow cytometry buffer. The suspension was layered over density gradient centrifugation medium
with a specific gravity of 1.077 g/ml in 50 ml Falcon tubes and centrifuged at 800 RCF for 30 minutes
at room temperature with low brake. Centrifugation took place at room temperature due to equipment
restrictions. The buffy coat, which is buff-coloured and found at the phase interface between the
density gradient centrifugation medium and the serum, was removed using a pastette and pooled
in a fresh 50 ml Falcon. The pooled buffy coat was centrifuged twice in Flow cytometry buffer at
300 RCF for 10 minutes at room temperature. The washed buffy coat was then used in assays or
further processed using Magnetic Activated Cell Sorting (MACS) as described in section 2.3.2.
2.3.2 Subpopulation isolation from buffy coat using magnetic beads
MACS was invented by Miltenyi Biotec. Magnetically labelled cells were run through a column
containing iron particles that is placed inside a powerful magnet. Labelled cells were retained
within the column, while unlabelled cells were washed through. The technique permits isolation of
both labelled and untouched cell populations. Cells were labelled using antibodies against either
specific, single cell surface markers or a cocktail of markers (to negatively label a population). Single
marker antibodies were directly conjugated to superparamagnetic nanoparticles. Cocktail antibodies
were biotinylated and a secondary anti-biotin antibody conjugated to the nanoparticles was used to
magnetically label the cells. The nanoparticles were always conjugated and not free thus their uptake
by phagocytic cell types, potentially resulting in undesirable cell activation, was avoided with this
method.
Cells were isolated using magnetic bead isolation kits from Miltenyi Biotec as below. Throughout,
enriched fractions are labelled ‘enr’ while depleted fractions are labelled ‘dep’. Therefore, a population
designated ‘CD45depCD31enr PBMC’ has undergone a two-step isolation, the first step being a CD45
depletion and the second a CD31 enrichment. In the same way, the population ‘CD45enr PBMC’
has undergone a single step isolation and been enriched for CD45, and the population ‘CD45dep
isolated PBMC’ has been depleted of CD45 positive in a single step. Where a cell marker is specified,
the enriched fraction contains cells directly labelled with an antibody conjugated to a magnetic
nanoparticle, and the depleted fraction contains unlabelled cells. This nomenclature has been chosen
to prevent confusion with cell populations characterised by single-colour or multiparametric flow
cytometry that are labelled as described in section 2.2.5.
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2.3.3 Magnetic activated cell sorting
Magnetic activated cell sorting using kits containing conjugated bead and antibody
Buffy coat cells isolated from LRS cones as described in section 2.3.1 were quantified using a counting
chamber as described in section 2.1.3 and samples were centrifuged at 300 RCF for 5 minutes at room
temperature in a 15 ml Falcon tube. Cells were resuspended and incubated at 4 to 8 ◦C in MACS Buffer
(autoMACS Rinsing buffer, 5 % v/v MACS Bovine Serum Albumin (BSA) Stock solution creates:
PBS, pH 7.2, 0.5 % BSA, 2 mmol EDTA) and conjugated magnetic beads. Where required by the
manufacturer’s instructions, an FCR block was applied to cells and mixed thoroughly prior to magnetic
bead addition. The volumes of MACS Buffer, FCR block (where used) and conjugated magnetic
beads were calculated according to the manufacturer’s instructions as shown in tables 2.6 to 2.8.
Table 2.6 Transwell Panel 1: Primary MACS of PBMC
Kit
Addition per 1×107 cells
(minimum isolation, scaled for larger)




Table 2.7 Transwell Panel 2: Secondary MACS of CD45dep PBMC with CD31 or CD146
Kit
Addition per 1×107 cells
(minimum isolation, scaled for larger)







Suspensions were mixed thoroughly and incubated at 2 to 8 ◦C for 15 minutes. Cells were washed in
1 ml MACS Buffer / 1×107 cells and resuspended in 500 µl MACS buffer / 1×108 cells. Labelled
Table 2.8 Transwell Panel 2: Secondary MACS of CD45dep PBMC with CD34
Kit
Addition per 1×108 cells
(minimum isolation, scaled for larger)





Fig. 2.1 Schematic showing outline of MACS separation
PBMC were labelled with antibodies conjugated to magnetic beads and passed through a pre-sep filter and LS
column held within a magnet. The flow-through, containing the depleted fraction, and the column bound cells,
containing the enriched fraction, were collected.
cells were passed through 30 µm Pre-Sep filters and LS columns pre-wetted with MACS Buffer in a
QuadroMACS, and rinsed 3 times with 3 ml MACS Buffer as shown in fig. 2.1. The column was then
removed from the QuadroMACS and eluted using 5 ml MACS Buffer. Both the flow-through and
column-bound fractions were retained for further use. Where secondary isolations were performed,
the flow-through fraction was used.
Magnetic activated cell sorting using kits containing biotinylated primary cocktail and anti-
biotin bead conjugated secondary antibody
Isolations were performed in exactly the same way as the conjugated bead and antibody method
described above, with the following exceptions:
• Incubation after addition of primary antibody was 5 minutes and not 15 minutes
• Secondary antibody was added after the first incubation (table 2.9) and incubated at 2 to 8 ◦C
for a further 10 minutes (table 2.10)
• There was no wash step: the cell suspension was added directly to the pre-wetted filter / column
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Table 2.9 Direct isolation of NK cells and monocytes from PBMC: first incubation (5 minutes, 2 to
8 ◦C)
Kit
Addition per 1×107 cells
(minimum isolation, scaled for larger)







Table 2.10 Direct isolation of NK cells and monocytes from PBMC: second incubation (10 minutes, 2
to 8 ◦C)
Kit
Addition per 1×107 cells
(minimum isolation, scaled for larger)









Ribonucleic acid extraction from cells: Direct-zol
The Direct-zol method of Ribonucleic Acid (RNA) extraction is based on TRIzol / Tri-Reagent
(brand names: scientific name guanidinium isothiocyanate-phenol-chloroform). The phenol and
guanidinium isothiocyanate denatured proteins, leading to cell lysis, and solubilised organic material.
The chloroform allowed isolation of proteins, Deoxyribonucleic Acid (DNA) and RNA by causing
phase separation. Protein partitioned to the organic phase, DNA to the interface and RNA to the
aqueous phase (Rio et al. 2010). The on-column method in the Direct-zol kit removed the need for
manual fractioning, improving yields by binding RNA from the aqueous phase to a membrane.
The Zymo Research Direct-zol RNA MiniPrep Plus or Microprep Plus kit was used to extract RNA
from cell cultures. Kit reagents were prepared as per manufacturer’s instructions.
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Medium was removed from the culture vessel, cells were rinsed with PBS, lysed using Trizol and
frozen at −70 to −80 ◦C at least overnight in 1.5 ml Eppendorf tubes. Between 350 to 650 µl Trizol
was used, depending on the cell number and as specified by the manufacturer. Cell lysates were
thawed on ice and an equal volume of 100 % molecular-grade ethanol was added and thoroughly
mixed by trituration. The lysate-ethanol mixture was applied onto a spin-column from the kit which
contained a membrane and was housed within a collection tube. The spin-column could contain
a maximum of 700 µl of liquid. Where a greater volume of liquid was present, the addition was
done in separate stages. The spin-column was centrifuged at 14 000 RCF for 30 seconds at room
temperature and the supernatant discarded. The spin-column was washed twice with RNA PreWash
in the same way. The spin-column was then washed at 14 000 RCF for 2 minutes with RNA Wash
Buffer. The spin-column was transferred to an Ribonuclease (RNAse) free tube and eluted with
Deoxyribonuclease (DNAse)/RNAse free water. For the MiniPrep kit, 30 µl of water was used and
15 µl was used for the MicroPrep kit. The RNA was quantified with a Nanodrop5000 and either stored
at −70 to −80 ◦C or used immediately.
Complementary deoxyribonucleic acid reverse transcription
The classical Polymerase Chain Reaction (PCR) cannot be performed using RNA. In order to
measure the transcription levels of messenger Ribonucleic Acid (mRNA) within a sample, a reverse
transcription reaction was performed. A reverse transcriptase enzyme synthesised the first strand
DNA from the single-stranded mRNA using an RNA template and three-prime (3’) complementary
primer. The resulting single-stranded DNA is referred to as complementary Deoxyribonucleic Acid
(cDNA) to identify that it was produced via reverse transcription from mRNA.
cDNA was prepared using the QuantiTect Reverse Transcription Kit according to the manufacturer’s
instructions from RNA isolated as described in section 2.4.1. The kit was thawed at room temperature,
tubes were gently agitated to mix reagents and then a centrifuge was used to pulse-spin the tubes.
Reagents were kept on ice. RNA was thawed on ice, gently agitated, spun down, and then placed
on ice. An aliquot containing the desired quantity of RNA, determined by assay requirements, was
taken for reverse transcription, with a sample also taken to prepare the reverse transcription control.
Reverse transcription was performed as shown in table 2.11 and table 2.12 for up to 1000 ng RNA
in 0.5 ml Eppendorf tubes using reagents supplied with the kit. Where more than 1000 ng RNA was
used, volumes were scaled accordingly. Genomic DNA was removed by adding reagents as specified
in table 2.11, then incubating for 2 minutes at 42 ◦C and placing on ice. Reverse transcription was
performed by adding the reagents at volumes outlined in table 2.12, incubating for 30 minutes at
42 ◦C, then3 minutes at 95 ◦C.
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Table 2.11 Reagent volumes for Genomic Deoxyribonucleic Acid (gDNA) removal from RNA
RNA / reagent Volume µl / 1000 ng
RNA As calculated above




Table 2.12 cDNA master mix volumes
RNA / reagent Volume µl / 1000 ng
Reverse Transcriptase 1 µl
Reverse Transcriptase Buffer 4 µl
Reverse Transcriptase Primer Mix 1 µl
Reverse transcriptase negative controls were produced in the same way, with the reverse transcriptase
substituted for an equal volume of RNAse / DNAse free water. cDNA was either used immediately or
stored at −20 ◦C. Full conversion of RNA to cDNA was assumed.
Reverse Transcription Quantitative Polymerase Chain Reaction
Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) is used to quantify the
transcription levels of mRNA within a sample. It can also be referred to as the Reverse Transcription
Real Time Polymerase Chain Reaction, also given the acronym RT-qPCR. Since RT-qPCR requires
DNA, the mRNA was first reverse transcribed as described in section 2.4.1 to form cDNA, a two-
step method. RT-qPCR could also have been performed in a one-step method where the reverse
transcription and RT-qPCR would have occurred within the same tube. This would have reduced
pipetting steps, time and experimental variation but ultimately would have been less sensitive since
conditions for the reverse transcription and RT-qPCR could not have been individually optimised. The
cDNA produced in the reverse transcription reaction (section 2.4.1) was used as the template for the
RT-qPCR reaction and was detected using specific primer sequences. The copy number of the cDNA
was measured in real time after each amplification cycle (denaturation, annealing, elongation) using
Sybr Green, a fluorescent double-stranded Deoxyribonucleic Acid (dsDNA) binding dye. The cycle
number where the fluorescence generated by the Sybr Green binding to the amplified cDNA passed
the background fluorescence threshold and gave a positive signal is the Cycle Threshold (Ct). The Ct
is inversely proportional to the quantity of target nucleic acid present, allowing quantification of the
transcript within the sample.
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Table 2.13 Primer Sequences for RT-qPCR
Gene Sense (5′–3′) Antisense (3′–5′) Source
CXCL10 TGGCATTCAAGGAGTACCTCTC CGTGGACAAAATTGGCTTGC 1
HIF-1a CCACAGGACAGTACAGGATG TCAAGTCGTGCTGAATAATACC 2
IDO CAAAGGTCATGGAGATGTCC CCACCAATAGAGAGACCAGG 3
IL6 TTCAATGAGGAGACTTGCCTG ACAACAACAATCTGAGGTGCC 4
SDF-1 TCAGCCTGAGCTACAGATGC CTTTAGCTTCGGGTCAATGC 5
VEGFa GAGCCTTGCCTTGCTGCTCTAC CACCAGGGTCTCGATTGGATG 6
FGF-2 N/A N/A Quantitect
B2M N/A N/A Quantitect
Primer sequences were obtained from 1: Marie Sicard (Division of Trauma and Orthopaedic Surgery), 2:
Depoix et al. 2016, 3: Thomas et al. 2007, 4: Deng et al. 2016, 5: Laird et al. 2011, and 6: J. Zhang et al. 2012.
Primers were produced by Integrated DNA Technologies and validated in-house. Primer kits were purchased
through Quantitect.
Table 2.14 RT-qPCR master mix volumes using custom primers
Reagent Volume per sample (µl)
Sybr Green 6
Forward primer (CONC) 0.77
Reverse primer (CONC) 0.77
RNAse / DNAse free water 2.46
Total volume 10
cDNA prepared as in section 2.4.1 was thawed on ice, along with primers and Sybr green, the flicked,
centrifuged at 300 RCF for 5 minutes at room temperature briefly and kept cold. cDNA was diluted
to 5 ng/µl in RNAse / DNAse free water. Master mixes were prepared as described in table 2.14, with
volumes scaled according to number of samples plus 10 % excess. Primer sequences are outlined in
table 2.13.
Custom primers were validated on a serial dilution of cDNA isolated from a cell or tissue source
expressing the gene of interest. cDNA was serially diluted in triplicate at 1:5, 5 times from 100ng/µl
to give six points ranging from 100ng/µl to 0.03ng/µl. Primers were prepared as intable 2.14 and
added to the serially diluted cDNA. The cycling profile was performed as described below. Primers
passed validation if they had a slope of −3.3±0.2, an R2 of > 0.95, an efficiency of (100±10) %,
and the melt curve showed a single, well-defined peak at the same temperature for all points on the
serial dilution.
Following assessment, B2M was selected as the housekeeper for human samples. Reactions were
dispensed into 96 well RT-qPCR plates, sealed and centrifuged at 300 RCF for 1 minute at room
temperature before reading on a Thermo Fisher StepOne Plus Real-Time PCR System.
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Table 2.15 RT-qPCR master mix volumes using pre-made commercial primer kits
Reagent Volume per sample (µl)
Sybr Green 6
Primer mix (conc) 1.25
RNAse / DNAse free water 2.75
Total volume 10
The cycling profile for the RT-qPCR was as follows: 5 minutes at 95 ◦C followed by 40 cycles of
denaturing at 95 ◦C for 10 seconds and combined annealing and extension at 60 ◦C for 30 seconds. A
melt curve was then performed, starting with 15 seconds at 95 ◦C, followed by 1 minute at 65 ◦C and
15 seconds at each increment of 1 ◦C between 65 to 95 ◦C, recording data at each increment. Data
were analysed in Excel and plotted in GraphPad Prism. Calculations were as follows:
∆Ct =CtG −CtH (2.1a)
∆∆Ct = ∆CtS −∆CtR (2.1b)













Low Range = 2−(∆∆Ct+σ∆∆Ct) (2.2c)
High Range = 2−(∆∆Ct−σ∆∆Ct) (2.2d)
Negative Error Bar = 2−(∆∆Ct)−Low Range (2.2e)
Positive Error Bar = High Range−2−(∆∆Ct) (2.2f)
Where:
• ∆ is difference or change
• Ct is the threshold cycle
• G is the gene of interest
• H is the housekeeper gene
• S is the sample of interest
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• R is the reference sample
• σ is the standard deviation
2.4.2 Protein analysis
Preparation of preconditioned medium from PBMC subpopulations
PBMC subpopulations isolated as described in section 2.3.3 were seeded at 2×105 cells per well
of a 12 well plate in Medium C (αMEM, 0.2 % v/v BSA, 2 mmol L-Glutamax, 5 µg/ml Gentamicin,
1.5 µg/ml Amphotericin B) and incubated under hypoxic culture conditions for 16 hours. Suspensions
were passed through a 0.22 µm filter and stored at −20 ◦C for further work.
Chemokine array assay
The Proteome Profiler Human Chemokine Antibody Array (R & D Systems) is based on a dot blot
assay. Capture antibodies were adsorbed on a nitrocellulose membrane in a dot matrix. Samples
were labelled with a detection antibody cocktail and applied to the array. If a specific chemokine was
present, the relevant protein-detection antibody complex formed and bound to its respective capture
antibody. This binding was visualised by staining the membrane with Streptavidin-Horseradish
Peroxidase and chemiluminescent dye and exposing X-ray film to the membranes.
The presence of a subset of chemokines within the supernatant was determined using the R&D
systems Proteome Profiler Human Chemokine Antibody Array kit and following the manufacturer’s
instructions. The list of chemokines detected may be found in table 2.16. Chemokine array membranes
were blocked twice in Array Buffer 6 for 1 hour while rocking at 60 RCF. Preconditioned medium
isolated as described in section 2.4.2 was thawed, an aliquot places within a 1.5 ml Eppendorf tube,
and Array Buffer 6, Array Buffer 4 and Detection Antibody Cocktail were added to each tube as per
manufacturer’s instructions. Tubes were incubated for 1 hour at room temperature.
All buffer was aspirated from the array films and the preconditioned medium-antibody cocktail mix
was added to the membranes. The membranes were incubated on a shaker at 60 RCF overnight at
2 to 8 ◦C. After incubation, the membranes were transferred to a labelled dish containing 1 time
concentration wash buffer prepared according to kit instructions and washed for 10 minutes, rocking
at 60 RCF, three times. Membranes were stained with 1-in-2000 Streptavidin-horseradish peroxidase
for 30 minutes at room temperature in the dark. Finally, membranes were washed 3 times in wash
buffer as before, sealed into pouches and stained with Chemi Reagent Mix prepared as per kit
instructions for 1 minute. Exposures were taken at 1, 3, 5, 8, 10 and 15 minutes onto GE Healthcare
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CCL15/MIP-1 delta/LKN-1 CXCL1/GRO alpha CXCL17/VCC-1
CCL17/TARC CXCL4/PF4 IL-16
CCL18/PARC CXCL5/ENA-78 Midkine
CCL19/MIP-3 beta CXCL7/NAP-2 XCL1/Lymphotactin
CCL20/MIP-3 alpha
Amersham Hyperfilm ECL in a GE Healthcare Amersham Hypercassette Autoradiography Cassette
and developed on a Protec Compact 2 NDT. A film digitiser was used to scan films and images were
analysed using FIJI and Giles Carpentier Protein Array Analyzer for ImageJ.
2.5 Migration assays
2.5.1 Boyden chamber
The Boyden chamber assay (also called the transwell assay) was first described by Stephen Boyden in
1962 for assessing the migration of leukocytes (Boyden 1962). The cell population of interest was
seeded onto a porous membrane held in a cell culture well insert. This insert was suspended in a cell
culture well containing the chemotactic agent and incubated for a defined period of time. At the end
of this time, the membranes were fixed and stained, and migrated cells were quantified.
Transwell inserts for 24 well plates with 8 µm pores were incubated for 30 minutes at room temperature
in FBS and rinsed in PBS. Bone marrow stromal cells isolated and characterised as in section 2.1.2
were detached and counted as in section 2.1.3. 1×104 cells were seeded into each transwell and
allowed to settle at room temperature for 30 minutes in 0.5 ml Medium C.
1×105 of the peripheral blood cells isolated in section 2.3 were added to the wells of 24 well plates.
Negative control wells were prepared in using cell-free Medium C and positive control wells in with
Medium A (DMEM with 10 % v/v FBS, 2 mmol L-GlutaMAX, 5 µg/ml Gentamicin, and 1.5 µg/ml
Amphotericin B). All wells were prepared in triplicate. Transwells containing BMSC were suspended
in the prepared 24 well plate using 2 mm Nitrile-70 O-rings to ensure separation between the transwell
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Fig. 2.2 Ibidi μ-slide 3D chemotaxis assay
The Ibidi μ-slide has three units, allowing three tests per slide. Each unit is composed of two side chambers,
where chemoattractive agents are added, and a central observation channel, containing the migratory cells of
interest. Samples are added through the insertion ports, which can be sealed using rubber plugs.
membrane and the well base. Plates were incubated for 16 hours under normoxic or hypoxic tissue
culture conditions.
After 16 hours transwell inserts were removed from plates, fixed in 10 % v/v formalin, permeabilised
with 0.1 % v/v Triton in PBS and stained for 1 hour in 14.3 mmol 4’,6-diamidino-2-phenylindole
(DAPI), in the dark at 2 to 8 ◦C. Non-migrated cells were physically removed from the interior surface
of the membrane with a cotton bud and the membranes rinsed with PBS. Transwell membranes were
placed into a fresh 24 well plate and kept hydrated in PBS. 3 images were taken of each transwell
membrane on 40x magnification using a DAPI filter on a Nikon Eclipse TI microscope. Images were
sited away from the rim of the transwell to prevent side-scatter influencing the assay. Images were
processed using FIJI.
2.5.2 Real time Ibidi μ-slide 3D chemotaxis assay
The Ibidi μ-slide 3D chemotaxis assay is designed for measurement of chemotaxis. Migration of
adherent cells, or cells within a gel matrix, can be viewed in real time. The bone marrow stromal
cells were seeded into a central observation chamber, and a gradient of potential chemoattractant was
applied over the central chamber by dosing the side chambers with the peripheral blood subpopulations.
This allowed visualisation of the behaviour of individual bone marrow stromal cells in response to
different peripheral blood subpopulations, permitting differentiation between chemotaxis, fugetaxis
and chemokinesis as well as identification of subpopulation effects.
Ibidi μ-Slide Chemotaxis slides and plugs, pipette tips, Medium B and Medium C were equilibrated
under normoxic or hypoxic culture conditions for 24 hours prior to the experiment. Human bone mar-
row stromal cells (hBMSC) were detached and resuspended in Medium B as described in section 2.1.3
at 3×106 cells/ml. 1.8×104 hBMSC were seeded into the central channel using the ports (fig. 2.2).
The ports on the side chambers were kept sealed with plugs during hBMSC addition. To fill a chamber,
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the medium or suspension was dropped onto the addition port. A pipette tip was then inserted into
the removal chamber and an equivalent volume of air for first addition, or medium for subsequent
additions, was aspirated. To avoid bubbles within the chambers, bevelled tips compatible with port
design were used, ports were consistently used for addition of media to, or removal from, the slide,
and the slide was tilted so the addition port was lower than the removal port, to encourage any extra
bubbles to leave the slide. After incubation, the plugs were removed and the hBMSC were allowed to
adhere for 2 hours under normoxic or hypoxic culture conditions in a petri dish kept hydrated with
moistened tissue to minimise evaporation. Plugs were placed back into the side ports, the central
chamber was then washed 3 times with Medium C and then filled with Medium C. Plugs were placed
into the central chamber and removed from one side chamber which was then filled with Medium C as
before. This was repeated with the other side chamber. All chambers were then re-sealed with plugs.
Blood subpopulations isolated as described in section 2.3 were centrifuged at 300 RCF for 5 minutes at
room temperature and resuspended in Medium C at 8.33×105 cells/ml. 2.5×104 blood subpopulation
cells were added to the left-hand chamber in the same way as before. The right-hand chamber was
left containing Medium C only. A positive control was set up by adding Medium B to the left-hand
chamber, while both chambers were left containing Medium C only for the negative control. All
chambers were sealed with plugs.
Migration was imaged on 40 fold magnification, brightfield, every 5 minutes for 16 hours using a
Nikon Eclipse TI microscope with automatic stage and shutter in a heated box kept at 37 ◦C. No
gas control was available; the plugs used to seal the ports were assumed to minimise gas exchange.
Advanced Biology Hamamatsu Legacy image capture software was used to record data. Time-lapse
footage was analysed manually using the MTrackJ Plugin for FIJI (Erik Meijering). 30 individual cells
were tracked every third frame (15 minutes) for the duration of the time-lapse, giving 65 time-points
in total. Cells for tracking were randomly selected, and then checked that they conformed to the
following criteria before tracking:
1. Cells were clearly individually distinguishable throughout the time-lapse
2. Cells did not divide throughout the time-lapse
3. Cells did not leave the observation chamber during the time-lapse
4. Cells did not die during the time-lapse
5. Cells were not within a clump or dense grouping of cells
Data were analysed using the Chemotaxis and Migration Tool from Ibidi and plotted in GraphPad
Prism.
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2.6 Human Bone Marrow Stromal Cell – Natural Killer cell co-cultures
2.6.1 7 day Human Bone Marrow Stromal Cell co-culture with Natural Killer Cells
NK cells were obtained from peripheral blood by magnetic-activated cell sorting as described sec-
tion 2.3.3. Paired characterised normoxic and hypoxic cultured hBMSC isolated as in section 2.1.2
were used. hBMSC were detached and counted as described in section 2.1.3 and 4.5×104 seeded
into the wells of a 48 well plate, then permitted to adhere for 1 hour under normoxic or hypoxic
culture conditions in 50-50 Medium (half-and-half Medium B and Medium E (RPMI-1640, 2 mmol
L-Glutamax, 5 µg/ml Gentamicin, 1.5 µg/ml Amphotericin B)). NK cells were added to the hBMSC at
0, 1, 5, 10 and 15 fold concentration (0, 4.5×104, 2.25×105, 4.5×105 and 6.75×105 cells per well
respectively) in 50-50 Medium. An NK only condition containing 4.5×105 cells was also prepared
in 50-50 Medium. Wells were prepared in quadruplets. 10 µg/ml IL-2 was added to 2 wells for each
condition. Plates were incubated under normoxic or hypoxic conditions for 7 days. After 7 days wells
were imaged using a Leica brightfield microscope, and cells were taken for assay work.
2.6.2 Real-Time Assessment of human bone marrow stromal cell – Natural Killer cell
co-culture dynamics using XCelligence Real Time Cell Analyser
The ACEA Biosystems XCelligence Real Time Cell Analyser Dual Purpose (RTCA DP) E-plate
16 well allows real-time non-invasive monitoring of the dynamics of both cellular proliferation and
death. Gold microelectrodes are fused to the glass internal base of the plates where the cells adhere
(fig. 2.3a). When the plate, while containing culture medium, was placed into the RTCA DP, a
22 mV electrical potential was applied and current was conducted in a saltatory manner between
the electrodes (fig. 2.3b). Following hBMSC addition and adhesion to the plate base, the flow of
electrons between the electrodes was disrupted due to coverage of the electrode by the adhered cells,
resulting in a change in measured current called impedence. The level of impedence was determined
by cell size, number and strength of adhesion to the substrate; NK cells (both IL-2 stimulated and
unstimulated) did not adhere and so did not alter the measured impedence. The output value was Cell
Index, which is the change in impedence relative to the baseline impedence of the electrodes exposed
to medium prior to cellular addition.
The XCelligence RTCA DP machine and Medium B and Medium E were placed into an incubator
under normoxic or hypoxic culture conditions and permitted to equilibrate for 24 hours. Xcelligence
E-plate 16 plates were coated with FBS for 2 hours, rinsed with PBS and allowed to dry overnight
under normoxic or hypoxic culture conditions. 50 µl 50-50 Medium was added to all wells on the
plates and the plates placed into the RTCA DP and blanked to provide a reference impedence value.
hBMSC were detached and counted as described previously (section 2.1.3), and seeded into the wells
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(a) Eplate View
16
(b) XCelligence RTCA DP containing Eplate 16
Fig. 2.3 Xcelligence RTCA DP and associated Eplate
The base of the Eplate 16 View is coated with gold micro-electrodes with a viewing strip to allow visual
inspection of the adhered cell monolayer (fig. 2.3a). Once seeded, the plate is inserted into the XCelligence
RTCA DP, pictured with a plate in the central cradle, which is placed in a tissue culture incubator for the
duration of the experiment (fig. 2.3b).
at 5000 cells per well. For low concentration experiments, NK cells were added at 0, 0.1, 0.2, 1, 5, 10
and 15 fold concentration relative to hBMSC numbers (0, 500, 1000, 5000, 2.5×104, 5×104 and
7.5×104 cells per well respectively) in 50-50 Medium. Wells were prepared in quadruplet and 1
pair of each was treated with 10 µg/ml IL-2. The total volume in each well was 100 µl. Cells were
permitted to settle for 1 hour at room temperature, then placed into the cradles on the XCelligence
RTCA DP machine, ensuring that the plate placed in each cradle was the same plate previously
used to provide a baseline in that cradle. Cell index was recorded at intervals of 5 to 15 minutes for
7 days under normoxic or hypoxic culture conditions. Each condition and set of concentrations was
performed using matched hBMSC strains.
Calculation of area under the real time cell trace curve (AUC) and analysis was performed using
eq. (2.3a), as described in Pan et al. 2013





• AUCx j measured percentage quantification of toxic intensity.
• AUCc represented the cumulative cell proliferation of control. AUCc was calculated by Graph-
Pad Prism for the hBMSC only culture in each condition using the mean Real Time Cell Trace
(RTCT).
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• AUC j represented cumulative cell proliferation of sample. AUC j was calculated by GraphPad
Prism for each condition (oxygen level, NK cell dose, stimulation) using the RTCT.
GraphPad Prism was used to fit a sigmoidal model to the data with the Sigmoidal Dose-Response
Curve (Variable Slope) to show the relationship between exposure and NK cell ratio using eq. (2.4a)





• x represented the NK cell : hBMSC ratio
• p1 represented the bottom of the curve fit, calculated by GraphPad Prism
• p2 represented the top of the curve fit, calculated by GraphPad Prism
• p3 represented the log(EC50), calculated by GraphPad Prism
• EC50 is the half maximal effective concentration
• p4 represented the Hillslope, calculated by GraphPad Prism
The NK cell ratio required to cause a 50 % decrease in the AUCc, the AUC50, showing the cumulative




)−1)∗ p4)+ p3) (2.5a)
2.6.3 CellTox Green
CellTox Green Cytotoxicity Assay is a fluorescent dye-based method of quantifying cell death.
CellTox Green is a “proprietary asymmetric cyanine dye” which fluoresces green when bound to DNA
(Promega 2018). The dye cannot pass through intact cellular and nuclear membranes of viable cells
and therefore viable cells do not influence the fluorescence. However, when these membranes were
disrupted during cell death, the dye was able to penetrate the cell and bind to the DNA, resulting in a
bright punctate signal from the dying or dead cell. This signal could be detected using a fluorescent
microscope to show the locations and numbers of dying cells.
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NK cells and hBMSC were isolated as previously described (section 2.3.3, section 2.1.2). hBMSC
were detached and counted as in section 2.1.3 and seeded at 5×104 cells per well in an 8 well
EZslide in 50-50 Medium equilibrated under normoxic or hypoxic conditions. Cells were allowed to
attach for 1 hour under normoxic or hypoxic culture conditions. NK cells were added at 0 or 10 fold
concentration (0 or 5×105 cells per well). Wells were prepared in quadruplet and 10 µg/ml IL-2 was
added to one pair of wells. 2 extra hBMSC control wells were also prepared: CellTox-free and Lysis
Positive control.
For endpoint experiments, slides were incubated for 72 hours under normoxic or hypoxic culture
conditions. After this point, CellTox Green and Lysis buffer were added. 0.5 µl of CellTox Green per
well was diluted in 10 µl 50-50 Medium per well and 10 µl mixed into all wells except the CellTox-free
control well to give a final dilution of 1-in-200 CellTox Green Dye. Lysis solution (from the CellTox
Green kit) was added into the Lysis Positive control well at a 1-in-50 dilution. Slides were then imaged
on a Nikon Eclipse TI microscope with automatic stage and shutter. Advanced Biology Hamamatsu
Legacy image capture software was used to record data.
2.7 Human bone marrow stromal cell – monocyte co-cultures
2.7.1 Monocyte differentiation
Monocytes were obtained from peripheral blood by magnetic-activated cell sorting as described in
section 2.3.3 and seeded into 6 well plates in Medium E. Wells were left unstimulated, or were treated
for 5 days with 50 ng/ml Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) for classi-
cally activated macrophage (M1) priming, or 50 ng/ml M-CSF for alternatively activated macrophage
(M2) priming. Primed cells were treated for 48 hours with cytokines for final differentiation under the
same conditions. M1 primed cultures were stimulated with 10 ng/ml TNFα and 50 ng/ml IFNγ, and
M2 primed cultures were treated with either 20 ng/ml IL-4 for alternatively activated macrophage type
A (M2a) or 20 ng/ml IL-10 for alternatively activated macrophage type C (M2c) differentiation. After
differentiation, wells were imaged using a Leica brightfield microscope, and differentiated monocytes
used in assays.
2.7.2 hBMSC-monocyte co-cultures
Monocytes and hBMSC isolated as described previously were co-cultured for 7 days at a 1:1 ratio in
50-50 Medium under normoxic or hypoxic culture conditions. Controls of monocyte or hBMSC only
wells were also made. Preconditioned medium was prepared and stored as in section 2.4.2
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Fig. 2.4 Sample image of pseudo-tubule network observed during tube forming assay
Pseudo-tubule network formed by HUVEC seeded onto BME and treated with VEGF, Fibroblast Growth
Factor 2 (FGF-2), Stromal Cell-Derived Factor (SDF) for 12 hours under normoxic conditions. Scale
bar = 100 µm
2.7.3 Endothelial cell tube forming assay
The endothelial cell tube forming assay is used to assess the pro-angiogenic effect of a compound,
cell mixture or supernatant. Endothelial cells with high angiogenic potential, here HUVECs, were
seeded onto a gel matrix, here reduced growth factor Basement Membrane Extract (BME) and treated
with supernatants from monocyte-hBMSC co-cultures. Pro-angiogenic effects could be observed
through the formation of pseudo-tubule networks on the BME by HUVECs in response to stimulation
(fig. 2.4). Characteristics of these networks, such as branching interval or total mesh area, gave an
indication of the presence and relative potency of the pro-angiogenic factors within the supernatants.
BME was thawed slowly on ice. 8 well EZSlide slides were coated with BME and incubated for
30 minutes under normoxic conditions. HUVECs were detached and quantified as described in
section 2.1.1. 2×105 HUVECs were added to each well containing BME in 20 µl 50-50 Medium.
Supernatants isolated from hBMSC-monocyte cultures as in section 2.7.2 were thawed, mixed, and
centrifuged at 14 000 RCF for 5 minutes and the pellet discarded. 200 µl supernatant was added to
all test wells. Control wells contained either 50-50 Medium without cytokines (negative control) or
50-50 Medium with 200 µg/ml VEGF, 100 µg/ml FGF-2 and 100 µg/ml SDF (positive control).
Endpoint experiments were incubated for 12 hours under normoxic conditions, then imaged on a
Nikon Eclipse TI microscope. Advanced Biology Hamamatsu Legacy image capture software was
used to record data.
Gilles Carpentier’s Angiogenesis Analyzer plugin for FIJI was used to analyse data. Graphs were
plotted in GraphPad Prism.
Chapter 3
Isolation and characterisation of hBMSC
under normoxic and hypoxic conditions
3.1 Abstract
Aim: To isolate robust, well-characterised populations of hBMSCs from human sources under
normoxic and hypoxic culture conditions.
Methods: hBMSCs were isolated from human bone marrow taken from donors undergoing total
knee replacement. Paired lines of hBMSCs were prepared from each donor by incubating under
normoxic and hypoxic culture conditions. These lines were characterised using CFU assay, trilineage
differentiation, and flow cytometry.
Results: hBMSCs showed features of hBMSC populations. The isolated hBMSCs had variable
growth. Differentiation potential varied between donors and also oxygen levels. Hypoxic conditions
ablated osteogenic differentiation, while enhancing chondrogenic and adipogenic differentiation.
Characterisation by flow cytometry showed that at least 80 % of the isolated populations were
(CD73+)(CD90+)(CD105+)(CD34−)(CD45−)(CD14−)(CD19−).
Conclusion: Robust populations containing a majority of hBMSCs were isolated in both normoxic
and hypoxic conditions and characterised. The data suggests that current characterisation methods for
BMSC do not encompass hypoxic isolation conditions.
72 Isolation and characterisation of hBMSC
3.2 Introduction
As an early intervention, surgical bone marrow stimulation techniques show promise as a therapy
for cartilage defects and osteoarthritis. However, significant development is required to improve
the biomechanical properties of the regenerated tissue. Studies have suggested that hBMSC are
critical mediators of the repair and regeneration resulting from surgical bone marrow stimulation, with
improved outcomes seen when the surgeries are combined with exogenous hBMSC administration
(Broyles 2017b; Saw 2011, 2013). In addition, alteration of the repair’s immune environment
following surgical bone marrow stimulation, such as by addition of the anti-inflammatory agent
hyaluronic acid, has been shown to improve the outcome of the therapy (K. Lee et al. 2007). Although
the mechanism by which hBMSC contribute to repair is not fully understood, hBMSC are known
to be potent immuno-modulatory cells: interactions between hBMSC and immune cells have been
shown to have significant impact on the repair outcomes following fracture (El-Jawhari et al. 2016;
Nicolaidou et al. 2012; Ramirez-GarciaLuna et al. 2017)
Understanding the significance of the interactions between hBMSC and immune cells could indicate
possible interventions to improve the outcomes of surgical bone marrow stimulation. However, while
the hBMSC niche and the environment of early repair are hypoxic, the majority of studies isolate,
characterise, and study hBMSC under normoxic conditions, or use hypoxic pre-conditioning of
hBMSC isolated under normoxic conditions as a proxy (Faulknor et al. 2017; Hung et al. 2012; Tian
et al. 2013; Yang et al. 2011). At present, the influence of oxygen level during isolation and culture
on hBMSC behaviour is poorly understood.
To allow the examination of hBMSC -immune cell interactions under both normoxic and hypoxic
conditions, strains of hBMSC isolated and cultured under said conditions were required. Further-
more, the strains needed to be well-characterised to allow comparison between this work and work
in the wider literature. In order to achieve this, paired strains were isolated under normoxic and
hypoxic conditions from bone marrow obtained, following informed consent, from patients un-
dergoing total knee arthroplasty. These strains were characterised using the ISCT guidelines for
hBMSC characterisation: 1) the ability to differentiate into adipogenic, chondrogeneic, and osteogenic
lineages; 2) plastic adhesion; 3) colony forming activity; and 4) cell surface marker expression
of (CD73+)(CD90+)(CD105+)(CD34-)(CD45-)(CD14-)(CD19-) as determined by flow cytometry
(Dominici et al. 2006).
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3.3 Results
In order to permit investigation into the interactions between human BMSC and immune cell subpop-
ulations, robust, well-characterised hBMSC populations were required. Bone marrow was obtained
with consent from donors undergoing total knee replacement and strains of adherent bone marrow
cells were isolated from the marrow of each donor under both normoxic and hypoxic conditions.
The phenotypes of the paired isolates were morphologically similar: cells isolated under normoxic
(fig. 3.1a) and hypoxic (fig. 3.1b) conditions both had a fusiform, fibroblastic appearance. Following
isolation, cells subsequently grown under hypoxia appeared to proliferate faster than their counterparts
in normoxia.
(a) Normoxic (b) Hypoxic
Fig. 3.1 Isolated adherent cells from human bone marrow under normoxic and hypoxic conditions
Human adherent bone marrow cells were isolated in Medium B under normoxic (fig. 3.1a) or hypoxic
(fig. 3.1b) conditions from bone marrow extracted during total knee replacement. Cells were washed after
72 hours and cultured for 10 days. N = 15. Scale bar = 100 µm
In total, isolations were attempted from 16 donors, which were numbered sequentially (table 3.1).
Paired isolations under normoxic and hypoxic condition were attempted from all donors received,
aside from HUM-008 where only the hypoxic condition was attempted, due to the small size of the
sample. Of the 16 donors, only 6 yielded paired strains in both normoxic and hypoxic conditions.
Of the remaining 10 donors, 5 did not yield strains under either condition, 1 yielded a strain under
normoxic conditions only, and the remaining 4 donors, including the aforementioned Donor 8, yielded
a strain only under hypoxic conditions.
Eight strains, consisting of paired normoxic and hypoxic strains from the first 4 donors yielding strains
under both conditions, were fully characterised by tripotential differentiation, colony forming unit
assay and flow cytometry. Strains were all isolated at different points and frozen. Characterisation
work was done simultaneously on all strains following thaw. There were clear differences between
the strains isolated from different donors in all criteria.
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Table 3.1 Isolated hBMSC strains from 16 donors
hBMSC were isolated under normoxic and hypoxic conditions from 16 donors. Strains which adhered and
reached 70 to 80 percent confluence after isolation were considered successfully isolated. Y: successful isolation,
N: unsuccessful isolation, *: no isolation attempted due to insufficient volume of bone marrow received.
Trilineage differentiation experiments using the 8 strains showed large variations. 3 out of 4 strains
showed osteogenic differentiation under normoxic conditions (figs. 3.2a, 3.3a and 3.4a), while the
fourth showed none (fig. 3.5a). In contrast, none of the hypoxic strains showed any osteogenic potential
(figs. 3.2b, 3.3b, 3.4b and 3.5b). A preliminary crossover experiment suggested that normoxic strains
differentiated in hypoxia had decreased osteogenic potential, but hypoxic strains differentiated in
normoxia still showed no osteogenesis (Data not shown).
Chondrogenic potential was more consistent, with all strains forming micromasses which stained
with Alcian Blue (figs. 3.2c, 3.2d, 3.3c, 3.3d, 3.4c, 3.4d, 3.5c and 3.5d). These micromasses were
roughly spherical under both normoxia and hypoxia in 2 donors, Donors 1 and 2 (figs. 3.2c, 3.2d,
3.3c and 3.3d) however with Donors 3 and 4 the hypoxic micromasses (figs. 3.4d and 3.5d) were
misshapen, but more spherical than their normoxic counterparts (figs. 3.4c and 3.5c). Donor 4, showed
no adipogenesis under either normoxic or hypoxic conditions (Figure A13e,f). The remaining donors
all had clear adipogenic differentiation, but this was weaker under normoxic (Figure A10e, A11e,
A12e) compared to hypoxic (A10f, A11f, A12f) conditions.
The CFU assay showed further differences between the strains. Both the average CFU potential
and the variability changed between donors (fig. 3.6). Donors 1 and 3 had the highest variability,
while donors 2 and 4 had low variability in both normoxic and hypoxic conditions. A two-way
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(a) Osteogenesis, normoxic (b) Osteogenesis, hypoxic
(c) Chondrogenesis, normoxic (d) Chondrogenesis, hypoxic
(e) Adipogenesis, normoxic (f) Adipogenesis, hypoxic
Fig. 3.2 Tripotential differentiation of isolated adherent cells from human bone marrow under
normoxic and hypoxic conditions from Donor 1
Adherent human bone marrow cells isolated from Donor 1 were differentiated under normoxic (figs. 3.2a, 3.2c
and 3.2e) or hypoxic (figs. 3.2b, 3.2d and 3.2f) conditions corresponding to isolation conditions. Cell
monolayers were driven down the osteogenic lineage for 21 days and stained with 2 % Alizarin Red (figs. 3.2a
and 3.2b). Cell micromasses were driven down the chondrogenic lineage for 14 days and stained with 1 %
Alcian Blue (figs. 3.2c and 3.2d). Cell monolayers were driven down the adipogenic lineage for 14 days and
stained with Oil Red O (figs. 3.2e and 3.2f). N = 3. Scale bar = 100 µm.
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(a) Osteogenesis, normoxic (b) Osteogenesis, hypoxic
(c) Chondrogenesis, normoxic (d) Chondrogenesis, hypoxic
(e) Adipogenesis, normoxic (f) Adipogenesis, hypoxic
Fig. 3.3 Tripotential differentiation of isolated adherent cells from human bone marrow under
normoxic and hypoxic conditions from Donor 2
Adherent human bone marrow cells isolated from Donor 2 were differentiated under normoxic (figs. 3.3a, 3.3c
and 3.3e) or hypoxic (figs. 3.3b, 3.3d and 3.3f) conditions corresponding to isolation conditions. Cell
monolayers were driven down the osteogenic lineage for 21 days and stained with 2 % Alizarin Red (figs. 3.3a
and 3.3b). Cell micromasses were driven down the chondrogenic lineage for 14 days and stained with 1 %
Alcian Blue (figs. 3.3c and 3.3d). Cell monolayers were driven down the adipogenic lineage for 14 days and
stained with Oil Red O (figs. 3.3e and 3.3f). N = 3. Scale bar = 100 µm.
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(a) Osteogenesis, normoxic (b) Osteogenesis, hypoxic
(c) Chondrogenesis, normoxic (d) Chondrogenesis, hypoxic
(e) Adipogenesis, normoxic (f) Adipogenesis, hypoxic
Fig. 3.4 Tripotential differentiation of isolated adherent cells from human bone marrow under
normoxic and hypoxic conditions from Donor 3
Adherent human bone marrow cells isolated from Donor 3 were differentiated under normoxic (figs. 3.4a, 3.4c
and 3.4e) or hypoxic (figs. 3.4b, 3.4d and 3.4f) conditions corresponding to isolation conditions. Cell
monolayers were driven down the osteogenic lineage for 21 days and stained with 2 % Alizarin Red (figs. 3.4a
and 3.4b). Cell micromasses were driven down the chondrogenic lineage for 14 days and stained with 1 %
Alcian Blue (figs. 3.4c and 3.4d). Cell monolayers were driven down the adipogenic lineage for 14 days and
stained with Oil Red O (figs. 3.4e and 3.4f). N = 3. Scale bar = 100 µm.
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(a) Osteogenesis, normoxic (b) Osteogenesis, hypoxic
(c) Chondrogenesis, normoxic (d) Chondrogenesis, hypoxic
(e) Adipogenesis, normoxic (f) Adipogenesis, hypoxic
Fig. 3.5 Tripotential differentiation of isolated adherent cells from human bone marrow under
normoxic and hypoxic conditions from Donor 4
Adherent human bone marrow cells isolated from Donor 4 were differentiated under normoxic (figs. 3.5a, 3.5c
and 3.5e) or hypoxic (figs. 3.5b, 3.5d and 3.5f) conditions corresponding to isolation conditions. Cell
monolayers were driven down the osteogenic lineage for 21 days and stained with 2 % Alizarin Red (figs. 3.5a
and 3.5b). Cell micromasses were driven down the chondrogenic lineage for 14 days and stained with 1 %
Alcian Blue (figs. 3.5c and 3.5d). Cell monolayers were driven down the adipogenic lineage for 14 days and
stained with Oil Red O (figs. 3.5e and 3.5f). N = 3. Scale bar = 100 µm.
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Fig. 3.6 Colony forming unit assay for adherent bone marrow cells from Donors 1, 2, 3 and 4
Adherent bone marrow cells isolated under normoxia and hypoxia from 4 Donors were used in a CFU assay.
Error bars show standard deviation (smaller than symbol for Donor 2). 2-way ANOVA, no significant
interactions. N = 4
Analysis Of Variance (ANOVA) was performed and found there were no statistically significant
differences between CFU activity between normoxic and hypoxic conditions isolated from the same
donor. The CFU activities of the donors can be grouped into 2: 2 donors with higher CFU activity,
but higher variance, and 2 donors with lower CFU activity and less variance. Visual inspection of
the data suggests that Donor 4 had the lower CFU, and that Donor 2 may have had a slightly lower
CFU compared to Donors 1 and 4, but the differences between the variances preclude statistical
comparisons.
The CFU results did not entirely reflect the observed in vitro growth rate of the BMSC, as indicated
by the passage frequency and cell yield on passage. Firstly, the hypoxic cultured BMSC grew more
rapidly than the normoxic culture BMSC and required more frequent splitting. Secondly, although
the CFU for Donors 2 and 4 were similar, the observed passage frequency was not and the colonies
within the CFU assay were larger in Donor 2, compared to Donor 4.
The isolated populations were characterised by multiparametric flow cytometry. Single colour analysis
of the data shows that all strains meet the 95 % positivity threshold for CD73 expression (fig. 3.7a). 5
strains meet the threshold criteria for CD90 (fig. 3.7b), and 4 for (fig. 3.7c). However, with the excep-
tion of 1 donor, Donor 2, at 87 % CD90 positivity, all strains have over 90 % positivity for key BMSC
markers. Aside from 1 donor, Donor 1, for CD14 with around 4 % expression, all strains had less than
2 % expression of each of 4 negative BMSC markers (fig. 3.8): CD34 (fig. 3.8a), CD45 (fig. 3.8b),
CD14 (fig. 3.8c), and CD19 (fig. 3.8d). When multiparametric analysis was performed, the percentage
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of ‘true’ BMSC, indicated by (CD73+)(CD90+)(CD105+)(CD45−)(CD34−)(CD14−)(CD19−)
was between 83 to 94 % (fig. 3.9).
There was no consistent difference in expression between marker expression in hBMSC isolated
under hypoxic or normoxic conditions for any donor. The normoxic condition isolated strains from
Donors 3 and 4 were the closest to having 95 % of cells matching the phenotype (CD73+)(CD90+)-
(CD105+)(CD45−)(CD34−)(CD14−)(CD19−), with the normoxic condition isolated strain from
Donor 2 showing the least number of cells matching the stated phenotype.
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Fig. 3.7 Single colour positive marker analysis of adherent bone marrow cells from Donors 1, 2, 3
and 4 by flow cytometry.
Adherent human bone marrow cells from 4 Donors isolated under normoxia and hypoxia were characterised
according to the ISCT criteria for human MSC using multiparametric flow cytometry. Cells were stained with
fluorescently conjugated antibodies against CD73, CD90, CD105 and treated with a Zombie live-dead stain.
Single-colour positive marker analysis of viable cells is shown using CD73 (fig. 3.7a), CD90 (fig. 3.7b) and
CD105 (fig. 3.7c).
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Fig. 3.8 Single colour negative marker analysis of adherent bone marrow cells from Donors 1, 2, 3
and 4 by flow cytometry.
Adherent human bone marrow cells from 4 Donors isolated under normoxia and hypoxia were characterised
according to the ISCT criteria for human MSC using multiparametric flow cytometry. Cells were stained with
fluorescently conjugated antibodies against CD34, CD45, CD14 and CD19 and treated with a Zombie live-dead
stain. Single-colour negative marker analysis of viable cells is shown using CD34 (fig. 3.8a), CD45 (fig. 3.8b),
CD14 (fig. 3.8c) and CD19 (fig. 3.8d).
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Fig. 3.9 Multiparametric analysis of adherent bone marrow cells from Donors 1, 2, 3 and 4 by flow
cytometry.
Adherent human bone marrow cells from four Donors isolated under normoxia and hypoxia were characterised
according to the ISCT criteria for human MSC using multiparametric flow cytometry. Cells were stained with
fluorescently conjugated antibodies against CD73, CD90, CD105, CD34, CD45, CD14 and CD19 and treated
with a Zombie live-dead stain. Multiparametric analysis was performed using all seven markers.
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3.4 Discussion
In order to be able to compare the interactions between hBMSC and immune cell subpopulations
under normoxic and hypoxic conditions, well-characterised, robust hBMSC populations were required.
Current comparisons of hBMSC phenotype and their response to culture in varying oxygen levels
have generally used hBMSC isolated under normoxic conditions and then exposed to hypoxic
conditions, rather than continuous culture under a single condition (Fink et al. 2008; Hung et al. 2012;
Wagegg et al. 2012; Yang et al. 2011). As a result, hBMSC isolated and cultured under hypoxic
conditions may have experienced different selection pressures compared to those isolated under
normoxic and then preconditioned in hypoxic conditions, with resulting changes in phenotype and
behaviour. Furthermore, constant culture under hypoxic conditions has greater biological relevance
to the conditions experienced in a haematoma or in the bone marrow due to the more comparable
oxygen levels present in these tissue environments. The use of well-characterised, paired populations
of hBMSC isolated from the same donor under normoxic and hypoxic conditions is a defining feature
of this study.
hBMSC were isolated from human bone marrow by tissue adhesion under normoxic (18.6 % oxygen)
and hypoxic (3 % oxygen). Oxygen levels were defined relative to ambient atmospheric levels
within a normoxic incubator at sea level and not to physiological levels) conditions, then cells were
continuously cultured and expanded under the same conditions. It should be noted that oxygen levels
within a normoxic incubator are lower than the usually quoted 21 % due to the humidity within
the incubator; saturation of air with water reduces the partial pressure of oxygen (Wenger et al.
2015). Once expanded, the populations were characterised through a combination of tri-potential
differentiation, colony forming unit assay, and flow cytometry as per the ISCT guidelines (Dominici et
al. 2006). This demonstrated that there were significant differences, not only between donors, but also
between the lines of hBMSC isolated from the same patient under the normoxic or hypoxic condition.
Surface marker expression and colony forming ability were similar between the paired lines, with
colony forming ability showing greater differences between donors than surface marker expression.
However, functional assessment of the hBMSC, as measured by their tripotential differentiation
abilities, showed dramatic differences both between donors and between the lines isolated under
normoxic and hypoxic conditions.
The greatest difference between the two conditions was the loss of osteogenic differentiation potential
in hypoxic cultured lines. In 3 out of the 4 donors assessed, osteogenic differentiation potential was
seen in the normoxic condition line, but not in the hypoxic. The fourth donor, Donor 4, was the
weakest at differentiating and did not show osteogenic potential in either condition. Examination of
the literature to date showed that no other study considered the influence of isolation and constant
culture of hBMSC in hypoxic conditions on osteogenesis; other studies have only used hBMSC
isolated in normoxic conditions and then preconditioned under hypoxic conditions. However, under
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these conditions there is no consensus on the effect of hypoxic conditions on osteogenesis; some
studies show hypoxic conditions enhance osteogenesis, while others show that osteogenesis is ablated
under hypoxic conditions (Hung et al. 2012; Wagegg et al. 2012; Yang et al. 2011). However, the
method and extent of the hypoxia created in these studies varied. Within in vitro biological research,
the term ‘hypoxia’ does not denote a specific oxygen level, merely that the level within the humidified
incubator is lower than ambient atmospheric at sea level (18.6 %), nor is there a single method for
creating hypoxic conditions. In the studies from the literature mentioned above, hypoxic conditions of
1 to 2 % oxygen were either created by nitrogen injection, or induced via chemical methods through
addition of desferrioxamine (DFO) or dimethyloxalylglycine (DMOG) to the culture, but only in cells
which had been previously isolated under normoxic conditions. Chemically-induced hypoxia targets
the Hypoxia Induced Factor 1 alpha (HIF-1α) pathway, while hypoxia via nitrogen injection more
closely mirrors the pathway effects seen in vivo (Yang et al. 2011). Interestingly, DMOG and DFO
appear to have differing effects on osteogenesis; a comparison of DFO and nitrogen injection induced
hypoxia found downregulation of osteogenesis in both cases through inhibition of RUNX-2 by Twist
(Formerly Dermo-1) (TWIST) / HIF-1α, while DMOG treatment appeared to enhance osteogenesis
(L. Ding and Morrison 2013; Yang et al. 2011). This would firstly suggest that the method of
developing hypoxia in the culture system has a strong effect on the outcome. Secondly, hypoxic
conditions generated by nitrogen injection appear to influence osteogenic differentiation in hBMSC
regardless of isolation condition. Performing a cross-over osteogenesis experiment, differentiating
normoxic-isolated hBMSC under hypoxic conditions and vice versa, would indicate whether the
observed effects presented here were a result of transient pathway alteration or due to selection of a
functionally different hBMSC population.
In my study, while less dramatic than the influence seen in the osteogenic differentiation, alterations
were seen in both the adipogenic and chondrogenic differentiation potential of the isolated strains.
For both strains, differentiation was stronger in the hypoxic compared to the normoxic condition,
although adipogenic differentiation was generally poor. While this is widely supported in the case of
chondrogenic differentiation (Adesida et al. 2012; Bornes et al. 2015), there is conflicting evidence
in the wider literature with regard to adipogenic differentiation with both enhancement and down-
regulation of adipogenesis seen in hBMSC in hypoxic compared to normoxic conditions (Fink et al.
2008; Wagegg et al. 2012). Additionally, chondrogenesis was the only characteristic differentiation
exhibited by all lines examined. Statements relating to the strength of the chondrogenic potential
are based upon the sphericity of the micromasses formed by the different lines isolated; in all
cases, the micromasses from hBMSC isolated and differentiated in hypoxic conditioned were more
spherical than those in the paired normoxic treated lines. There was also donor-to-donor variation
in sphericity; donors which showed greater osteogenic potential in the normoxic condition also had
the most spherical micromasses, with the least variation between normoxic and hypoxic conditions.
Differences in sphericity could result from variable chondrogenesis throughout the micromass, either
due to a globally weak chondrogenic phenotype developing, or patchy differentiation due to hBMSC
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subpopulation distribution resulting in uneven matrix deposition. This would result in unequal internal
forces within the micromass, preventing condensation into a sphere and resulting in a misshapen mass.
Despite the fact that adipogenic and chondrogenic differentiation appeared to be enhanced by the
hypoxic isolation and culture conditions of the hBMSC, the two potentials appeared not to be linked;
the donor with the most misshapen micromasses in both normoxic and hypoxic conditions, indicating
weak chondrogenesis, in fact had the strongest adipogenic differentiation in both conditions. The use
of sphericity as a measure of the homogeneity and stability of chondrogenically-differentiated hBMSC
spheroids has been previously documented Bellotti et al. 2016. A more quantitative assessment of
differentiation strength of the chondrogenic cultures, such as DNA or Glycosaminoglycan (GAG)
content alongside immunohistochemistry could give a clearer indication of the source of the variation
in sphericity of the micromasses.
Out of the 8 lines characterised, paired normoxic- and hypoxic-condition isolated hBMSC from 4
donors, only 3 met the ISCT hBMSC criteria for trilineage differentiation potential, all of which
were lines isolated and differentiated under normoxic conditions, although strength of differentiation
did vary between donors (Dominici et al. 2006). The paired hypoxic lines from the same donors all
showed bi-lineage potential, being competent at differentiating down the adipogenic and chondrogenic
lineages. The final donor characterised showed only chondrogenic differentiation potential in both
conditions, being uni-lineage competent. The inhibition of osteogenic differentiation by hypoxic
conditions may have functional significance in the healing cascade. The early trauma site is profoundly
hypoxic due to vascular damage, with increasing oxygenation as a result of re-vascularisation and
increased organisation (Epari et al. 2008; Hirao et al. 2006; Mountziaris and Mikos 2008). In a
fracture, the haematoma is converted to soft callus, composed of unmineralised cartilage, which then
becomes hard callus and ultimately remodelled bone (Einhorn and Gerstenfeld 2015). The increasing
mineralisation progresses in synchronicity with increasing vascularisation, perhaps representing an
intrinsic control mechanism to prevent heterotopic ossification. In this case, enhanced chondrogenesis
and decreased osteogenesis in hypoxic conditions, and the reverse in normoxic conditions, may
indicate a temporal and micro-environment dependent component to hBMSC differentiation ability.
The CFU assay demonstrated that all lines were capable of proliferation and colony forming activity,
There was no significant difference between lines isolated under hypoxic or normoxic conditions from
the same donor, but there were differences between the individual donors. Interestingly, the donor
giving uni-lineage competent lines in normoxic and hypoxic conditions gave the lowest CFU of all the
donors, although the CFU of the remaining 3 donors did not track with their differentiation potential
or strength of observed differentiation. However, observations made during tissue culture indicated
that cultures under hypoxic conditions required more frequent passaging, and that the colonies in
the CFU assay were larger in hypoxic conditions compared to normoxic isolated and cultured lines.
A study using similar hBMSC isolation and culture protocols, including a hypoxic condition of 3 %
oxygen by nitrogen injection, found that lines isolated and cultured under hypoxic conditions had
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measurably higher colony forming activity compared to those isolated and cultured under normoxic
conditions (Adesida et al. 2012). The difference could be in part due to the variability in CFU seen
in the lines in this study, demonstrating the heterogeneity of the population. The study also ran the
CFU assay for 14 days, rather than the 10 days used in this study. Further, the contrasting study used
marrow taken from the iliac crest of patients aged 34 to 62. In this study, marrow was obtained from
the tibial and femoral reamings removed during prosthetic fitting as part of total knee replacement
surgery, with patients being aged 64 to 87. Comparisons of CFU in tibial and iliac crest marrow have
shown that tibial marrow derived hBMSC have lower CFU than those from the iliac crest (Suzuki
et al. 2001). Further, CFU declines with age, particularly in females, although CFU does not appear
to be decreased in marrow from patients with OA when compared to matched healthy individuals
(Muschler et al. 2001; Stiehler et al. 2016). Taken together, this would indicate that the CFU observed
in this study would be expected to have been lower than that in the iliac crest study, and that the effect
of age and donation site may have concealed the variation between normoxic and hypoxic conditions.
Alongside this, the observed passage frequency and cell yield on passage did not necessarily track
with the CFU value, again perhaps related to the donor age or population heterogeneity. Monitoring
of the passage frequency showed that the paired isolates showing trilineage potential in normoxic,
and bi-lineage in hypoxic conditions also had a passage frequency after initial adhesion to tissue
culture plastic of around 5 to 7 days, being slightly lower in the hypoxic compared to the normoxic
condition and varying between donors. To contrast, the paired isolates from the from the fourth donor,
which were only uni-lineage competent, had a passage frequency of greater than 14 days. As a result,
isolates with a passage frequency of more than 7 days were excluded from future experiments. The
variation in differentiation potential and CFU activity might suggest that the populations could be
easily distinguished by cell surface marker analysis using flow cytometry, but this was not the case.
In fact, levels of expression for both positive and negative hBMSC markers as laid out by the ISCT
flow cytometry criteria were fairly similar both between donors and between conditions. However,
only 1 line completely met the criteria, with greater than 95 % expression of CD73, CD90, and
CD105, and less than 2 % expression of CD34, CD45, CD14, and CD19 in single-staining analysis,
and had the highest (CD73+)(CD90+)(CD105+)(CD34−)(CD45−)(CD14−)(CD19−) population
using multiparametric analysis. This line was, in fact, the hypoxic line isolated from the uni-lineage
competent donor. Furthermore, the donor with the lowest adherence to these flow criteria, both in
single-staining and multiparametric analysis was the normoxic trilineage competent line from one
of the donors with strong differentiation seen in each lineage. This might indicate that the marker
expression could have relevance to the behaviour of the hBMSC. In one study, CD90 expression was
found to be reduced on hBMSC in hypoxic conditions, with a correspondingly greater chondrogenic
ability in the cell population (Adesida et al. 2012). However, my study showed that CD90 expression
was slightly increased under hypoxic conditions. At the same time, marker expression has been
seen to be strongly related to passage of hBMSC, with expression levels varying with increasing
passage number (Karim Fekir, Unpublished data, University of Cambridge). Finally, and perhaps
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most importantly, the ISCT criteria are based on hBMSC isolated from the iliac crest of healthy
individuals; while there do not appear to be differences in surface marker expression between tibial
and iliac crest hBMSC, a study has shown that CD90 expression is altered in hBMSC isolated from
patients with OA relative to healthy patients, suggesting differences between diseased and healthy
hBMSC (Narbona-Carceles et al. 2014; Stiehler et al. 2016).
3.4.1 Limitations of the study
This study had several limitations related to donor selection and generation of hypoxia. The conditions
of supply and current ethics surrounding the bone marrow collection limited the information available
about donors undergoing total knee replacement to age and sex. This precluded any possibility of
stratifying or excluding patients, on the basis of information including co-morbidity or medication
usage. As an example, bisphosphonate usage is a common reason for donor exclusion, due to its
influence on hBMSC behaviour (Hu et al. 2016). During this study, all useable donor material
was taken for hBMSC isolation. Due to the age of the donors, bone marrow was extremely fatty,
being primarily comprised of yellow marrow as a result of reconversion in the appendicular skeleton,
although islets of red marrow may have been present (Małkiewicz and Dziedzic 2012). Further, due
to the isolated bone marrow essentially being a by-product of the surgical cuts performed during
prosthetic fitting, the samples contained a mixture of marrow, blood, and some fluids used for washing
the cavity. Sample volume was dependent on the discretion of the surgeon and, in some cases, was
less than 5 ml including blood and other fluids. This means contaminating cell types may have been
present and that the sample may not have contained truly representative populations of the bone
marrow, perhaps with only a small subset being present at time of isolation; losses during adhesion to
tissue culture plastic due to isolation and selection pressures may have resulted in skewed populations.
It should be noted that other cell types in marrow or blood besides hBMSC also have the potential to
adhere to plastic. Additionally, these populations were isolated from elderly patients with advanced
OA. The use of tissue samples from elderly donors undergoing knee replacement is uncommon in
this field, where most studies use tissue from younger donors taken from the iliac crest. Ageing has
been shown to decrease chondrogenesis and adipogenesis, and CFU activity in adipose-derived MSC
and alter hBMSC phenotypes and replicative ability under normoxic conditions, but the influence of
hypoxia on hBMSC from elderly donors with OA has not been examined (Block et al. 2017; Ganguly
et al. 2017; Marędziak et al. 2016). This represents a neglected area of research and therefore my
study is a valuable contribution to the current knowledge.
A further limitation of this study related to the generation of the hypoxic culture condition, a well-
acknowledged source of controversy. As already alluded to, there are a range of methods of generating
hypoxic conditions in vitro. Modification of the oxygen level by nitrogen injection into a specific
incubator was selected for this study due to the ability to select the oxygen level within the incubator,
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and the less artificial, multi-pathway response on the part of the cells. However, oxygen level was
determined by sampling the atmosphere within the incubator and not by peri-cellular measurement of
the oxygen level. Since pericellular oxygen level is highly dependant on cell number and metabolism,
the values given within this thesis refer only to the atmosphere within the incubator and not the oxygen
level experienced by the cells. In addition, equilibration of media in hypoxic environments is slow –
one estimate suggests that it takes 38 minutes for media at a depth of 1.78 mm to equilibrate to a 2 %
oxygen level from external atmospheric levels (Wenger et al. 2015). To try and circumvent this, media
were equilibrated within the incubator prior to use in culture. However, equilibration of bulk media
within a warm environment is sub-optimal for removal of oxygen; a better solution would have been
to bubble nitrogen gas through cold media, which was not possible in this instance due to lack of gas
lines. Further, opening the door of a hypoxic incubator, or removal of the cells for processing rapidly
disrupts the oxygen gradient within the medium, leading to multiple re-oxygenation insults. Due to
the lack of hypoxic chambers for cell processing, this was mitigated where possible through rapid
handling of the cells and use of equilibrated media. It is possible that cells will have been exposed to
fluctuating oxygen levels, which may have had an impact on their biology. Finally, the selection of
the oxygen level used, 3 % oxygen, was based upon a compromised value; ideally, a concentration
of around 1 % would have been used to simulate bone marrow or haematoma conditions (Spencer
et al. 2014). As a result, the hypoxic culture conditions throughout this study have flaws which were
mitigated where possible, and are acknowledged here. Future work would ideally utilise a hypoxic
incubator with the ability to monitor pericellular oxygen levels based on measurement of oxygen levels
found in vivo within microfracture or haematoma environments. In addition, a hypoxic processing
station with the ability to equilibrate media and prevent re-oxygenation insults would permit a more
constant level of hypoxic conditions to be administered and prevent corresponding modification of
the cellular behaviour due to fluctuations when handling cells. It should be remembered that this
limitation was by no means unique to this study, and represents the significant challenges inherent in
attempting to artificially create hypoxic environments.
On a related note, the temperature of the incubator used for hBMSC culture could also be considered a
confounding factor. In line with standardised tissue culture techniques, and as described in all papers
related to hBMSC culture, the incubators were set at 37 ◦C. As discussed in the introduction, this
temperature may not represent the temperature experienced by hBMSC, particularly when isolated
from the extremities, in this case the knee. Human knee intra-articular temperature ranges from 31 to
33 ◦C at rest, increasing during exercise (Becher et al. 2008; Harris and McCroskery 1974). Therefore,
the incubator temperature is 4 to 6 ◦C higher than the potential resting temperature experienced by
tibial or distal femoral hBMSC in-situ when at rest, although it may be close to the temperature within
the knee during exercise. As a result, the culture conditions may mimic prolonged pyrexic conditions,
resulting in increased stress on the hBMSC and therefore an increased risk of abnormal behaviour,
such as early senescence or increased inflammatory response. While many studies do use iliac crest
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isolated hBMSC, which may experience a temperature closer to 37 ◦C, there is a widespread lack of
consideration given to the specific niche conditions of cells in vitro.
3.4.2 Future directions
This study considered the basic ISCT recommended phenotypic characteristics of hBMSC isolated
from the proximal tibial and distal femoral region of a small group of unstratified donors. These
donors were exclusively elderly and had advanced OA, in contrast to the primary group targeted
in micro-fracture, which tends to be younger with focal cartilage defects. Recruitment of younger
donors with less advanced disease would allow comparison between elderly and younger cohorts.
Further, improved stratification of patients would permit identification and exclusion of donors with
co-morbidities or medications which may confound the study, as well as enabling comparisons of the
influence of different factors, such as sex, on hBMSC behaviour.
Additionally, a study making use of a greater range of phenotypic markers might allow greater
identification of differences between the subpopulations. For example, use of additional flow markers
such as CD44, CD146, CD271, and CD29 have been suggested to identify an hBMSC population
(Adesida et al. 2012; W. Chen et al. 2018; James et al. 2015; Sotiropoulou et al. 2006). Use of a greater
number of markers on a well-stratified patient population could assist identification of markers with
functional significance, especially within the hypoxic condition isolated hBMSC. Running crossover
tripotential differentiation experiments would further indicate whether the changes in behaviour seen
in the hBMSC were a result of population selection, and therefore independent of oxygen level, or
were a result of transient inhibition of specific pathways, and therefore reversible by culture in the
opposite condition. Finally, a more comprehensive gene expression analysis could be undertaken,
perhaps using Affymetrix or RNASeq, which would allow a more holistic picture of alterations to
behaviour during hypoxic or normoxic isolation, culture, and differentiation to be elucidated. This
would assist in updating the ISCT recommendations for characterising hBMSC, particularly with
regard to those isolated and cultured under hypoxic conditions.
3.4.3 Summary
Paired hBMSC lines isolated under hypoxic and normoxic conditions from 4 donors were characterised
and shown to have some features consistent with an MSC population as defined by the ISCT, although
adherence to these criteria differed based on donor-to-donor variation and isolation / culture conditions
(See table 3.2). As a result of differences between the ISCT MSC criteria and the findings of this study,
the hBMSC denomination has been adopted. Based on the findings of this study, hBMSC populations
isolated from further donors during this study were characterised solely by multiparametric flow
cytometry and only populations with passage frequencies of less than 7 days were used in experiments.
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Table 3.2 Summary of hBMSC phenotyping
A = adipogenic, C = chondrogenic, O = Osteogenic differentiation. Colony forming activity based on relative
assessment of donors. Flow markers show multiparametric analysis with percentages relating to number of
cells meeting the phenotype (CD73+)(CD90+)(CD105+)(CD45−)(CD34−)(CD14−)(CD19−)
Donor ID Oxygen level Differentiation Colony forming Flow markers
1 HUM001
Normoxic A, C, O Good, but variable 86.3%
Hypoxic A, C Good, but variable 85.0%
2 HUM004
Normoxic A, C, O Good 85.3%
Hypoxic A, C Good 82.7%
3 HUM005
Normoxic A, C, O Good, but variable 87.8%
Hypoxic A, C Good, but variable 88.7%
4 HUM009
Normoxic C Poor 87.9%
Hypoxic C Poor 93.5%
This study has shown that the ISCT guidelines, which are still widely used, do not take into account
cells isolated and cultured under hypoxic conditions, and therefore require updating. This study
supports the finding that hypoxic differentiation conditions inhibit osteogenesis, and adds to the body
of knowledge by suggesting that this is not due to a stress response from a normoxic condition isolated
and cultured population entering a hypoxic condition, but rather an intrinsic inhibitory mechanism.
To conclude, hBMSC isolated from the bone marrow of elderly donors with OA were viable, although
donor-to-donor variation was observable. Furthermore, isolation and culture of hBMSC under hypoxic
conditions did not influence colony forming activity or cell surface markers, but did alter differentiation
ability relative to normoxic conditions. As a result, well-defined strains of hBMSC were isolated for
use in my studies.

Chapter 4
Characterisation of a peripheral blood
subpopulation influencing hBMSC
migration under normoxic and hypoxic
conditions
4.1 Abstract
Aim: To identify a subpopulation of cells within the peripheral blood inducing significant migration
in hBMSC in hypoxic and/or normoxic conditions
Methods: PBMC from leukocyte reduction system cones were fractionated using magnetic activated
cell sorting. The resulting subpopulations were used in Boyden Chamber and real-time migration
assays in normoxic and hypoxic conditions. The subpopulation causing the greatest migration
compared to its partner was characterised through protein expression, cell surface marker expression,
differentiation, and co-culture assays.
Results: The subpopulation inducing the greatest migration was the CD45depCD31enr population.
This population secreted proteins which appeared monocytic but did not respond to monocyte
differentiation stimuli. Flow cytometry demonstrated that the subpopulation had a (CD56+)(CD16+)-
(CD3−)(CD19−) identity, indicating NK cells. Co-cultures of these cells with hBMSC and IL-2
resulted in an increased level of cell death in the hBMSC population.
Conclusion: The subpopulation inducing the greatest difference in migration compared to its paired
opposite was characterised as being an NK cell subpopulation.
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4.2 Introduction
The outcome of repair following trauma is heavily dependent on the cellular profile of the damaged
region, a phenomenon seen in many studies. For example, ablation of the adaptive immune system
is associated with improved fracture repair, while macrophage depletion leads to delayed and poor-
quality bone repair and hBMSC administration can enhance healing of large bone defects (Y. Chen
et al. 2017; Dupont et al. 2010; Petri et al. 2013; Schlundt, El Khassawna, et al. 2018; Toben et al.
2011). Furthermore, being strongly immuno-modulatory, hBMSC are known to have bi-directional
interactions with many components of the immune system with consequences for the outcome of
the repair. As an example, interactions with monocytes during fracture repair induce osteoblastic
differentiation and matrix mineralisation by hBMSC, while interactions between HSPC and hBMSC
promote vascularisation (Guihard et al. 2018; Moioli et al. 2008; Nicolaidou et al. 2012). In addition,
hBMSC appear to have an anti-fibrotic effect through their regulation of the immune response: this is
highly desirable in the case of surgical bone marrow stimulation, where reduction of fibrocartilage
formation in favour of hyaline cartilage is critical to improving the outcome of the therapy (Phinney
and Pittenger 2018). While paracrine signalling pathways play a role in these interactions, direct
contact between cell types has been shown to mediate many of the responses. As a result, cell-to-cell
interactions between hBMSC and components of the immune system are likely to have a powerful
role in determining the outcome of a repair.
Both hBMSC and immune cells are highly migratory, and rapidly home to sites of damage, such
as that caused by surgical bone marrow stimulation (Geissmann et al. 2010; Granero-Moltó et al.
2009). While this has been extensively studied, the partitioning of the cells within the damaged region,
and the consequences thereof, are less well understood. In this work, the uni-directional recruitment
of hBMSC from the bone marrow to the site of the surgically induced repair by immune cells was
modelled. It was postulated that hBMSC would be recruited to the site of damage by the immune
cells, resulting in co-localisation of the hBMSC and the recruiting cell type. In this case, the hBMSC
would partition with the immune cell type producing the most powerful migratory response and,
as a result, the hBMSC would therefore interact with said recruiting cells in a cell-to-cell manner,
thereby indicating a common or significant interaction occurring in the repair site. This chapter
aimed to identify a subpopulation of immune cells resulting in migration of hBMSC under normoxic
and hypoxic conditions as a prelude to characterising the interaction between the hBMSC and the
identified migration-inducing cell type.
In order to achieve the aim of this chapter, the hBMSC which had been isolated and characterised in
the previous chapter were exposed in a paracrine system to peripheral blood populations fractionated
using magnetic activated sorting. Sequential sorting was used to screen populations and identify the




Throughout this section, the subscript ‘enr’ refers to PBMC which have been enriched by MACS for a
specific marker, and the subscript ‘dep’ likewise refers to populations depleted for a specific marker by
the same method. Markers in brackets, such as (CD45+) or (CD16−) refer to cell surface marker
expression as determined by flow cytometry.
4.3.1 Transwell part 1
PBMC were isolated from LRS cones by density gradient centrifugation and collection of the buffy
coat. The PBMC were fractionated using magnetic bead activated cell sorting. Paired samples
containing the enriched and depleted fractions were isolated from the same sample. The first transwell
panel compared the migration of hBMSC in hypoxic and normoxic conditions when exposed to
unfractionated PBMC, and CD45enr and CD45dep PBMC (fig. 4.1). Responses to PBMC were
variable, although normoxic hBMSC seemed to have more consistently increased migration compared
to hypoxic hBMSC, however this did not reach statistical significance (fig. 4.1a). The CD45dep PBMC
appeared to induce greater hBMSC migration in both normoxic and hypoxic conditions, but statistical
analysis using a paired T-test showed that this was only significant in the hypoxic condition (p < 0.05)
(fig. 4.1b).
Fig. 4.1 Migration of BMSC across transwell membranes when in paracrine culture with peripheral
blood subpopulations isolated using Panel 1
Results were scaled so negative control = 0 and positive control = 1 (dotted lines on graphs). Variance is not
shown due to use of scaling. BMSC were co-cultured with PBMC (fig. 4.1a) or CD45 enriched and depleted
PBMC subpopulation (fig. 4.1b). A, B, C, and D refer to biological replicates using different BMSC donors
and separate isolations of PBMC (fig. 4.1a) or CD45enr/dep PBMC (fig. 4.1b). Statistical analysis showed that in
hypoxic condition, CD45dep isolated subpopulation stimulated greater migration than CD45enr (Paired T-test,
p < 0.05). No significance seen in normoxic condition. N = 4.
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4.3.2 Transwell part 2
As the CD45dep PBMC were found to be of interest, this fraction was further divided by a second
round of MACS isolation, using CD31 (fig. 4.2a), CD34 (fig. 4.2b) and CD146 (fig. 4.2c) enriched and
depleted fractions as the most likely candidates. Due to the low yields from the double-step isolation,
the transwell assay could only be repeated in the hypoxic condition. None of the differences between
the conditions were statistically significant (paired T-test), although trends in the data indicated that
the CD45depCD31enr and CD45depCD146enr PBMC may have caused greater migration in the hBMSC
than their paired opposites.
Due to the limitations of Boyden chamber migration assays, these conditions were taken forward to a
system capable of recording more aspects of migration: the Ibidi μ slide 3D. Since lower numbers
of PBMC were required, both normoxic and hypoxic conditions could be used. Here, illustrative
results from a single experiment will be discussed. The greatest differences were seen with the
CD45depCD31dep/enr populations (fig. 4.3). In both hypoxia (figs. 4.3a and 4.3c) and normoxia
(figs. 4.3b and 4.3d), hBMSC exposed to the CD45depCD31enr population moved further from their
original starting point (figs. 4.3a and 4.3b) compared to those exposed to the CD45depCD31dep
population (figs. 4.3c and 4.3d). While the CD45depCD31dep exposed hBMSC clustered around the
origin, the CD45depCD31enr exposed hBMSC had much greater spread, with a possible increased
distribution left of the origin, towards the chamber containing the CD45depCD31enr PBMC, with the
gradient indicated by fig. 4.3e.
By contrast, there was much less difference between migration of the hBMSC exposed to the enriched
and depleted fractions of the CD45depCD146dep/enr PBMC (fig. 4.4). All populations, whether hypoxic
(figs. 4.4a and 4.4c) or normoxic (figs. 4.4b and 4.4d) were clustered around the origin. Distribution
of the cells appeared to be roughly central, although there was greater spread and a possible left-wards
shift towards the chamber containing the CD45depCD146enr PBMC (fig. 4.4e) for the hBMSC exposed
to the CD45depCD146enr PBMC in normoxia (fig. 4.4b).
Analysis of the velocity of hBMSC in the real-time tracing experiment showed a difference between
cell PBMC only in the hypoxic condition (fig. 4.5). The CD45depCD31enr PBMC induced a greater
migration velocity in the hBMSC than the CD45depCD31dep PBMC, with no difference seen in the
normoxic condition (two-way ANOVA with Tukey’s post hoc test; fig. 4.5a). Further, the migra-
tion velocity stimulated by the CD45depCD31enr PBMC in the hBMSC was greater under hypoxic
compared to normoxic conditions. The same analysis showed that the CD45depCD146dep PBMC
induced a higher migration velocity in the hBMSC than the CD45depCD146enr PBMC in hypoxia,
but again no difference was seen in the normoxic condition (fig. 4.5b). In both cases, differences in
migration velocity were marginal, and velocity was similar between both the CD45depCD31dep/enr and
CD45depCD146dep/enr PBMC.
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Fig. 4.2 Migration of BMSC across transwell membrane when in paracrine culture with peripheral
blood subpopulations isolated using Panel 2
PBMCs were isolated from LRS cones by lymphoprep and run through a two-step magnetic-activated cell
sorting protocol. BMSC were permitted to migrate across a transwell membrane for 16 hours under hypoxic
conditions while in paracrine culture with blood subpopulations, then migrated cells were stained, imaged and
quantified. Results were scaled so negative control = 0 and positive control = 1 (dotted lines on graphs). BMSC
were co-cultured with CD45depCD31enr/dep (fig. 4.2a), CD45depCD34enr/dep (fig. 4.2b) and
CD45depCD146enr/dep (fig. 4.2c) PBMC. Variance is not shown due to use of scaling. A, B, and C refer to
biological replicates using different BMSC donors and separate isolations of PBMC (fig. 4.1a) or CD45enr/dep
PBMC (fig. 4.1b). Statistical analysis (paired t-test, p < 0.05) did not show significant differences between any
pairing. N = 3.
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(a) Hypoxic CD45depCD31enr PBMC (b) Normoxic CD45depCD31enr PBMC
(c) Hypoxic CD45depCD31dep PBMC (d) Normoxic CD45depCD31dep PBMC
(e) Direction of gradient
Fig. 4.3 Raw traces for BMSC migrating in response to CD45depCD31enr/dep PBMC in normoxia and
hypoxia
BMSC isolated under normoxic or hypoxic conditions were seeded into the central chamber of an Ibidi μ slide
3D. CD45depCD31enr and CD45depCD31dep PBMC were placed into a side chamber, creating a gradient of
secreted factors across the BMSC. Migration of 30 BMSC was tracked for 16 hours and data analysed. Dots
show relative end points of cell movements from a normalized start point (0,0). Location of maximum
concentration: (0,−300), minimum: (0,300). Example data, N = 3
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(a) Hypoxic CD45depCD146enr PBMC (b) Normoxic CD45depCD146enr PBMC
(c) Hypoxic CD45depCD146dep PBMC (d) Normoxic CD45depCD146dep PBMC
(e) Direction of gradient
Fig. 4.4 Raw traces for BMSC migrating in response to CD45depCD146enr/dep PBMC in normoxia
and hypoxia
BMSC isolated under normoxic or hypoxic conditions were seeded into the central chamber of an Ibidi μ slide
3D. CD45depCD146enr and CD45depCD146dep PBMC were placed into a side chamber, creating a gradient of
secreted factors across the BMSC. Migration of 30 BMSC was tracked for 16 hours and data analysed. Dots
show relative end points of cell movements from a normalized start point (0,0). Location of maximum
concentration: (0,−300), minimum: (0,300). Example data, N = 3
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Fig. 4.5 Real-time tracing analysis of BMSC migration velocity in response to CD45depCD31enr/dep
and CD45depCD146enr/dep PBMC
Analysis of real time tracing showing BMSC migration velocity in response to CD45depCD31enr/dep (fig. 4.5a)
or CD45depCD146enr/dep (fig. 4.5b) PBMC in normoxic and hypoxic conditions. Two-way ANOVA with
Tukey’s post hoc test, p < 0.05. N = 3, 30 tracks per replicate
Fig. 4.6 Real-time tracing analysis of BMSC migration directness in response to CD45depCD31enr/dep
and CD45depCD146enr/dep PBMC
Analysis of real time tracing showing BMSC migration directness in response to CD45depCD31enr/dep
(fig. 4.6a) or CD45depCD146enr/dep (fig. 4.6b) PBMC in normoxic and hypoxic conditions. Two-way ANOVA
with Tukey’s post hoc test, p < 0.05. N = 3, 30 tracks per replicate
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There were clear differences between the directness of migration, i.e. the ratio between total dis-
tance travelled and linear distance from the origin, stimulated by the CD45depCD31dep/enr and the
CD45depCD146dep/enr populations (fig. 4.6). The CD45depCD31enr PBMC stimulated migration of the
hBMSC with significantly greater directness under both normoxic and hypoxic conditions compared
to the CD45depCD31dep PBMC (fig. 4.6a). The directness of hBMSC migration was higher in the
normoxic condition, as opposed to the hypoxic condition, with the CD45depCD31enr PBMC. To
contrast, there were no significant differences between the directness of migration of the hBMSC
under either normoxic or hypoxic condition with the CD45depCD146enr and CD45depCD146dep PBMC
(fig. 4.6b). The directness of migration stimulated by the CD45depCD31enr PBMC was greater than
that stimulated by either the CD45depCD146enr or CD45depCD146dep PBMC. As a result, it was
concluded that the CD45depCD31enr PBMC identified as having a greater role in stimulating hBMSC
migration than its paired negative, or the CD45depCD146dep/enr isolated PBMC and was taken forward
for characterisation.
4.3.3 Characterisation of CD45depCD31enr PBMC
Identification of secreted chemokines can indicate cell identity. Supernatants were taken from the
CD45depCD31enr PBMC and used in a Proteome Profile Human Chemokine array (fig. 4.7). The
strongest signals from the CD45depCD31enr double-step population were SDF-1, Macrophage Derived
Cytokine (MDC) and IFNγ-inducible protein 10 (IP-10), also known as C-X-C motif chemokine
Ligand 10 (CXCL10) expression with lower Chemerin and Macrophage Inflammatory Protein 3 beta
(MIP-3b) levels, indicative of a monocyte population.
A screening panel based on the protein secretion data and expected cell phenotypes due to the double-
step isolation method was used to characterise the cell populations (fig. 4.8). Single colour analysis
demonstrated that the CD45depCD31enr PBMC was in fact over 50 % positive for CD45, and over 40 %
positive for CD16 with less than 10 % expression of CD31 (fig. 4.8a). Expression of other markers was
less than 3 %. Considering the CD16 and CD45 positive cells further, 21.5 % were (CD45+)(CD16+),
20.1 % were (CD45+)(CD16−), but the majority (58.4 %) were (CD45+)(CD16+) (fig. 4.8b). Of
the (CD45+)(CD16+) population, over 97.5 % were negative for CD31 (fig. 4.8c). The greatest
concentration of CD31 positive cells was found within the dead cell fraction (data not shown).
Characterisation by flow cytometry indicated a myeloid origin for the CD45depCD31enr PBMC. To
confirm this, a macrophage differentiation assay was run using monocytes isolated using MACS Pan
Monocyte isolation kit (figs. 4.9a and 4.9c), and the CD45depCD31enr PBMC (figs. 4.9b and 4.9d).
Cells were exposed to GM-CSF to stimulate M1 macrophage differentiation (figs. 4.9a and 4.9b) and
M-CSF to stimulate M2 macrophage differentiation (figs. 4.9c and 4.9d) for 5 days under hypoxic
conditions. Monocytes exposed to GM-CSF became adherent with a rounded, M1-like morphology
(fig. 4.9a), while those exposed to M-CSF had a fusiform, adherent phenotype consistent with an
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Fig. 4.7 Proteome profiler Human Chemokine array blot using CD45depCD31enr PBMC
16 hour hypoxic supernatants from CD45depCD31enr PBMC were applied to the Proteome Profiler Human
Chemokine Array. Hits with an intensity of greater then 30 000 were taken. N = 2.
M2-like morphology (fig. 4.9c). The CD45depCD31enr PBMC did not respond to either GM-CSF
(fig. 4.9b) or M-CSF (fig. 4.9d) and instead all cells within these cultures died.
Further multiparametric flow characterisation using a monocyte-specific panel demonstrated that
cells isolated from the LRS cone using the Pan Monocyte kit had a typical monocyte distribution of
(HLA-DR+)(CD56−)(CD3−)(CD19−) cells with CD14/CD16 markers giving the expected 80:5:15
ratio of Classical : Intermediate : Non-classical monocytes (fig. 4.10a). However, the same panel
run on the CD45depCD31enr cells showed that there were fewer than 1 % monocytes within the
population (fig. 4.10b). Further analysis showed that the double-step population had strong staining
for CD56 and CD16 (fig. 4.11a). Of cells expressing CD56 and CD16, over 83 % were double positive
(CD56+)(CD16+) cells. This double positive population was negative for both CD3 (fig. 4.11b)
and CD31 (fig. 4.11c). Again, CD31 positive staining was found only within the dead cell fraction
(data not shown). This (CD56+)(CD16+)(CD3−)(CD19−) phenotype suggested the possibility of
a NK cell identity. Deeper examination of the flow cytometric characterisation allowed subdivision
of the NK cell population into the five classical NK cell subpopulations based on CD56 and CD16
expression (fig. 4.12). The majority of NK cells were (CD56dim)(CD16bright) at over 87 % expression
(table 4.1). (CD56bright)(CD16−) NK cells made over 6 % of the population, with the remaining
NK cells being split between (CD56bright)(CD16dim), (CD56dim)(CD16−), and (CD56−)(CD16bright)
resulting in 8.46 % of cells being (CD56bright).
To further examine the NK phenotype, co-cultures of CD45depCD31enr PBMC and hBMSC were




Fig. 4.8 Flow screening panel for CD45depCD31enr PBMC
CD45depCD31enr double-step isolated PBMC were characterised using a 10 colour plus viability
multiparametric flow cytometry panel immediately after isolation. Results were assessed by single colour
(fig. 4.8a) and multiparametric (figs. 4.8b and 4.8c) analysis, showing that 58.37 % of cells were
(CD45+)(CD16+) and of those, 97.53 % were (CD31−), resulting in a majority population
(CD45+)(CD16+)(CD31−).
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(a) Monocytes with GM-CSF (b) CD45depCD31enr PBMC with GM-CSF
(c) Monocytes with M-CSF (d) CD45depCD31enr PBMC with M-CSF
Fig. 4.9 Stimulation of magnetically separated peripheral blood fractions with GM-CSF and M-CSF
Peripheral blood fractions were stimulated for 5 days with either GM-CSF (figs. 4.9a and 4.9b) or M-CSF
(figs. 4.9c and 4.9d) under hypoxic conditions. Fractions used were Monocytes (figs. 4.9a and 4.9c) using the
Pan Monocyte MACS kit, and CD45depCD31enr PBMC (figs. 4.9b and 4.9d) using the CD45 and CD31 MACS
kits. N = 3. Scale bar = 100 µm
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Fig. 4.10 Comparison of monocytes and CD45depCD31enr PBMC using monocyte characterisation
panel
Monocytes were isolated using the Miltenyi MACS Pan Monocyte isolation kit, and CD45depCD31enr PBMC
using the Miltenyi MACS CD45 and CD31 kits. Cells were characterised immediately using a flow panel
designed for monocyte characterisation containing fluorescently conjugated antibodies against HLA-DR,
CD19, CD56, CD3, CD14 and CD16 (Mukherjee et al. 2015). Cells were characterised as using Boolean
gating and then assessed to characterise monocyte subpopulation distribution. Both monocytes (fig. 4.10a) and
CD45depCD31enr PBMC (fig. 4.10b) were characterised.
culture conditions. Solo cultures of CD45depCD31enr PBMC contained more phase bright cells when
treated with IL-2 in both hypoxic (fig. 4.13a) and normoxic (fig. 4.14a) conditions compared to
untreated (fig. 4.13b and fig. 4.14b respectively), suggesting increased viability of cells. Co-cultures
of hBMSC and CD45depCD31enr PBMC with IL-2 under both hypoxic (fig. 4.13c) and normoxic
(fig. 4.14c) conditions contained clumps of floating debris, which were not visible in co-cultures
without IL-2 (fig. 4.13d and fig. 4.14d respectively). Significantly more debris can be seen in both
normoxic co-cultures (figs. 4.14c and 4.14d) than in the hypoxic co-cultures (figs. 4.13c and 4.13d).
Cellular morphology in normoxic co-cultures treated with IL-2 is poorer than those without, with cells
having a more senescent appearance and lower confluence. There was no apparent difference between
hBMSC cultured with IL-2 under hypoxic (fig. 4.13e) or normoxic conditions (fig. 4.14e), and those
cultured without IL-2 (fig. 4.13f and fig. 4.14f respectively). Thus, IL-2 activated the CD45depCD31enr
PBMC to induce cell death in hBMSC.
There were no visible differences between phase bright cells in CD45depCD31enr PBMC cultures
with (fig. 4.14a) or without IL-2 (fig. 4.14b). BMSC morphology appeared poorer in co-cultures
with CD45depCD31enr PBMC , although more clumps of debris were visible in cultures with IL-2
(fig. 4.14c) than those without (fig. 4.14d). No difference was visible between BMSC grown with
(fig. 4.14e) and without (fig. 4.14f) IL-2. N = 3.
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(a)
(b) (c)
Fig. 4.11 CD45depCD31enr PBMC characterised using alternative gating on monocyte
characterisation panel
CD45depCD31enr PBMC were analysed using a novel gating strategy. CD56 and CD16 positive cells were
examined for double-positive staining (fig. 4.11a). The double positive cells were then tested for CD3 and
CD14 staining (fig. 4.11b), and then finally for CD31 positive staining (fig. 4.11c).
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Fig. 4.12 NK cell subtype analysis of CD45depCD31enr PBMC






Percentages can be found in table 4.1.
Table 4.1 NK cell subtype abundance of CD45depCD31enr PBMC, NK cell subtypes as gated in
fig. 4.12 expressed as a percentage of total NK cell present based on five major subtypes.
Subset Percentage of NK cells Percentage of CD56bright
(CD56bright)(CD16−) 6.09 % 72.20 %
(CD56bright)(cd16dim) 2.35 % 27.80 %
(CD56dim)(CD16−) 2.01 % n/a
(CD56dim)(cd16bright) 87.01 % n/a
(CD56−)(CD16bright) 2.54 % n/a
The average cell yield for the CD45depCD31enr PBMC from buffy coat was <0.1 % (N=3, range:
0.04 to 0.1 %), equating to 1×105 to 2×105 cells per processed LRS cone. Since characterisation
experiments suggest at an NK identity for the CD45depCD31enr PBMC, it was decided to use the
Miltenyi MACS NK Cell kit to isolate untouched NK cells directly from the buffy coat, rather than
use a two-step process. Cell yield was improved by using the NK cell isolation kit: a sample of 8
isolations gave an average yield of 4.8 % (range: 2.0 to 7.1 %) from the buffy coat. Between 1×107
and 3×107 NK cells could be obtained per isolation.
A comparison of the cell markers on cell isolated from the NK cell kit and through the CD45depCD31enr
double-step process was performed by flow cytometry (fig. 4.15). Populations were extracted from
buffy coat using the NK kit and the CD45/CD31 kit, then characterised using the panel and gating
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(a) CD45depCD31enr PBMC alone, with
IL-2 stimulation
(b) CD45depCD31enr PBMC alone, with no
cytokine stimulation
(c) CD45depCD31enr PBMC co-cultured
with hBMSC, with IL-2 stimulation
(d) CD45depCD31enr PBMC co-cultured
with hBMSC, with no cytokine stimulation
(e) hBMSC alone, with IL-2 stimulation (f) hBMSC alone, with no cytokine
stimulation
Fig. 4.13 Co-cultures CD45depCD31enr PBMC and BMSCs with or without IL-2 stimulation in
hypoxia
CD45depCD31enr PBMC were obtained using magnetic selection with Miltenyi MACS CD45 and CD31 kits.
Cultures were set up containing CD45depCD31enr PBMC cells alone (figs. 4.13a and 4.13b), CD45depCD31enr
PBMC with BMSC (figs. 4.13c and 4.13d) or BMSC alone (figs. 4.13e and 4.13f) under hypoxic culture
conditions for 7 days. Half of the cultures were treated with IL-2 (figs. 4.13a, 4.13c and 4.13e) and half were
left unstimulated (figs. 4.13b, 4.13d and 4.13f). N = 3. Scale bar = 100 µm
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(a) CD45depCD31enr PBMC alone, with
IL-2 stimulation
(b) CD45depCD31enr PBMC alone, with no
cytokine stimulation
(c) CD45depCD31enr PBMC co-cultured
with hBMSC, with IL-2 stimulation
(d) CD45depCD31enr PBMC co-cultured
with hBMSC, with no cytokine stimulation
(e) hBMSC alone, with IL-2 stimulation (f) hBMSC alone, with no cytokine
stimulation
Fig. 4.14 Co-cultures of CD45depCD31enr PBMC and BMSCs with or without IL-2 stimulation in
normoxia
CD45depCD31enr PBMC were isolated by double-step MACS. Cultures containing CD45depCD31enr PBMC
only (figs. 4.14a and 4.14b), CD45depCD31enr PBMC and BMSC (figs. 4.14c and 4.14d) and BMSC only
(figs. 4.14e and 4.14f) were grown for 7 days under normoxic conditions. Half the cultures were stimulated
with IL-2 (figs. 4.14a, 4.14c and 4.14e) and the other half were left untreated (figs. 4.14b, 4.14d and 4.14f).
Scale bar = 100 µm
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Fig. 4.15 Flow comparison of NK kit and CD45depCD31enr PBMC containing
(CD45+)(CD56+)(CD16+)(CD3−)(CD19−) cells
Cells were freshly isolated from the buffy coat of LRS cones and either enriched for NK cells using the
Miltenyi MACS NK cell kit or CD45depCD31enr PBMC . Viable cells were gated for
(CD56+)(CD16+)(CD45+)(CD31−)(CD3−)(CD14−) and percentage of viable cells with said marker profile
calculated. N = 2
strategy described in fig. 4.13. Cells from a single donor were characterised for the NK cell kit, and
2 donors for the CD45depCD31enr PBMC. The NK cell kit gave over 80 % purity of NK cells in the
viable cell fraction, determined by the marker profile (CD45+)(CD56+)(CD16+)(CD3−)(CD19−).
The proportion of cells with these markers isolated by the double-step method was variable. 1 donor
gave less than 30 % purity, while the other yielded a population containing more than 70 % cells with
the aforementioned marker profile. Cell viability was lower in the double-step isolations compared to
the direct method; the viability of cells isolated using the NK kit in fig. 4.15 was 88 %, compared to
49 % and 64 % respectively for the double-step isolations.
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4.4 Discussion
Recruitment of hBMSC to the site of trauma-induced repair following micro-drilling is thought to
be important to the eventual resolution of injury, based on their contributions to repair in fracture
as as well as other tissues such as the kidney (Dupont et al. 2010; Granero-Moltó et al. 2009;
Khalilpourfarshbafi et al. 2017). This recruitment occurs through a combination of direct signalling
from damaged tissues, and factors released by rapid-infiltrating immune cells. The migration of
hBMSC towards these subpopulations may lead to specific partitioning of cells within the haematoma,
as well as cell-cell contact between the recruiting cell type and the migrating hBMSC. Understanding
which immune subpopulations have the strongest influence on hBMSC recruitment would indicate
the PBMC subpopulations that hBMSC are most likely to co-localise, and potentially interact, with.
The aim of this chapter was to isolate and characterise an immune subpopulation which stimulated
hBMSC migration under normoxic and hypoxic conditions. To understand how this may be significant
in repair, I used hBMSC isolated and characterised under normoxic and hypoxic conditions as
described in chapter 3. Immune cell subpopulations were isolated from LRS cones obtained as a
by-product of platelet donation from healthy, consenting donors using MACS. The migratory influence
of these subpopulations on the hBMSC was established through the use of Boyden chambers and real
time migration assays. Protein secretion, cell surface markers, and functional assays were used to
establish the identity of the active immune subpopulation. The use of paired normoxic and hypoxic
conditions indicated not only how migratory behaviour may be modified by the changing oxygen
levels within the early haematoma, but also the importance of culture conditions when developing
in vitro models of cell behaviour. The unique feature of this study was the comparison between the
chemoattractant properties of paired enriched and depleted fractions of the peripheral blood in both
normoxia and hypoxia, rather than comparison of specifically selected cell subtypes. Using these
techniques, I have shown that a population obtained through a CD45− depleted CD31− enriched
(CD45depCD31enr) double-step MACS isolation had a stronger migration-inducing influence on the
hBMSC than its counterpart under both normoxic and hypoxic conditions. This population was
subsequently identified to primarily contain a complete NK cell population. NK cells as a whole are
among the earliest infiltrators to the sites of damage, accumulating in sites of inflammation through
multiple signalling pathways including the CXCR1 / CXCL8 axis (Agaiby and Dyson 1999). In
addition, a biomaterial study has shown that NK cells can recruit hBMSC into artificial scaffolds
therefore, this timeline supports the putative role of NK cells in recruiting hBMSC to the site of
damage (Almeida et al. 2012) .
The initial Boyden chamber experiments showed that the CD45dep subpopulation resulted in greater
hBMSC migration than the paired CD45enr subpopulation in the hypoxic condition, with an apparently
similar trend in the normoxic condition. Granulocytes such as basophils may express low levels
of CD45 (CD45dim) and hence not be selected by the MACS method, but these populations had
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already been removed using the density gradient centrifugation (Gane et al. 2018). The CD45 negative
fraction of blood contains haematopoietic, “mesenchymal” (see section 1.5), endothelial, skeletal
and osteogenic stem and progenitor cells (Golledge et al. 2007). Other CD45 negative populations
found in the peripheral blood include circulating endothelial cells, subsets of mature, terminally-
differentiated haematopoietic populations, such as T cells, and cells of the erythroid or megakaryocyte
lineage (Golledge et al. 2007; Noulin et al. 2013; Starlinger et al. 2011; Tomer 2004). A common
combination of markers used to characterise these subpopulations is CD31, CD34 and CD146, and so
these markers were selected for further subdivision of the CD45dep subpopulation in order to identify
the key subpopulations which induced hBMSC migration.
Boyden chamber experiments comparing the double-step isolated CD45depCD31enr/dep, CD45dep-
CD34enr/dep, and CD45depCD146enr/dep showed that there were no differences between the CD45dep-
CD34enr and CD45depCD34dep fractions, with a non-significant difference in favour of CD45dep-
CD146enr subpopulation, and a significant difference in favour of CD45depCD31enr being seen
over their respective negative partners. The lack of directional data in the Boyden chamber meant
that chemotaxis could not be distinguished from chemokinesis or fugetaxis, and so a real-time
chemotaxis assay based on the Ibidi μ slide system was used. Since the CD45depCD146enr and
CD45depCD31enr subpopulations had shown a level of altered hBMSC migration, both were taken
forward, but the CD45depCD34enr and CD45depCD34dep subpopulations were not due to lack of any
observed difference.
The CD45depCD146enr and CD45depCD146dep populations showed minimal differences in the real-
time migration assay, with the only difference being marginally increased migration velocity in
hBMSC stimulated with CD45depCD146dep cells in the hypoxic condition. The hBMSC directness
appeared to be higher in the normoxic compared to the hypoxic condition, but was not different
between the CD45depCD146enr and CD45depCD146dep subpopulations, suggesting that the hBMSC
isolated and cultured under normoxic conditions had a greater underlying directness of migration
independent of treatment. As a result, the CD45depCD146enr/dep populations were not taken forward.
The CD45depCD31enr cell population isolated using double-step MACS stimulated hBMSC migration
with increased directionality in both the normoxic and hypoxic conditions, although the directness
was higher under normoxic conditions when studied in the real-time migration assay, as seen in the
CD45depCD146enr/dep subpopulations. Further, in the hypoxic condition, the hBMSC migration had
marginally higher velocity than when stimulated with either the CD45depCD31dep subpopulation
under any condition, or the NK population in normoxic conditions. hBMSC isolated and cultured
under hypoxic conditions have been previously found to have greater baseline migration compared to
equivalent cells isolated and cultured under normoxic conditions, but this was not seen here (Vertelov
et al. 2013). This could be due to the source of bone marrow in the aforementioned study which was
obtained commercially from the iliac crest of a healthy donor aged 18 to 45 years (Lonza 2018). As
discussed in chapter 3, age has a significant effect on hBMSC behaviour, meaning that the observed
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migration in the hBMSC derived from aged, OA patients could be very different to that from the
commercial donors. Furthermore, the oxygen level within the quoted study was 5 % as opposed to
the 3 % used in my study. It is possible that the directness of the hBMSC was lower in the hypoxic
condition due to a weak chemokine gradient, resulting from the low cell number used, which was
insufficient to overcome the baseline non-directed migration of the hBMSC and induce directed
migration.
As a result, the CD45depCD31enr subpopulation was identified as the population of interest, and later
characterised as a whole NK cell subpopulation. This might seem unexpected, since NK cells do
express CD45 and therefore might not be thought to be found within the CD45 depleted fraction.
However, the MACS technique, unlike flow sorting, does not produce a pure population. Prior work
has shown that, in the case of rare markers with less than 2 % expression in the original population,
positive selection using MACS results in a ten-fold enrichment of said marker within the resulting
population, with the depleted fraction still containing a reduced number of cells expressing the marker
of interest (Sophie Frankham-Wells, unpublished work, Kymab Ltd). Accordingly, since the cells
isolated from the LRS cone are predominately CD45 positive, with one study suggesting up to 98 %
positivity, it follows that negative selection would result in a depletion, rather than complete removal of
CD45 positive cells (Néron et al. 2007). The same study found that NK cell abundance within an LRS
cone may be up to 17 %, accounting for their abundance within the CD45dep subpopulation. Further,
NK cells express CD31, also known as PECAM-1, and so these cells would have been captured in the
second round of MACS using the CD31 beads (Berman et al. 1996). However, CD31 is also expressed
on many other immune populations, including monocytes (Geissmann et al. 2010). Differentiation
of cells isolated from the LRS cone and enriched for CD31 by single-step MACS into macrophages
showed that the CD31 beads were able to capture functional monocytes in a single-step method (data
not shown). With that being said, the CD45dep subpopulation lacked CD14 expression, indicating
that any monocytes present had likely been partitioned into the CD45enr subpopulation (data not
shown). As a result, the presence of the enriched NK cell subpopulation within the CD45depCD31enr
subpopulation was likely a combination of overflow from the CD45 depletion step and then selection
in the CD31 enrichment step. This lack of purity in the MACS isolated fractions made characterisation
more challenging, but the speed and minimal handling required for manual MACS as opposed to flow
sorting, as well as the possibility of serendipitous findings as in the case of this thesis, made MACS
an attractive option.
NK cells can be subdivided into 5 subpopulations based on their relative expression of CD56 and
CD16, with the relative expression patterns of these markers indicating the function of the NK cell
subpopulation (Poli et al. 2009). In fresh whole blood, the (CD56dim) NK cells form over 90 % of
all NK cells, and 95 % of those are (CD56dim)(CD16bright) (Cooper et al. 2001). In the population
isolated from the LRS cone using the double-step method, 85 % of NK cells were (CD56dim) and of
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those, nearly 98 % were (CD56dim)(CD16bright). This agreed with the proportions seen in whole blood
and indicated that the population isolated was functionally relevant.
Although the majority of NK cells present within the population of interest were CD56dim, the
CD56bright subset are the major producers of IFNγ in the haematopoietic system, as well as producing
many other cytokines including TNFα, GM-CSF, IL-10, IL-13, and IP-10 (Fauriat et al. 2010; Poli et
al. 2009). IP-10 was among the strongest signals in the protein array analysis of the CD45depCD31enr
subpopulation, and is a known hBMSC chemoattractant, albeit more typically in the context of
macrophage-driven hBMSC migration (Anton et al. 2012). Indeed, the positive hits on the panel
suggested a monocytic identity for the, at the time, unidentified CD45depCD31enr subpopulation. As
already discussed, the presence of contaminating cell types was anticipated due to the MACS method
for isolating the subpopulations. Moreover, the cell number in the isolated subpopulation was very
low, and therefore the supernatants isolated for this work would have been very dilute due to the
volumes required for said assay. The basal medium used only contained 0.2 % BSA, reducing the
risk of contaminating cytokines from the serum, although use of a charcoal stripped or xeno-free
serum substitute would have been preferable to ensure a complete lack of contamination from serum
was present. Future work would use a cell-free control to provide an accurate baseline for cytokine
presence within the supernatants. As a result of this, the protein array data was used to help inform
the design of the later flow panels, in particular the inclusion of CD16 and CD14.
Crucially, NK cell recruitment of hBMSC is known to be dose-dependent, which may explain the
weaker migration induced in the hBMSC population during this experiment, resulting from the low
cell number used as the chemoattractive agent within the assay (Almeida et al. 2012). Using the
live cells as a chemoattractive agent was intended to allow for bi-directional paracrine interactions
occurring between the population of interest and the hBMSC. However, due to the extremely low
yields of cells isolated using the double-step MACS procedure, an improved method might have been
to use pre-conditioned medium formed from the supernatants of the PBMC subpopulations. This
would have prevented bi-directional paracrine interactions from occurring but would have created a
greater concentration of NK cell secreted factors which may have enhanced the observed migration.
Further, the cells used in the migration assays were non-activated, and hence secreted lower levels of
cytokines compared to activated NK cells.
4.4.1 Limitations of the study
LRS cones are a waste product generated during platelet donation and contain leukocytes, which
are retained in the cone and not returned to the donor following the procedure. While the PBMC
isolated from LRS cones were from allogenic sources, the use of LRS cones has several advantages,
and is a common source of leukocyte for research purposes. The cones are easily accessible and
permit a consistent method for obtaining large numbers of leukocytes without the specific ethical or
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safety concerns and logistical complexities of direct donations for research. Further, the donors from
which the LRS cones originate are healthy and regularly screened. This improves both the quality of
cells obtained, and the safety of the blood product. While LRS cone cell numbers are lower than in
whole blood, the ratios of different cell types within the cone are the same as whole blood and cell
activities are also not affected (Néron et al. 2007). The drawbacks include lower leukocyte numbers
than in whole blood, so rare populations present in whole blood are correspondingly scarce within the
cones. Further, cones are received the day after they are isolated from the donor and so there could be
changes in the cell activation states, or loss of short-lived cell types in the time between donation and
processing. However, the use of LRS cones to isolate active leukocytes, such as NK cells, B cells or T
cells, for research is well-documented, and isolated cells have characteristics and behaviour consistent
with cells isolated from fresh, whole blood (Dietz et al. 2006; Hwang et al. 2012; Néron et al. 2007;
Wiencke et al. 2016). The drawbacks of using allogenic PBMC will be considered in chapter 5.
On a related note, the yields of cells obtained through the CD45depCD31enr double-step isolation
method were extremely low, of the order of 1×105 cells per cone, severely limiting the potential assay
work. Each cone could often only be used for a single replicate of a single condition, increasing the risk
of donor-to-donor or sample-to-sample variation. As a result, when the population was characterised
as containing a majority of NK cells, the isolation method was altered to use the Miltenyi MACS NK
cell isolation kit rather than the double-step isolation method in order to permit a greater number of
assays. As seen in the protein array data and indeed within the flow cytometry, the population was
not pure NK cells, with other cell types present that may also have influenced the observed hBMSC
migration. A future study should directly compare the hBMSC migration stimulated and the proteins
secreted by the double-step population with that observed from the NK cells isolated with the kit to
confirm that the NK cells present within the double-step population were in fact the driving force
behind the observed migration.
The flow characterisation of the CD45depCD31enr subpopulation did not show CD31 positive staining
in the characterisation panel. CD31, also known as Platelet and Endothelial Cell Adhesion Molecule
1 (PECAM-1), has multiple splice variants, which may be expressed on different cell subsets and
therefore the epitope recognised by specific antibody clones may vary in abundance on the subsets
(Yongji Wang and Sheibani 2002). The anti-CD31 antibody clone used in the flow cytometric
phenotyping was WM-59 and, while this clone is routinely used in flow cytometry to examine human
CD31 expression, it might have been more appropriate to use L133.1, which was generated specifically
using human NK Cells (Biosciences 2018).
4.4.2 Future directions
Future work could attempt to unpick the interactions between the isolated NK cell population and the
hBMSC resulting in hBMSC migration. Greater understanding of the secretome of the NK cells, and
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how it is altered under normoxic and hypoxic conditions could explain the differences observed in
hBMSC migration. Crossing over the conditions, with normoxic hBMSC migration studied in hypoxic
conditions and vice versa could indicate whether the behaviours again were transiently influenced or a
result of subpopulation selection resulting from the oxygen level. Further, the influence of the hBMSC
on the migration of NK cells could be explored, to establish whether any potential co-localisation was
bi-directional. Additionally, examination of the hBMSC genome, with particular attention paid to
genes related to migration, could indicate whether the migration under normoxic or hypoxic conditions
occurs through stimulation of the same, or different pathways. Another layer which could be added is
the consideration of a pro-inflammatory environment. The isolated NK population was not activated,
which would not be the case in NK cells found within a haematoma following micro-drilling. NK
cell activation results in vastly heightened secretion of a range of cytokines, including those such as
IP-10 which have a strong chemotactic effect on hBMSC (Anton et al. 2012). Examining how an
inflammatory microenvironment, modelled using cytokine mixtures, would impact on the hBMSC
migration could have more functional relevance to the model in question. Further, the NK cells
themselves could be fractionated to observe which fraction had the greatest chemoattractive influence
on the hBMSC. in vivo validation of this finding, by looking for markers of NK cell and stromal
populations in osteochondral defects using immunohistochemistry, or fluorescent reporter mice, could
indicate whether the observed in vitro migration results in in vivo co-localisation. This would be
challenging, due to the cytotoxic behaviours observed in NK cells, which will be covered in chapter 5.
4.4.3 Summary
This work has identified that a whole NK cell population isolated by double-step MACS isolation
resulted in increased hBMSC migration in both normoxic and hypoxic conditions. hBMSC migration
in the normoxic condition was more direct, regardless of the stimulating PBMC subpopulation, than
that seen in the hypoxic condition. NK cell mediated migration of hBMSC has been previously
observed, although the approach taken in this study of comparing the paired enriched and depleted
PBMC populations is a novel approach.
NK cells play a key role in the recruitment of hBMSC to sites of trauma. The more direct migration
in the normoxic condition may indicate a stress response stimulated in vivo by the oxygen burst
following trauma.
Chapter 5
Functional consequences of hBMSC -
NK cell co-cultures under hypoxic and
normoxic conditions
5.1 Abstract
Aim: To characterise the interactions between NK cells and hBMSCs under normoxic and hypoxic
conditions.
Methods: hBMSCs were co-cultured with varying ratios of NK cells, with or without IL-2 stimulation,
and under either normoxic or hypoxic conditions. Co-cultures were assessed by visual inspection,
CellTox Green, real-time impedence assay, and flow cytometry. Paracrine cultures were set up
in a Boyden chamber and compared to cell-to-cell contact assays. Gene expression of CXCL10,
Indoleamine-2 3-dioxygenase (IDO), and HIF-1α were examined using RT-qPCR.
Results: Non-activated NK cells had greater effects on hBMSC proliferation in normoxic compared
to hypoxic conditions. IL-2 activated NK cells caused hBMSC lysis in both normoxic and hypoxic
conditions. The ratio of NK cells influenced the effects seen. NK cell mediated effects were reliant on
cell-to-cell contact. Co-cultures of NK cells and hBMSC did not alter hBMSC marker expression as
measured by flow cytometry, but did result in oxygen-dependent changes in all genes examined.
Conclusion: NK cell interactions with hBMSC vary with oxygen level, activation status, and ratio
of NK : hBMSC numbers. Interactions in hypoxic conditions increase immunomodulatory gene
expression, while normoxic conditions increase inflammatory gene expression.
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5.2 Introduction
Natural Killer cells are a component of the innate immune system, and make up 5 to 20 percent of
lymphocytes within the peripheral blood (Néron et al. 2007). They are an effector cell type, and are
recruited and activated through a variety of pathways, including cytokines such as IL-2, Interleukin
15 (IL-15), and Interleukin 18 (IL-18), other immune cells such as macrophages or dendritic cells,
and cell-surface receptor interactions, particularly Natural Killer Group 2 Member D (NKG2D) and
toll-like receptors (Vivier et al. 2008). NK cells are typically considered to be primarily involved
with control of microbial infection and tumour suppression through their cytotoxic abilities. However,
there is increasing evidence that subpopulations of NK cells also have regulatory roles, such as in
maternal-fetal tolerance and suppression of auto-immunity, suggesting that NK cells are involved
with immune surveillance and tolerance (Fu et al. 2014; Gross et al. 2016). Indeed, the role of NK
cells in repair also encompasses immuno-modulatory functions, such as regulation of pro- and anti-
inflammatory macrophages during inflammation, or secretion of TNFα, which increases recruitment
and differentiation of progenitor cells in fracture repair as well as cytotoxic behaviour (Glass et al.
2011; El-Jawhari et al. 2016; Tosello-Trampont et al. 2017). The previous chapter demonstrated
that NK cells appeared to be the most potent recruiting cell type for hBMSC in both normoxic and
hypoxic conditions, based on the system used. The premise of this chapter is that the recruited
hBMSC will partition with the NK cells within the repair site, leading to direct cell-to-cell interactions
between hBMSC and NK cells. While studies have examined the interactions between NK cells
and hBMSC, the results have been mixed. Some studies have shown that NK cells are important
in priming hBMSC for repair and that NK cells do not kill hBMSC, while others have shown that
any interaction between NK cells and hBMSC leads to the death of the hBMSC through NK cell
mediated cytotoxicity (Almeida et al. 2012; El-Jawhari et al. 2016). The majority of current studies
examining the interactions between NK cells and hBMSC have done so under normoxic conditions,
or through the use of hypoxic pre-conditioning, despite work showing that both hBMSC and NK
cell biology is influenced by oxygen level (W.-H. Huang et al. 2014; Hung et al. 2012; Loeffler et al.
1991; Wagegg et al. 2012; Yang et al. 2011). As a result, there is a lack of understanding of the
functional consequences of interactions between hBMSC and NK cells under hypoxic conditions. This
chapter aims to explore the consequences of direct cell-to-cell interactions between hBMSC and NK
cells under normoxic and hypoxic conditions through co-cultures and functional assays. Interactions
modelled in hypoxic conditions may be more biologically relevant to the early, pre-revascularisation
phase of repair, while normoxic interactions may have more relevance to later stages of repair, as




NK cells cultured with IL-2 for seven days under hypoxic (fig. 5.1a) or normoxic (fig. 5.1c) conditions
became semi-adherent and formed colonies of replicating cells. These colonies were noticeably larger
in hypoxic conditions (fig. 5.1a). NK cells cultured without IL-2 did not adhere or proliferate under
either hypoxic (fig. 5.1b) or normoxic (fig. 5.1d) conditions, and when observed appeared to be dead;
the cells were not phase-bright, but instead were dull with an irregular, shrivelled appearance.
(a) Hypoxic with IL-2 (b) Hypoxic without IL-2
(c) Normoxic with IL-2 (d) Normoxic without IL-2
Fig. 5.1 Culture of NK cells with or without IL2 stimulation under normoxic and hypoxic conditions
NK cells isolated using Miltenyi MACS NK cell kit were cultured under hypoxic or normoxic conditions for
one week with or without IL-2 stimulation. Scale Bar = 100 µm, N = 3
Co-cultures of hBMSCs and NK cells, with or without IL-2 stimulation, were set up and incubated
for 7 days under hypoxic (figs. 5.2 and 5.3) or normoxic (figs. 5.4 and 5.5) conditions using the
corresponding hBMSC isolates. Ratios of NK cells ranged from 1 NK cell (figs. 5.2b, 5.3b, 5.4b
and 5.5b), 5 NK cells (figs. 5.2c, 5.3c, 5.4c and 5.5c), 10 NK cells (figs. 5.2d, 5.3d, 5.4d and 5.5d)
through to 15 NK cells (figs. 5.2e, 5.3e, 5.4e and 5.5e) per 1 hBMSC, with an hBMSC-alone (figs. 5.2a,
5.3a, 5.4a and 5.5a) condition as a control for IL-2 stimulation. Visual inspection of cultures showed
that, regardless of oxygen level, there was no visible difference in hBMSC morphology or number
between hBMSC cultured alone with (figs. 5.2a and 5.4a) or without (figs. 5.3a and 5.5a) IL-2. Further,
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unstimulated NK cells did not appear to influence hBMSC morphology or number, regardless of
cell ratio (figs. 5.3 and 5.5). In the unstimulated cultures, NK cell numbers appeared low compared
to the IL-2 stimulated cultures in both hypoxic (fig. 5.2) and normoxic (fig. 5.4) conditions. The
non-stimulated NK cells did not adhere or proliferate.
IL-2 stimulated co-cultures contained semi-adherent NK cells, with numbers increasing with increas-
ing NK cell : hBMSC ratio. Loss of the hBMSC, interpreted as hBMSC death, was seen at ratios
above 5:1 NK cells : hBMSC in both hypoxic and normoxic (figs. 5.4c to 5.4e) conditions. The
perceived hBMSC death scaled with increasing ratios, with the highest ratio of NK cells (15:1 NK
cells : hBMSC) showing the greatest loss from the hBMSC monolayer. Further, clumping in the
NK cell populations was seen at higher NK cell : hBMSC ratios, although definitive NK cell colony
formation was not seen.
The co-cultures gave observational results at an individual time-point. To quantify the effect of the
NK cells on the hBMSC in more detail, the XCelligence RTCA E-plate system was used to give
a real-time indication of cytotoxicity. NK cell to hBMSC ratios of 0, 0.1, 0.2, 1, 5, 10 and 15 to 1
were used to give a range for dose-response analysis. The co-cultures were set up and run for 7 days
in hypoxic (fig. 5.6) and normoxic (fig. 5.7) conditions without IL-2 (figs. 5.6a and 5.7a) and with
IL-2 (figs. 5.6b and 5.7b). Optimisation experiments showed that NK cells, both unstimulated and
stimulated with IL-2 did not influence the impedance measured, demonstrating that only hBMSC
were quantified (data not shown). A Cell Index value of zero or lower on the Real Time Cell Trace
(RTCT) was interpreted as complete cell death.
In hypoxic conditions, the RTCT for the unstimulated NK cell – hBMSC co-cultures clustered together
following a similar initial trend (fig. 5.6a). A trough during the adhesion period was observed after
approximately 10 hours (fig. 5.6a, black arrow), followed by an inflexion point at approximately
50 hours (fig. 5.6a, blue arrow) in the RTCT for hBMSC with unstimulated NK cells. Following the
inflexion, all RTCT except the 15:1 NK cell : hBMSC condition, which plateaued, appeared to have
an increasing cell index. In co-cultures with IL-2 stimulation, the same adhesion trough was seen at
around 10 hours on the RTCT (fig. 5.6b, black arrow). However, while the inflexion point was around
50 hours again for the hBMSC with lower NK cell ratios (fig. 5.6b, blue arrow), the hBMSC with
higher NK cell ratios showed a peak at around 23 hours followed by a decline in the RTCT (fig. 5.6b,
red arrow). The lower NK cell numbers (0.1 to 1 NK cell per hBMSC) showed the same trend as seen
in the unstimulated co-cultures, with an apparent increase in cell number. To contrast, the RTCT of
hBMSC with higher NK cell numbers (5 to 15 NK cell per hBMSC) showed a decrease in cell index.
The trace for hBMSC with 5 NK cells per hBMSC did not reach zero, and had a less steep slope than
those for both the 10 and 15 NK per hBMSC RTCT, which both reached zero. This indicated that
the hBMSC were dying at a slower rate in the 5 NK per hBMSC compared to the 10 and 15 NK per
hBMSC co-cultures.
5.3 Results 121
(a) hBMSC only (b) 1:1 NK cells to hBMSCs
(c) 5:1 NK cells to hBMSCs (d) 10:1 NK cells to hBMSCs
(e) 15:1 NK cells to hBMSCs
Fig. 5.2 Hypoxic co-culture of BMSC and varying NK cell ratios with IL-2 stimulation
NK cells isolated using Miltenyi MACS NK cell kit were co-cultured for 1week with hypoxic-isolated hBMSC
at ratios of 0, 1, 5, 10, and 15 NK cells per hBMSC under hypoxic conditions with IL-2 stimulation.
Scale Bar = 100 µm, N = 3
122 hBMSC - NK cell co-cultures under hypoxic and normoxic conditions
(a) hBMSC only (b) 1:1 NK cells to hBMSCs
(c) 5:1 NK cells to hBMSCs (d) 10:1 NK cells to hBMSCs
(e) 15:1 NK cells to hBMSCs
Fig. 5.3 Hypoxic co-culture of BMSC and varying NK cell ratios without IL-2 stimulation
NK cells isolated using Miltenyi MACS NK cell kit were co-cultured for 1week with hypoxic-isolated hBMSC
at ratios of 0, 1, 5, 10, and 15 NK cells per hBMSC under hypoxic conditions with no cytokine stimulation.
Scale Bar = 100 µm, N = 3
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(a) hBMSC only (b) 1:1 NK cells to hBMSCs
(c) 5:1 NK cells to hBMSCs (d) 10:1 NK cells to hBMSCs
(e) 15:1 NK cells to hBMSCs
Fig. 5.4 Normoxic co-culture of BMSC and varying NK cell ratios with IL-2 stimulation
NK cells isolated using Miltenyi MACS NK cell kit were co-cultured for 1week with normoxic-isolated
hBMSC at ratios of 0, 1, 5, 10, and 15 NK cells per hBMSC under normoxic conditions with IL-2 stimulation.
Scale Bar = 100 µm, N = 3
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(a) hBMSC only (b) 1:1 NK cells to hBMSCs
(c) 5:1 NK cells to hBMSCs (d) 10:1 NK cells to hBMSCs
(e) 15:1 NK cells to hBMSCs
Fig. 5.5 Normoxic co-culture of BMSC and varying NK cell ratios without IL-2 stimulation
NK cells isolated using Miltenyi MACS NK cell kit were co-cultured for 1week with normoxic-isolated
hBMSC at ratios of 0, 1, 5, 10, and 15 NK cells per hBMSC under normoxic conditions with no cytokine




Fig. 5.6 Real-time cell killing assay using hBMSC with varying NK ratio and IL-2 stimulation in
hypoxia
hBMSC were co-cultured with varying ratios of NK cells without (fig. 5.6a) or with (fig. 5.6b) IL-2 stimulation
under hypoxic conditions in Xcelligence RTCA E-plate 16 for 7 days. Measurements were taken every
10 minutes. Black arrow: adhesion trough. Blue arrow: inflexion point 1. Red arrow: inflexion point 2. N = 6.
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(a)
(b)
Fig. 5.7 Real-time cell killing assay using hBMSC with varying NK ratio and IL-2 stimulation in
normoxia
hBMSC were co-cultured with varying ratios of NK cells without (fig. 5.7a) or with (fig. 5.7b) IL-2 stimulation
under normoxic conditions in Xcelligence RTCA E-plate 16 for 7 days. Measurements were taken every
10 minutes. Black arrow: adhesion trough. Blue arrow: inflexion point 1. Red arrow: inflexion point 2. N = 6.
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In normoxic conditions, the RTCT for hBMSC co-cultured with the different ratios unstimulated NK
cells did not show the same trends (fig. 5.7a), unlike the equivalent experiment in hypoxic conditions
(fig. 5.6a). The adhesion trough at 10 hours and inflexion at 50 hours were still present (fig. 5.7a black
and blue arrows, respectively), however after the inflexion the RTCT diverged. The lowest NK cell
ratios (0.1 to 1 NK cell per hBMSC) clustered with the hBMSC alone and appeared to plateau, rather
than increase as seen in the hypoxic condition. However, a clear separation was seen between these
RTCT and the RTCT for the hBMSC with 5 NK cells per hBMSC, which still plateaued but at a
lower value, and again for the 10 to 15 NK cell per hBMSC, which showed decreases in cell index.
The co-cultures with IL-2 stimulated NK cells behaved similarly to those in the hypoxic condition,
although the lower ratios had a lower final cell index, and the 5 NK per hBMSC RTCT reached zero
(fig. 5.7b). Further, the inflexion point for the higher ratios occurred later, at around 34 hours (fig. 5.7b,
red arrow).
Analysis of the endpoint values (7 days) showed that for the 0.1, 0.2 and 1 NK cell per hBMSC
condition, and hBMSC alone, there was no difference in RTCT end-point between the unstimulated
and IL-2 stimulated cultures in both the hypoxic (fig. 5.8a) and normoxic (fig. 5.8b) conditions.
In hypoxic conditions, the endpoint values for the unstimulated 5, 10 and 15 NK cell per hBMSC
condition were not different from those for the lower ratios (fig. 5.6a). However, the values for the
IL-2 stimulated conditions were significantly lower than their unstimulated counterparts at the higher
ratios.
The normoxic condition showed a similar trend: there were no differences between the traces for
hBMSC alone or co-cultured with the lower NK cell ratios (between 0.1 to 1 NK per hBMSC). In
addition, at these lower ratios there were no differences between co-cultures with or without IL-2
stimulation (fig. 5.8b). Addition of IL-2 resulted in the same decrease in RTCT endpoint for the
higher ratios (5 to 15 NK cells per hBMSC). However, while the RTCT for the unstimulated 5 NK
per hBMSC was not different to the lower ratios, the unstimulated 10 or 15 NK per hBMSC were
lower. Directly comparing the unstimulated co-cultures in normoxic and hypoxic showed that the
RTCT endpoint at higher ratios were significantly lower in normoxic conditions compared to hypoxic
conditions (fig. 5.9a). However, there were no differences between the RTCT end-points in normoxic
and hypoxic conditions when co-cultures were stimulated with IL-2 (fig. 5.9b).
Further analysis was performed considering when the RTCT reached zero Cell Index for the IL-2
stimulated co-cultures (fig. 5.10). Only the ratios of between 5 and 15 NK cells per hBMSC with
IL-2 stimulation were used, since no other traces reached zero. As indicated on the chart, in the 5
NK per hBMSC condition, 5 out of 6 RTCT in the hypoxic, and 3 out of 6 in the normoxic condition
never reached zero. In fact, even in the higher ratios, 1 of the hypoxic condition RTCT still never
reached zero, although consideration of the data shows that the RTCT was close to the cut-off. An
apparent trend was seen in the data, particularly in the hypoxic condition, with the time to reach zero
decreasing with increasing NK cell numbers. However, this was not significant, nor was there any
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Fig. 5.8 Endpoint analysis of real-time cell killing comparing condition with or without IL-2
stimulation
Endpoint analysis of Xcelligence RTCA traces at 7 days showing comparison between hBMSC and varying
NK cell ratios co-cultured with and without IL-2 stimulation under hypoxic (fig. 5.8a) or normoxic (fig. 5.8b)
culture conditions. Significances shown on charts, Two-way ANOVA with Tukey’s post hoc test, p values:
∗∗< 0.005, ∗∗∗∗< 0.0001. Error bars show standard deviation. N = 6.
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Fig. 5.9 Endpoint analysis of real-time cell killing comparing hypoxic and normoxic condition
Endpoint analysis of Xcelligence RTCA traces at 7 days showing comparison between hBMSC and varying
NK cell ratios co-cultured hypoxic or normoxic culture conditions without (fig. 5.9a) and with (fig. 5.9b) IL-2
stimulation. Significances shown on charts, Two-way ANOVA with Tukey’s post hoc test, p values: ∗< 0.05,
∗∗< 0.005, ∗∗∗∗< 0.0001. Error bars show standard deviation. N = 6.
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Fig. 5.10 Time when cell index of IL-2 stimulated NK cell – hBMSC co-cultures reached zero
Analysis of Xcelligence RTCA traces showing the time RTCT reached zero for hBMSC cultured with various
NK ratios and stimulated with IL-2. Line at 168 shows end-point time for experiment (7 days). Ratios 0, 0.1,
0.2 and 1 NK : 1 hBMSC are not shown since these traces never reached zero. The number above the bar
indicates the number of traces reaching the cut-off within the period of measurement. No significant
differences found, Two-way ANOVA with Tukey’s post hoc test, P < 0.05. Error bars show standard deviation.
N = 6 (except where shown; the numbers above the bars indicate the number of traces which reached zero
within the measure time-frame)
difference between the time to reach zero under hypoxic or normoxic conditions for each NK cell
dose.
Assessment of NK cell cytotoxicity showed clear differences between co-cultures with and without
IL-2 stimulation, and between the hypoxic and normoxic condition. The dose-response curves for
the hypoxic condition show that as the ratio of IL-2 stimulated NK cells to hBMSC increases, the
AUC(xj) decreases in a dose-dependent fashion (fig. 5.11). The AUC50 for hBMSC co-cultured with
IL-2 stimulated NK cells was 4.98 NK cells per hBMSC. To contrast, co-cultures of hBMSC with
non-stimulated NK cells showed either no difference between the AUCj and the AUCc, or a higher
AUCj relative to the AUCc at all concentrations studied. In the normoxic condition, the same trend
could be seen in the co-cultures stimulated with IL-2 as in the hypoxic IL-2 stimulated condition,
although the AUC50 was slightly lower at 4.51 NK cells per hBMSC (fig. 5.12). However, the result
for the non-stimulated co-cultures was starkly different to that seen in the hypoxic condition. At lower
NK cell concentration (0.1 to 1 NK cell per hBMSC), the AUCj and the AUCc were the same, but at
higher concentrations, the AUC(xj) increased, showing that the AUCj had decreased relative to the
AUCc. An AUC50 could not be calculated for the non-stimulated co-cultures in normoxic conditions,
since the AUC(xj) did not reach 50 % in the range of NK cell ratios studied.
To identify whether NK cell killing of hBMSC was specific, i.e. individual hBMSC were actively
targeted and killed by NK cells, as opposed to hBMSC dying en-masseco-cultures of 10 NK cells per
hBMSC with IL-2 stimulated were set up under normoxic and hypoxic conditions for 72 hours, then
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Fig. 5.11 Assessment of NK cell cytotoxicity in hypoxic conditions using glsAUC50
The AUC was calculated based on the real time cell traces from NK cell co-cultures with hBMSC, with or
without IL-2 stimulation under hypoxic conditions using the hBMSC-alone cultures as a reference. A
sigmoidal dose-response curve with variable slope was fitted using GraphPad Prism. With IL-2, AUC50 = 4.98.
Without IL-2, no cytotoxicity was seen in range examined. N = 6.
Fig. 5.12 Assessment of NK cell cytotoxicity in hypoxic conditions using AUC50
The AUC was calculated based on the real time cell traces from NK cell co-cultures with hBMSC, with or
without IL-2 stimulation under normoxic conditions using the hBMSC-alone cultures as a reference. A
sigmoidal dose-response curve with variable slope was fitted using GraphPad Prism. With IL-2, AUC50 = 4.51.
Without IL-2, cytotoxicity was too low to calculate AUC50 within range examined. N = 6.
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(a) Hypoxic (b) Normoxic
Fig. 5.13 72 hour CellTox Green of hBMSC - NK cell cultures stimulated with IL-2
hBMSC were co-cultured with IL-2 stimulated NK cells at 1:10 hBMSC : NK cells under normoxic (fig. 5.13b)
and hypoxic (fig. 5.13a) culture conditions for 72 hours. Nuclei of dying hBMSC highlighted in yellow, Scale
bar = 100 µm. N = 3.
treated with CellTox Green to visualise hBMSC death (fig. 5.13). Under both hypoxic (fig. 5.13a) and
normoxic (fig. 5.13b) conditions, hBMSC death was punctate and discrete, with the death isolated to
single hBMSC and not being transmitted to the neighbouring hBMSC surrounding the dying hBMSC.
To investigate whether the hBMSC death was a result of cell-to-cell interaction, co-cultures were set
up in hypoxic conditions with NK cells either in direct co-culture, or in a Boyden chamber, incubated
for 7 days, and the hBMSC death quantified (fig. 5.14). The data showed that cell death in cultures of
hBMSC alone, and hBMSC with IL-2 stimulation were similar, supporting the observations made
using the Xcelligence. While hBMSC death appeared slightly higher in direct co-cultures of hBMSC
and NK cells without IL-2, this interaction was not significant, but stimulation with IL-2 resulted in
significantly higher levels of hBMSC death. To contrast, paracrine (transwell) co-cultures of hBMSC
and NK cells, whether or not they were stimulated by IL-2, showed little hBMSC death, comparable
to the hBMSC alone condition and significantly lower than the direct co-culture with IL-2 stimulation
and NK cells.
To determine whether the NK cell – hBMSC interactions had consequences beyond the death of the
hBMSC, gene expression analysis was performed by RT-qPCR on co-cultures of hBMSC and NK
cells incubated under normoxic and hypoxic conditions for 7 days (fig. 5.15). 3 genes were examined:
HIF-1α, an important moderator in cellular responses to hypoxic conditions, and IDO and CXCL10,
both important immunoregulatory genes involved with various reparative pathways. Under hypoxic
conditions, CXCL10 expression was increased in the co-cultures, while under normoxic conditions
expression levels did not change (fig. 5.15a). The opposite was true of IDO expression, where an
increase was seen in the normoxic condition with an apparent decrease under hypoxic conditions
(fig. 5.13b). HIF-1α expression was not affected by the IL-2 stimulated co-culture under either hypoxic
or normoxic conditions (fig. 5.15c).
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Fig. 5.14 NK cells kill hBMSC in a cell contact dependant manner
hBMSC were co-cultured with NK cells, with or without IL-2 stimulation. Co-cultures were at 1:5 hBMSC :
NK cell and were either direct cell-cell (juxtacrine) or with NK cells seeded into a Boyden chamber with
0.4 µm pore size above hBMSC (paracrine). BMSC: BMSC alone, no cytokines or NK cells, BMSC + IL-2:
BMSC alone with IL-2, no NK cells, BMSC + NK: BMSC with no cytokines in juxtacrine culture with NK
cells, glsBMSC + NK Trans: BMSC with no cytokines in paracrine culture with NK cells, BMSC + NK + IL-2:
BMSC with IL-2 in juxtacrine culture with NK cells, BMSC + NK + IL-2 Trans: BMSC with IL-2 in paracrine
culture with NK cells. Cultures were maintained for 7 days under hypoxic culture conditions. At the end of
incubation, wells were treated with CellTox Green and the number of dying hBMSC nuclei quantified using
ImageJ. Significance shown on chart, Two-way ANOVA with Tukey’s post hoc test, p < 0.01. Error bars show
standard deviation. N = 3.
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Fig. 5.15 Gene expression data for hBMSC – NK cell co-cultures stimulated with IL-2 in normoxic
and hypoxic conditions
hBMSC were co-cultured with NK cells and IL-2 stimulation for 7 days in normoxic and hypoxic conditions.
cDNA was prepared from the samples and RT-qPCR performed to investigate the expression of CXCL10
(fig. 5.15a), IDO (fig. 5.15b), and HIF1a (fig. 5.15c) in the co-cultures. Fold change relative to unstimulated
cultures. Student’s T-test, p values: ∗< 0.05. Error bars show compound standard deviation, as described in
section 2.4.1 N = 3.
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5.4 Discussion
NK cells are among the earliest infiltrating cell types into regions of trauma, and were shown to
influence hBMSC migration under both normoxic and hypoxic conditions (chapter 4). It therefore
follows that co-localisation of NK cells and hBMSC within the marrow clot is likely to occur early
on in the repair process. At present, the implications of NK - hBMSC interactions following bone
marrow stimulation are not fully explored. However, a study found that hBMSC were lost to tracing
after 48 hours within the haematoma, indicating either migration away from the site of damage, or
death of the hBMSC: it is possible that the hBMSC were lost as a result of NK cell activity (Bastian
et al. 2016). Understanding the consequences of these interactions, and how they are influenced by
NK cell number and oxygen level could indicate fundamental mechanisms governing the outcome of
repair, as well as indicating potential therapeutic interventions.
The aim of this chapter was to understand how oxygen level and dose of NK cells influenced the
behaviour and survival of hBMSC. Co-cultures of hBMSC and NK cells were set up, under normoxic
(18.9 % oxygen) and hypoxic conditions (3 % oxygen), with varying IL-2 stimulation and NK cell
ratios. These co-cultures were interrogated through visual inspection, CellTox Green (a fluorescent
marker of cell death), real-time cell growth monitoring using the Xcelligence RTCA system, and
gene expression by RT-qPCR. Paracrine (transwell / Boyden chamber) co-cultures were used to
demonstrate the importance of direct cell-to-cell contact on NK cell mediated hBMSC cytotoxicity.
As in described in earlier data presented in chapter 3, the hBMSC used in the co-cultures had been
isolated and cultured under the corresponding experimental oxygen level, with allogeneic NK cells
isolated from LRS cone buffy coats using NK specific negative MACS. This work demonstrated that
NK cells had dose-dependent, saturable effects on hBMSC which were modified by IL-2 stimulation
and oxygen level as summarised in tables 5.1 and 5.2.
Co-cultures of non-stimulated NK cells and hBMSC with low ratios (0.1 to 1 NK per hBMSC)
showed similar behaviour in both normoxic and hypoxic conditions when studied using real time cell
tracing, with the hBMSC continuing to proliferate following the inflexion point, albeit to a greater
Table 5.1 Summary of the effects of NK cells on hBMSC in vitro without
IL-2.
Oxygen Level
Hypoxic (3 %) Normoxic (18.9 %)
Ratio of NK : hBMSC Low
1 Proliferate Proliferate
High2 No change No change / Death
1 0.1 to 1 NK cell per hBMSC.
2 5 to 15 NK per hBMSC.
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Table 5.2 Summary of the effects of NK cells on hBMSC in vitro with
IL-2.
Oxygen Level
Hypoxic (3 %) Normoxic (18.9 %)
Ratio of NK : hBMSC Low
1 Proliferate No change
High2 Death Death
1 0.1 to 1 NK cell per hBMSC.
2 5 to 15 NK per hBMSC.
extent in the hypoxic condition. This would agree with the previous observation (chapter 3) that
hBMSC isolated and cultured under hypoxic conditions have a greater proliferation rate than those in
normoxic conditions. Other studies have shown that hBMSC are able to suppress the proliferation
of resting NK cells and hBMSC lysis when co-cultured at up to 20 resting NK cells per hBMSC
under normoxic conditions, contradicting the results of my work in the real time system at high ratios
(Rasmusson et al. 2003; Sotiropoulou et al. 2006; Spaggiari et al. 2006). However, these studies all
used hBMSC isolated from healthy young adult iliac crest, or healthy paediatric spinal marrow and,
as discussed earlier (chapter 3), ageing has significant effects on the qualities of hBMSC. That being
said, the co-cultures assessed visually do appear to agree with the work in the aforementioned studies,
with minimal apparent effects being seen in either the non-stimulated normoxic co-cultures, or the
non-stimulated hypoxic co-cultures, even at the higher ratios. However, visual assessment did not
quantify the cell numbers, and it was noted that NK cell distribution across the wells was not even:
NK cells were concentrated at the well edges, likely due to vortex effects on the non-adherent cells in
the unstimulated co-cultures. As a result, hBMSC distribution may also have had variable distribution
across the well base, which was not shown in the images. Due to this lack of quantification, the visual
assessment was chiefly used to assess feasibility, the appropriate NK cell ratios, and identify possible
outcomes prior to translation into the Xcelligence RTCA system.
While the effect of altering NK cell to hBMSC ratio on hBMSC behaviour has been studied under
normoxic conditions, comparable work has not been done under hypoxic conditions. While not
apparent in the non-stimulated co-cultures assessed visually, this was very clearly indicated in the real
time cell tracing. Unstimulated co-cultures in hypoxic conditions showed cell growth following the
inflexion point, regardless of the NK cell ratio used. However, in the normoxic conditions, the low
ratios showed no growth and the highest ratios (10 or 15 NK per hBMSC) showed hBMSC death.
Allogeneic co-cultures of hBMSC and NK cells in normoxic conditions in a study actually showed
very low levels of lysis of hBMSC by resting NK cells, with around 5 % lysis being seen at ratios
of 40 NK per hBMSC, significantly lower than values seen in my study, and possibly due again
to the use of hBMSC from younger donors (Poggi et al. 2005). In both the normoxic and hypoxic
condition, the traces from the low ratio co-cultures tracked with the solo hBMSC cultures, indicating
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that the presence or lack or growth was due to the inherent properties of the hBMSC used and was not
influenced by the NK cells. However, while the high ratios also did not influence hBMSC growth
in the hypoxic conditions, clear differences could be seen between the high and low ratios in the
normoxic condition. The 5 NK per hBMSC condition showed a growth plateau at a lower value, while
the highest ratios showed decreases indicating hBMSC death. Further, the NK cells were found to be
unable to result in a 50 % decrease in the area under the real time cell trace curve (AUC50) in either
normoxic or hypoxic conditions.
However, while the unstimulated hypoxic NK cell co-cultures showed no influence on the area under
the real time cell trace curve at any ratio, the same system in the normoxic condition showed a definite
change with ratios of 5 NK per hBMSC or higher. Although the high NK cell ratios never achieved
an AUC50, the 10 and 15 NK per hBMSC conditions approached this value. This showed that the
unstimulated NK – hBMSC co-cultures in the normoxic condition had a dose-dependent effect, and
may have had a quantifiable AUC50 if higher ratios than 15 NK per hBMSC had been used, but that
hypoxic NK – hBMSC co-cultures were not dose dependent within this range. It is not possible to say
whether higher NK cell ratios could have resulted in hBMSC lysis in the hypoxic co-culture based on
this data.
There are three possible explanations for these results:
1. That NK cells are less cytotoxic under hypoxic conditions than normoxic conditions.
2. That hBMSC isolated under hypoxic conditions are more immunomodulatory than those
isolated under normoxic conditions.
3. A combination of both factors.
Addressing the first point, one study has shown that resting NK cell cytotoxicity against multiple
myeloma is decreased under anoxic (here pre-conditioning with 0 % oxygen) relative to normoxic
conditions (Sarkar et al. 2013). When comparing co-culture of hypoxic pre-conditioned or normoxic
hBMSC with unstimulated NK cells, no lysis was seen in the former, while normoxic hBMSC were
lysed (W.-H. Huang et al. 2014). More generally, hypoxic conditions have been shown to influence NK
cell cytotoxicity by downregulating receptors which result in activation of NK cell killing behaviour
(W.-H. Huang et al. 2014; Loeffler et al. 1991). With regard to the second point, a study in mice
has shown that implanted hypoxic murine hBMSC resulted in decreased NK cell accumulation in
regions of damage compared to normoxic murine hBMSC (W.-H. Huang et al. 2014). Furthermore,
the hypoxic murine hBMSC engraftment was improved compared to the normoxic hBMSC due to
decreased NK cell mediated lysis. A similar study examining xenogenic hBMSC administration in a
murine myocardial infarct model showed that hypoxic hBMSC not only decreased infiltrating NK
cells in the region of the infarct, but also the number of NK cells in the spleen when compared to
the results with normoxic hBMSC (Lipinksi and Epstein 2016). This would suggest that hypoxic
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isolated and cultured hBMSC have potent immuno-modulatory capacity against NK cells even when
implanted in a xenogenic in-vivo model, and support the greater immuno-modulatory potential seen in
my allogeneic, in-vitro model. As a result, the third explanation is likely to be correct: a combination
of reduced NK cell cytotoxicity and increased hBMSC immuno-modulatory ability when isolated and
cultured under hypoxic conditions resulted in the decreased effects of unstimulated NK cells on the
hBMSC.
The results for the IL-2 stimulated NK cells were very different. This was immediately apparent in the
visually assessed co-cultures, where the NK cells had apparently become semi-adherent and therefore
were more evenly distributed across the well base, and clear hBMSC death could be seen through the
loss of the monolayer in both normoxic and hypoxic conditions, albeit on a dose-dependent basis. In
both conditions, alterations in the hBMSC monolayer could be seen above 5 NK per hBMSC. The
IL-2 stimulated co-cultures traced on the Xcelligence RTCA further supported this observation. Under
both normoxic and hypoxic conditions, the low ratios of NK to hBMSC showed the same growth
as the hBMSC cultured alone. Furthermore, the endpoints of these co-cultures were not different
to the corresponding endpoints without IL-2 stimulation, indicating that neither the IL-2, nor the
activated NK cells were influencing the hBMSC. The lack of IL-2 influence on the hBMSC contrasts
with a previous study using human Adipose-Derived Stromal Cell (hADSC), supposedly functionally
equivalent cells to hBMSC but derived from adipose tissue. This study showed that a lower level
of IL-2 exposure for a shorter period of time than in my study triggered replicative senescence and
decreased immuno-modulatory properties in the hADSC (Niu et al. 2015). However, while hADSC
have similar functional properties to hBMSC, they are derived from a different tissue source, with a
very different microenvironment particularly related to inflammatory status and as such may not be
directly comparable.
Interestingly, IL-2 stimulation in the highest (10 and 15 NK per hBMSC) ratio co-cultures completely
restored NK cell cytotoxicity in hypoxic conditions, with the end point and general trend of the
real time trace being very similar to the normoxic condition. At 5 NK per hBMSC, the killing was
complete in the normoxic condition, but incomplete in the hypoxic condition, which indicates that
although NK cell cytotoxicity was induced in high ratios stimulated with IL-2, the hypoxic conditions
still exerted an immuno-modulatory effect, either directly on the NK cells or via the hypoxic culture
hBMSC. The restoration of hypoxic NK cell cytotoxicity with IL-2 treatment to similar levels to
normoxic IL-2 stimulated NK cells has been seen before in studies on NK – multiple myeloma
co-cultures (Sarkar et al. 2013). This study did not consider variable doses of NK cells, instead only
using 20 NK cells per myeloma cell, nor did it consider hBMSC. However, the restoration of NK cell
cytotoxicity upon IL-2 stimulation does support the results seen here in the highest ratio used in my
study, 15 NK cells per hBMSC.
In work presented here, IL-2 stimulated NK cells exhibited an AUC50 when at a ratio of 4.98 NK
cells per hBMSC in hypoxic conditions and 4.51 NK cells per hBMSC in normoxic conditions.
5.4 Discussion 139
The slight difference in AUC50 could result from the immuno-modulatory effects of the hypoxic
system. Previous studies have shown that IL-2 stimulation restores hypoxic NK cell cytotoxicity
to near the level seen in normoxic cultures, which agrees with the results shown here (Sarkar et al.
2013). Interestingly, other studies have given different values for the ratio, albeit only in the normoxic
condition. One study suggests the ratio is around 6 NK cells per hBMSC to cause 50 % lysis, while
another, which used IL-15 stimulation, claimed that hBMSC inhibited NK cell lysis up to 10 NK cells
per hBMSC, with the number causing 50 % lysis presumably somewhat higher (Sotiropoulou et al.
2006; Spaggiari et al. 2006). Once again, both studies used hBMSC from healthy paediatric spinal
or healthy young adult iliac crest sources, indicating that hBMSC immunomodulation of NK cell
cytotoxicity decreases with age, although the 10 NK per hBMSC value was from the adult patients.
That particular study did use IL-15 to stimulate the NK cells, but was able to replicate the same result
using IL-2, combined Interleukin 12 (IL-12) and IL-15, or combined IL-12 and IL-18 stimulation,
showing that the cytokine(s) used to activate the NK cells did not appear to influence the result in that
system (Sotiropoulou et al. 2006).
It is important to note that when NK cells were cultured alone, NK cells stimulated with IL-2 formed
more and larger colonies in the hypoxic condition when compared to the normoxic condition. This
would suggest that hypoxic conditions enhance NK cell proliferation independently of the influence
on the NK cell cytotoxic effect. There is very little research on the in-vitro growth of NK cells
under hypoxic conditions as the research has focussed instead on NK cell cytotoxicity, but one study
claimed that NK cell proliferation was decreased 1000 times after 28 days at 1 % oxygen, compared
to normoxic conditions (Ang et al. 2010). However, these NK cells were grown under more extreme
hypoxia, 1 % compared to 3 % oxygen used in work presented here, for a longer period, 28 days
compared to 7 days which may explain the difference. As previously noted, hypoxic culture of NK
cells did not appear to influence their viability (Sarkar et al. 2013). The anti-proliferative effects
of hypoxic hBMSC and hypoxic co-culture on NK cell proliferation have not been established, but
normoxic co-cultures of up to 16 NK cells per hBMSC with IL-2 stimulation showed reduced NK
cell proliferation (Spaggiari et al. 2006). This indicates that the observed cytotoxic effects are due to
alterations in the activation state and degranulation of the NK cells present within the well, and not
due to increasing numbers of NK cells resulting in greater levels of hBMSC lysis.
The killing of the hBMSC by the NK cells was cell-contact dependent and isolated to interacting cells,
as demonstrated by Boyden chamber experiments. The cell death was therefore targeted and not a
generalised response by the hBMSC to NK cell cytotoxic effects. This is in line with the literature
which suggests that hBMSC - NK cell interactions require cell-to-cell contact (Smyth et al. 2005).
Critically there was a significant difference between direct co-culture of hBMSC with IL-2 activated
NK cells and indirect, paracrine co-culture of hBMSC with IL-2 activated NK cells in a Boyden
chamber. The cultures of hBMSC alone treated with IL-2 did not show increased death compared to
the untreated solo hBMSC cultures during the assay indicating that the cell death seen was a direct
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result of activated NK cells killing hBMSC. This demonstrates that the IL-2-activated NK cells must
have cell-cell contact with the hBMSC in order for killing to occur, and that paracrine signalling is not
influencing hBMSC death. Further, this indicates that the cytotoxic effect on the hBMSC is a result of
NK cell directed killing, rather than hBMSC death in response to NK cell death. The cell-contact
dependant, target-specific cytotoxicity of NK cells is widely known, therefore the combination of
results showing that the killing was specific and relied on cell-cell contact validated both the model
and approach used in this study (Smyth et al. 2005).
NK cell mediated lysis of hBMSC became visible after between 23 to 50 hours, following the inflexion
point on the real time cell traces from the Xcelligence. At this point, the traces began to decline,
indicating that cell death was occurring. This timeframe aligns with the described timings after
which transplanted hBMSC cease to be traceable when administered in vivo in some studies (S.-H.
Li et al. 2009). As a result, it is possible that the loss of hBMSC following administration in vivo
results at least in part from the action of NK cells within the region of trauma. This is supported by
murine in-vivo studies which have found NK cell accumulation and activation in the damaged region
following trauma is correlated with death of the grafted hBMSC (W.-H. Huang et al. 2014).
A further observation is the alteration of gene expression in the co-cultures under hypoxic and
normoxic conditions when stimulated with IL-2. Opposite influences were seen in terms of CXCL10
and IDO transcript levels, with CXCL10 increasing in hypoxic co-cultures, and remaining unchanged
in normoxic and the reverse being seen with IDO. On the other hand, no change in HIF-1α expression
was seen in either condition. HIF-1α was chosen as it is the quintessential marker of cellular response
to hypoxic conditions, being widely used as a marker of low-oxygen conditions, and was used
here to examine responses to the hypoxic co-cultures (Komatsu and Hadjiargyrou 2004; Mills et al.
2009; Raheja et al. 2011).CXCL10 and IDO were selected for examination as together they act as a
barometer of early inflammatory changes associated with responses to disease or injury, providing
rapid, clear responses. Broadly speaking, CXCL10 is associated with pro-inflammatory and IDO with
immuno-modulatory responses. Although changes in gene expression do not necessarily translate to
changes in protein secretion, alterations in these genes could indicate a global shift towards a pro-
inflammatory or immuno-modulatory phenotype. To extend this work, other inflammatory markers
such as IFNγ, TNFα, IL-10, or IL-6 could be examined.
CXCL10, also called IP-10, has diverse roles in the pro-inflammatory response, including the re-
cruitment of hBMSC (Anton et al. 2012). As the name suggests, it is a cytokine upregulated by
release of IFNγ by cells in the region of damage, and is used as a key marker for disease severity
and inflammatory status in infection, auto-immune disorders and wound repair (J. Li et al. 2017;
Liu et al. 2011; Rees et al. 2015; Ridiandries et al. 2018). CXCL10 acts as a regulator of diverse
pathways, including PI3K, cAMP kinase, and MAPK, mediating inflammation through recruitment,
adhesion, and proliferation of cells. More to the point, the release of CXCL10/IP-10 by the was
observed in the preceding chapter by the CD45depCD31enr (later characterised to be NK cells), indi-
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cating that it is present in the system and therefore expression may be influenced by the co-culture
(chapter 4).CXCL10 can be expressed by NK cells, but is more likely to be produced by hBMSC as
a result of IFNγ secretion by activated NK cells (Croitoru-Lamoury et al. 2007; Fauriat et al. 2010;
Keppel et al. 2015). CXCL10 is a potent cytokine, acting on multiple cell types including NK cells
(Saudemont et al. 2005). In addition, hBMSC CXCL10 expression is regulated by interaction with
immune cells, including macrophages and NK cells, leading to an hBMSC phenotype with increased
migration, pro-angiogenic and pro-inflammatory properties (Anton et al. 2012; Y. Yu et al. 2016).
However, studies in hADSC have shown that hypoxic conditions do not alter CXCL10 expression
under cytokine stimulation, which does not explain the upregulation seen only in the hypoxic IL-2
stimulated co-cultures (Roemeling-Van Rhijn et al. 2013). A possible explanation is related to the
role of NK cells and CXCL10 in tumour suppression. In-vivo models of tumour suppression have
shown that CXCL10 secretion by transfected tumour cells, or engrafted hBMSC, can result in tumour
regression through the recruitment of NK cells, due to their anti-tumour activity (Saudemont et al.
2005; Y. Yu et al. 2016). Early tumour development has many features in common with wound
healing: formation of a fibrin clot, presence of stromal cells, inflammation, hypoxia, initiation of
neo-angiogenesis and similarities in gene expression changes (Schäfer and Werner 2008).
The microenvironment within a tumour tends to be hypoxic, even compared to ‘physoxia’, the normal
physiological oxygen level for a tissue. In normal tissues, aside from bone marrow, which, as discussed
in the introduction, is profoundly hypoxic, oxygen levels tend to range from 3 to 7.4 %, while median
tumour oxygen levels range from 0.3 to 4.2 % with most having below 2 % oxygen (McKeown 2014).
Furthermore, NK cells themselves are known to selectively target undifferentiated, de-differentiated,
or poorly differentiated stem and progenitor cells (Tseng et al. 2010). It is therefore possible that the
different response to the IL-2 stimulation in the normoxic and hypoxic co-cultures was a result of an
anti-tumour-like response caused by the hypoxic conditions. Due to the lack of alteration in HIF-1α
expression in the hypoxic IL-2 stimulated co-cultures, it is reasonable to suggest the involvement
of other pathways or down-stream post-transcriptional regulation of HIF-1α activity, which could
perhaps be identified through RNA Sequencing (RNA-Seq) or Western blotting. In addition, other
hypoxia-related genes with more direct responses could be interrogated, such as TNFα, VEGF, or
MMP9 (Ohnishi et al. 2007). On the other hand, the CXCL10 upregulation could represent the
induction of a pro-reparative phenotype in the hBMSC, potentially heralding the initiation of the
pro-angiogenic response.
To contrast, co-cultures of NK cells and hBMSC with IL-2 stimulation in normoxic conditions showed
an increase in IDO expression, which was unchanged in the hypoxic co-cultures. Similar to CXCL10,
IDO is also upregulated by the release of IFNγ, although IDO itself is an enzyme. However, IDO
has a marked immunosuppressive effect through its local degradation of tryptophan (Soliman et al.
2010; Thomas et al. 2007). This degradation of tryptophan in the region of inflammation results in
decreased immune cell activation, either as a result of the decreased supply of a critical amino acid
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for activation, or due to possible pro-apoptotic effects of the resulting break-down products (Moffett
and Namboodiri 2003). Interestingly, IDO plays a key role in immune evasion during tumourigenesis
to allow cancerous cells to ‘hide’ from the immune system (Soliman et al. 2010). It is possible
that the hBMSC were producing IDO in response to the NK cell cytotoxic effects as a regulatory
response to the cell lysis. IDO production by hBMSC is stimulated by IFNγ, among other cytokines
(Roemeling-Van Rhijn et al. 2013). IFNγ can be secreted by NK cells, and is significantly upregulated
by binding with hBMSC, in normoxic co-cultures (Poggi et al. 2005). It is possible that no IDO
upregulation was seen in the hypoxic condition since expression was already maximal. The other
possibility is that IFNγ secretion by NK cells is downregulated by hypoxic conditions. There is
very little work on this, but one study using oligomycin treatment of NK cells, which approximates
chemical hypoxia by inhibiting oxidative phosphorylation, showed that IFNγ synthesis following NK
cell receptor activation was decreased in treated NK cells (Keppel et al. 2015). However, CXCL10
expression is dependent on IFNγ and so this is unlikely to be the sole mechanism. Further work on
the cytokine profiles of NK cells in hypoxic conditions with or without stimulation with IL-2, or
other cytokines, might demonstrate whether IFNγ secretion is altered by oxygen level. The lack of
alteration in the HIF-1α expression following IL-2 stimulation again may not indicate no response to
hypoxic conditions, but rather that the expression in the unstimulated co-cultures was already maximal
and therefore no further increase was possible. It must be noted that this work solely examined the
gene expression and not the transcription or secretion of these proteins. To truly understand the
functional consequences of these changes, protein analysis is required.
A final finding from this work is a potential new characterisation marker for hBMSC. During the
adhesion phase of the hBMSC on the Xcelligence, an adhesion trough was observed on the traces.
This trough appears to be unique to hBMSC, and was remarkably consistent between all donors, as
well as hypoxic and normoxic strains. The feature has been previously observed on normoxically
cultured hBMSC, but not on those isolated under hypoxic conditions (Moniri et al. 2014). The initial
peak in the Xcelligence traces and the trough appeared at approximately the same times on all hBMSC
traces, regardless of donor, oxygen level, or indeed treatment with NK cells or IL-2. The initial
peak value, minimal value and magnitude of the trough was also consistent. This feature has not
been observed on Xcelligence traces of any other cell type, including astrocytes, lung carcinoma,
HeLa, peripheral blood lymphoma, pancreatic cancer, embryonic stem cells, or embryonic stem cell
/ induced pluripotent stem cell-derived cardiomyocytes, suggesting that it could be used as a novel
characterisation technique for hBMSC (Bio 2018; Moodley et al. 2011; Papke et al. 2016; Zhao et al.
2017).
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5.4.1 Limitations of the study
Use of the Xcelligence further permitted real-time monitoring of hBMSC lysis by NK cells. The
Xcelligence system records impedance of signal across the well base, and uses a function of the
impedance (‘Cell Index’) to indicate changing coverage of the well base with cellular material. An
increased Cell Index can therefore indicate increasing numbers of cells, increased cell size, or a
combination of the two, with the inverse also being true. The concern was that a decreased cell index
in the experiment might have been due to cells decreasing in size, or entering suspension rather than
dying. However, other experiments performed in this chapter demonstrated that lysis was occurring in
the hBMSC population. Decreased adhesion and hBMSC rounding may have been occurring during
the lysis process, but this cannot be separated from the cell index change due to cell death. The
output is qualitative only, and therefore only relative statements regarding numbers of cells remaining
can be made. Further experiments could quantify this with complementary assays such as lactate
dehydrogenase or Pico Green to give an absolute number of hBMSC in the well at specific time-points.
A potential confounding factor was that IL-2-activated NK cells did show semi-adherence which
could have altered the impedance. However, neither in this experiment, nor in a similar experiment
using astrocytes and activated NK cells, was interference from the NK cells seen (Moodley et al.
2011). This particular study also supports the conclusions made here that the decreased cell index
was due to NK cell mediated lysis.
A final consideration with the system was the presence of gold on the well base which was in contact
with the adhered hBMSC. The gold was fixed to the well base, and hence transfer of material was
expected to be negligible. While gold is considered biologically inert, gold nanoparticles have been
observed to alter cell morphology in culture (Söderstjerna et al. 2013). However, gold films used as
substrates appear to promote normal cell growth, viability, and morphology and so any influence from
the basal gold electrodes was considered to have no influence on the results (Menti et al. 2016).
Co-cultures were not fed during the assay, in line with similar experiments performed using the
Xcelligence, so the wells containing higher numbers of NK cells could have been influenced due
to culture medium exhaustion. The decreased energetic requirements of cells in hypoxic culture
conditions could explain the difference in the traces of different oxygen levels. However, there are
several points against this. First is that visual inspection of the plates after the 7 day period did not
show large variation in the colouration of medium, which retained a pink tint, across the different NK
to hBMSC ratios indicating that the medium was not fully depleted. Secondly, increasing ratios of
NK cells are known to have greater growth suppressive effects (Moodley et al. 2011). Further, the
stratification of cell index relative to NK cell ratio was evident from approximately 50 to 60 hours and
was relatively consistent thereafter with the trends established at this point being maintained. This
early indication and trend stability argues against medium depletion being a factor, as this would be
expected to be visible at a later timepoint.
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A further limitation of this work, and many similar studies, could be that observed phenomena were
due to the use of allogenic NK cells, rather than autologous. NK cells display self-tolerance in
healthy individuals, preventing auto-aggression through interaction with Major Histocompatibility
Complex (MHC) Class I and various other inhibitory receptors (Orr and Lanier 2010). It might be
expected, therefore, that co-cultures of NK cells with autologous hBMSC would not show lysis due
to the suppression of NK cell cytotoxicity by the regulatory receptors. However, this is not the case.
In-vitro experiments using autologous and allogenic NK cell – hBMSC co-cultures showed that, when
activated, NK cells had equal lytic ability against both autologous and allogenic hBMSC in normoxic
conditions (Sotiropoulou et al. 2006; Spaggiari et al. 2006). A study examining NK responses to
engraftment of murine hBMSC isolated from an inbred mouse strain and implanted into the same
strain showed that the NK cells lysed the hBMSC (W.-H. Huang et al. 2014). Although not truly
autologous, the use of inbred mouse strains where individuals are considered genetically identical
suggests that NK cells lyse autologous hBMSC in-vivo.
Although the use of allogenic hBMSC and NK cells has been reported in previous studies, my study
differs in the use of NK cells isolated from presumably younger, healthy donors, and hBMSC from
aged donors with advanced OA. This difference in donor age and health status may have resulted in
some of the observed differences seen between my results and other studies. As previously discussed
(section 3.4), ageing influences hBMSC, reducing their proliferative and immuno-modulatory potential,
among other features (Muschler et al. 2001; Stiehler et al. 2016). However, ageing also influences
NK cells, resulting in decreased activity in addition the generalised dysregulation of innate immunity,
leading to alterations in relative subpopulation prevalence and activation status, seen as ageing
progresses (Hazeldine and Lord 2013; Shaw et al. 2013). As a result, the observed interactions
between ‘elderly’ hBMSC and ‘young’ NK cells may differ from those seen where donors are age
matched: it is possible that the ‘young’ NK cells have higher activity due to the age of the donor
and the fact that the ‘elderly’ hBMSC have lost immuno-modulatory potential, leading to a more
potent observed NK cell cytotoxic effect. The use of aged donors is uncommon, making comparable
research scarce.
The IL-2 concentration used in this study was widely supported by other studies and selected due
to its ability to activate NK cells in-vitro. However, the concentration may not be representative of
the in-vivo concentration in a haematoma. Furthermore, a haematoma contains a complex mixture
of cytokines as well as other NK cell activating factors, with both temporal and spatial variations in
the composition. As previously discussed, IL-2 stimulation was found to have similar effects on NK
cell activation as other single or combination cytokine treatments, such as combine IL-12 / IL-15
administration (Sotiropoulou et al. 2006) This drawback is not unique to this study.
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5.4.2 Future Directions
While both autologous or allogenic NK cells have been shown to have similar effects on the hBMSC,
the donor age and health status mismatch may alter the observed interactions. The wider research has
used samples taken solely from young donors. Use of autologous samples from elderly donors would
be ideal, but would have ethical and practical constraints: NK cells would need to be isolated between
14 to 28 days after hBMSC isolation to allow hBMSC adhesion and expansion. Donors would have
therefore recently undergone a significant surgery, which may alter their immune status. Therefore,
allogenic cultures could be used, although donor inclusion criteria would be challenging due to the
prevalence of co-morbidities in elderly cohorts. In this instance, use of non-human tissue sources,
such as inbred mice, would be preferable. Additionally, the replication of this work on hBMSC and
NK cells isolated from young, healthy, human donors, where the hypoxic / normoxic comparison has
not been done, would allow for autologous cell usage, as well as being in a more relevant population
due to the suggested age at which bone marrow stimulation treatments might be employed.
The ratios of NK cells and the stimulation technique, IL-2, were derived from optimisation work and
previous studies. However, the biological significance of these conditions is unknown. Use of an in-
vivo model of bone marrow stimulation, or of early fracture haematoma samples from human donors
would provide evidence of the prevalence of relevant cell types. This could be examined through
techniques including immunohistochemistry or flow cytometry. Further, the cytokine profile of the
haematoma could be identified. This could provide more biologically relevant stimulation methods,
either through artificial addition of supplements to medium, or through addition of haematoma
supernatants to co-cultures. Understanding how the hBMSC, NK cells, and their combination interact
and react to these conditions could provide greater understanding of the functional consequences of
the early haematoma microenvironment on repair outcome. Future work could focus more closely on
the functional changes occurring within the hBMSC populations, including but not limited to markers
of stress, senescence, differentiation or protein secretion. As an extended project, further elements of
the haematoma microenvironment could be added to the model, such as decreased pH and a three
dimensional (3D) substrate.
5.4.3 Summary
hBMSC isolated from elderly OA donors retain immuno-modulatory properties enabling them to
regulate lysis by IL-2 activated NK cells in a dose-dependent manner. However, the AUC50 values
were lower when compared to previously reported values obtained using hBMSC from young adults
indicating a possible age-related loss of immuno-modulatory capacity in vitro. Further, culture under
hypoxic conditions reduced NK cell-mediated hBMSC cytotoxicity in both unstimulated co-cultures,
where no influence on hBMSC survival was seen at any ratio, and in stimulated co-cultures compared
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to the normoxic conditions. The killing of hBMSC by NK cells was contact-dependent and targeted.
Further, the co-cultures elicited very different gene expression profiles, demonstrating that hBMSC
interactions with and responses to NK cells are strongly dependent on oxygen level.
Chapter 6
Examining the interactions between
hBMSC and monocytes under normoxic
and hypoxic conditions
6.1 Abstract
Aim: To characterise the interactions between monocytes and hBMSC under normoxic and hypoxic
conditions.
Methods: Expression of Vascular Endothelial Growth Factor A (VEGF-a), SDF-1, and FGF-2 in
co-cultures of hBMSC and monocytes were compared with that in monocytes stimulated down M1,
M2a, and M2c macrophage lineage under normoxic and hypoxic conditions. Gene expression of key
markers of monocyte differentiation were examined by flow cytometry for co-cultures in hypoxic
and normoxic conditions. The tube forming stimulating activity of supernatants from normoxic and
hypoxic condition hBMSC-monocyte co-cultures was assessed using a HUVEC tube forming assay.
Finally, the chemotactic effects of monocytes in normoxic and hypoxic conditions were assessed by
real-time migration assays.
Results: SDF-1, FGF-2, and VEGF-a expression were higher in normoxic compared to hypoxic
conditions in the co-cultures, and most similar to the M2c differentiated macrophages. However,
gene expression showed that a major subpopulation of the co-cultured monocytes in normoxic condi-
tions was (CD209+)(CD16+)(CD163+), with a further subpopulation expressing CD80. Hypoxic
conditions appeared to prevent development of this subpopulation. Supernatants from co-cultures
under normoxic conditions resulted in increased tube forming activity in HUVECs compared to
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control, while no change was seen in the hypoxic conditions. Finally, monocytes appeared to have a
chemotactic effect on hBMSC in normoxia, and a more chemokinetic effect in hypoxic conditions.
Conclusion: The oxygen level used in hBMSC isolation and co-culture with monocytes has significant
effects on the interaction between the cells. Interaction in normoxic conditions resulted in the
development of an immunomodulatory macrophage-like population with pro-angiogenic properties,
which was not seen in the hypoxic condition.
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6.2 Introduction
Forty-eight hours after fracture occurs, monocytes are among the most numerous cell types within a
haematoma (Könnecke et al. 2014; Pence and Woods 2014). These rapidly migrating cells, which
comprise between 3 to 8 percent of circulating cells in a healthy adult, are key mediators of repair
(Monie 2017). Monocytes mediate repair directly, through phagocytosis, antigen-presentation, and
cytokine release, as well as through differentiation into macrophages and dendritic cells (Geissmann
et al. 2010). Recent studies in the heart and liver have shown that monocytes / macrophages have an
important regulatory role in the development and resolution of fibrosis, an ability of particular interest
with regards to surgical bone marrow stimulation techniques, due to the prevalence of fibrocartilage
within the repair tissue (Lech and Anders 2013; Pellicoro et al. 2014). The monocyte-derived
effector cells, macrophages and dendritic cells, retain features of the monocyte (antigen-presentation,
phagocytosis and cytokine release) while also having more specialised roles in repair. For example,
monocytes are able differentiate into macrophages which can be polarised towards pro-inflammatory
(M1, or classically activated) macrophages, or broadly anti-inflammatory (M2, or alternatively
activated) macrophages, depending on the environment (Lech and Anders 2013; Wu et al. 2013).
Generally speaking, M1 macrophages have greater phagocytic behaviour and are associated with
clearance of debris and the anti-microbial response, while M2 macrophages are more secretory and
are associated with the resolution of repair. The M1:M2 balance has profound consequences for
repair; following fracture, a skew towards an M1 phenotype is detrimental to bone formation, since a
delayed repair is ultimately less problematic than an infected wound, while an M2 skew enhances
bone formation as a result of increased osteoblastogenesis (Gu et al. 2017; Lu et al. 2017; Pajarinen
et al. 2018; Schlundt, El Khassawna, et al. 2018). Indeed, the increased osteoblastogenesis appears
to result from cross-talk between monocytes / macrophages and hBMSC and is an example of one
instance where monocytes / macrophages interact with hBMSC to bring about repair.
Interactions between monocytes / macrophages and hBMSC have been studied under normoxic
conditions, but the understanding of interactions under hypoxic conditions is incomplete or has been
performed using hBMSC isolated and cultured under normoxic conditions (Rosová et al. 2008).
In the previous chapters, it was shown that the isolation conditions of the hBMSC have profound
consequences for their behaviour, both in mono- and co-cultures. As a result, it was hypothesised
that the oxygen conditions of the hBMSC-monocyte co-culture could be critical to the outcome of
the interaction, resulting in altered phenotypes in both cell types. In this chapter, the influence of
the co-culture on monocyte behaviour was interrogated first. This was examined by considering
gene expression, cell surface markers, and functional outputs (angiogenesis) through RT-qPCR, flow
cytometry, and tube forming assays. Finally, the chemotactic influence of monocytes on hypoxic and
normoxic isolated and cultured hBMSC was explored to demonstrate physical association between
the cell types.
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Fig. 6.1 Comparison of gene expression of HIF-1α by co-cultures of monocytes and hBMSC in
normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes co-cultured
with hBMSC for 7 days under normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and
expression of HIF-1α was measured using RT-qPCR. Fold change relative to unstimulated cultures. Student’s
T-test p < 0.05. Error bars show compound standard deviation, as described in section 2.4.1 N = 3.
6.3 Results
Monocytes are among the most rapidly infiltrating cell types in the early haematoma, and previous
studies have shown that they are able to influence hBMSC migration. To characterise the consequences
of hBMSC – monocyte interactions within the haematoma in more detail, monocytes were extracted
from buffy coats and characterised by flow cytometry. An example of the population isolated can be
found in fig. 4.10a. Co-cultures of monocytes and hBMSC were set up for 7 days under normoxic
and hypoxic conditions, and changes in gene expression analysed using RT-qPCR. HIF-1α expression
was not altered by co-culturing monocytes with hypoxic isolated hBMSC under hypoxic conditions,
or with normoxic isolated hBMSC under normoxic conditions (fig. 6.1). However, the normoxic
co-cultures showed significantly higher expression of both IL-6 (fig. 6.2a) and CXCL10 (fig. 6.2b)
compared to the hypoxic co-cultures. Further, CXCL10 expression was not increased by co-culturing
monocytes and hBMSC under hypoxic conditions, although IL-6 expression was increased. The
relative increase in IL-6 expression was also higher than the increase in CXCL10 expression in the
normoxic co-culture.
Differences in the expression of pro-angiogenic genes between normoxic and hypoxic co-cultures
were also seen (fig. 6.3). Expression of FGF-2 (fig. 6.3a), SDF-1 (fig. 6.3b), and VEGF-a (fig. 6.3c)
were all significantly higher in normoxic co-cultures compared to hypoxic. Expression of FGF-2 and
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Fig. 6.2 Comparison of gene expression of IL-6 and CXCL10 by co-cultures of monocytes and
hBMSC in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes co-cultured
with hBMSC for 7 days under normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and
expression of IL-6 (fig. 6.2a), and CXCL10 (fig. 6.2b) were measured using RT-qPCR. Fold change relative to
unstimulated cultures. Student’s T-test p values: ∗< 0.05. Error bars show compound standard deviation, as
described in section 2.4.1 N = 3.
VEGF-a were increased in the hypoxic co-cultures relative to controls, but SDF-1 expression was not.
As with IL-6 and CXCL10 expression, the fold change increase in expression maintained a similar
ratio for FGF-2, SDF-1, and VEGF-a in both the normoxic and hypoxic co-cultures, with the greatest
increase in FGF-2, followed by VEGF-a, and SDF-1 showing the lowest increase.
To aid the further characterisation of monocytes co-cultured with hBMSC, macrophage subtypes
were produced from monocytes polarised into M1, M2a, and M2c subtypes using cytokine cocktails
of GM-CSF + IFNγ + TNFα, M-CSF + IL-4, and M-CSF + IL-10 respectively under normoxic
and hypoxic conditions. After monocyte differentiation the expression of the aforementioned pro-
angiogenic genes FGF-2 (fig. 6.4a), SDF-1 (fig. 6.4b), and VEGF-a (fig. 6.4c) were measured using
RT-qPCR. Under these conditions, the M2c polarised monocytes were the only subtype showing
upregulation of these three genes. As in the co-cultures, the upregulation was highest in FGF-2, lowest
in SDF-1 with VEGF-a being intermediary. However, unlike the co-cultures, the upregulation was
higher in the hypoxic condition compared to the normoxic.
To explore the similarity between the pro-angiogenic gene expression signature of co-cultured
monocytes and those differentiated with M-CSF + IL-10 in greater detail, monocytes were either
differentiated with M-CSF + IL-10 or co-cultured with hBMSC for 7 days under normoxic or hypoxic
culture conditions. A panel of surface antigen markers were used to characterise the monocytes
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Fig. 6.3 Comparison of gene expression of FGF-2, SDF-1, and VEGF-a by co-cultures of monocytes
and hBMSC in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes co-cultured
with hBMSC for 7 days under normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and
expression of FGF-2 (fig. 6.3a), SDF-1 (fig. 6.3b), and VEGF-a (fig. 6.3c) were measured using RT-qPCR. Fold
change relative to unstimulated cultures. Student’s T-test p values: ∗< 0.05. Error bars show compound
standard deviation, as described in section 2.4.1. N = 3.
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Fig. 6.4 Comparison of gene expression of FGF-2, SDF-1, and VEGF-a by monocytes differentiated
using three different cytokine panels in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes were either
differentiated using either GM-CSF + IFNγ + TNFα, or M-CSF + IL-4, or M-CSF + IL-10 for 7 days under
normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and expression of FGF-2 (fig. 6.4a),
SDF-1 (fig. 6.4b), and VEGF-a (fig. 5.4c) were measured using RT-qPCR. Fold change relative to unstimulated
cultures. Error bars show compound standard deviation, as described in section 2.4.1 N = 3.
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Fig. 6.5 Comparison of CD64, CD14, and CD31 marker expression on differentiated and co-cultured
monocytes in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes were either
differentiated using M-CSF and IL-10 (fig. 6.5a, N = 3), or co-cultured with hBMSC (fig. 6.5b, N = 4) for
7 days under normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and the CD45-positive
fraction was characterised by flow cytometry for expression of CD64, CD14, CD31, CD200R, Tie2, CD11b,
CD163, CD16, CD209, and CD80. No significance was found between normoxic and hypoxic pairs within a
sample. CD14 expression was significantly different in both conditions between the differentiated cells and the
co-culture (Multiple T-test, p < 0.05).
following the 7 day period. These markers were assessed by both single colour (figs. 6.5 to 6.7) and
multiparametric (figs. 6.8 and 6.9) flow cytometer analysis.
Assessment of key monocyte markers CD64, CD14, and CD31 (fig. 6.5) showed that there was no
difference between expression levels of any of the markers when cells were cultured under hypoxic
or normoxic conditions for both the differentiated (fig. 6.5a) and co-cultured (fig. 6.5b) monocytes.
Expression of CD64, and CD31 was the same in the differentiated and co-cultured monocytes. CD14
expression was higher in the co-culture condition in both hypoxic and normoxic conditions (fig. 6.5b)
compared to the corresponding hypoxic and normoxic conditions for the differentiated monocytes
(fig. 6.5a). Assessment of pro-inflammatory monocyte markers CD200R, CD11b, Tie2, and CD80
(fig. 6.6) showed that levels of markers were expressed at a low level in both differentiated (fig. 6.6a)
and co-cultured monocytes (fig. 6.6b). There was no statistical difference between the levels of
expression of CD200R, CD11b, or Tie2 in hypoxic and normoxic conditions for either differentiated
or co-cultured monocytes, or between paired conditions as before. By contrast, CD80 was significantly
higher in normoxic conditions than hypoxic in the co-culture condition, and both were higher in the
co-culture than in the differentiated monocytes. The most striking differences were in the expression
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Fig. 6.6 Comparison of CD200R, Tie2, CD11b, and CD80 marker expression on differentiated and
co-cultured monocytes in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes were either
differentiated using M-CSF and IL-10 (fig. 6.6a N = 3), or co-cultured with hBMSC (fig. 6.6b N = 4) for
7 days under normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and the CD45-positive
fraction was characterised by flow cytometry for expression of CD64, CD14, CD31, CD200R, Tie2, CD11b,
CD163, CD16, CD209, and CD80. No significance was found between normoxic and hypoxic pairs within a
sample, or between conditions in the differentiated and co-culture samples for CD200R, TIE2 or CD11b.
Expression of CD80 was significantly different between co-cultured, but not differentiated samples in hypoxic
and normoxic conditions (Multiple T-test, p values: ∗∗< 0.005). Error bars show standard deviation.
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Fig. 6.7 Comparison of CD163, CD16, and CD209 marker expression on differentiated and
co-cultured monocytes in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes were either
differentiated using M-CSF and IL-10 (fig. 6.7a N = 3 ), or co-cultured with hBMSC for 7 days (fig. 6.7b
N = 4) under normoxic or hypoxic culture conditions. After 7 days, cells were retrieved and the CD45-positive
fraction was characterised by flow cytometry for expression of CD64, CD14, CD31, CD200R, Tie2, CD11b,
CD163, CD16, CD209, and CD80. No significant difference was seen between expression levels in the
differentiated samples. Expression of all markers was significantly different between the normoxic and hypoxic
condition in the co-cultured samples. (Multiple T-test, p values: ∗∗< 0.005, ∗∗∗< 0.0005). Error bars show
standard deviation.
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Fig. 6.8 Comparison of multiparametric marker expression of CD163, CD16, and CD209 on
co-cultured monocytes in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes were
co-cultured with hBMSC for 7 days under normoxic or hypoxic culture conditions. After 7 days, cells were
retrieved and the CD45-positive fraction was characterised by flow cytometry for expression of CD64, CD14,
CD31, CD200R, Tie2, CD11b, CD163, CD16, CD209, and CD80. Multiparametric marker expression of
CD163, CD16, and CD209 on monocytes co-cultured with hBMSC, N = 4. Significant difference between
normoxic and hypoxic culture conditions (Student’s T-test, p values: ∗∗< 0.005). Error bars show standard
deviation.
Fig. 6.9 Comparison of multiparametric marker expression of CD163, CD16, CD209, and CD80 on
co-cultured monocytes in normoxic and hypoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes were
co-cultured with hBMSC for 7 days under normoxic or hypoxic culture conditions. After 7 days, cells were
retrieved and the CD45-positive fraction was characterised by flow cytometry for expression of CD64, CD14,
CD31, CD200R, Tie2, CD11b, CD163, CD16, CD209, and CD80. Multiparametric marker expression of
CD163, CD16, CD209, and CD80 on monocytes co-cultured with hBMSC, N = 4. Significant difference
between normoxic and hypoxic culture conditions (Student’s T-test, p values: ∗∗∗∗< 0.0001). Error bars
show standard deviation.
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of the more immunoregulatory markers CD163, CD16, and CD209 (fig. 6.7). CD209 was significantly
upregulated in both conditions of the co-culture (fig. 6.7b), compared to their paired counterparts
in the differentiated monocytes (fig. 6.7a). In the differentiated monocytes (fig. 6.7a), there were
no difference between the hypoxic and normoxic condition. However, expression of CD163, CD16,
and CD209 were all significantly higher in the normoxic condition than the hypoxic condition in
the co-culture (fig. 6.7b). Multiparametric analysis of the data showed that CD163, CD16, and
CD209 co-expression was present in over 40 % of co-cultured monocytes in normoxia (fig. 6.8). By
contrast, fewer than 10 % of monocytes showed triple-positive co-expression in the hypoxic co-culture
condition. Furthermore, around 13 % of co-cultured monocytes in the normoxic condition showed
quadruple positive expression of CD163, CD16, CD209, and CD80 (fig. 6.8). As a result of increased
pro-angiogenic gene expression and to assess the potential of the monocyte-hBMSC co-cultures
to influence blood vessel formation, a tube forming assay was developed and performed. Tube
formation assay optimisation was performed to determine the optimal seeding density of HUVECs,
concentration of cytokines, and timepoint for endpoint analysis (data not shown). The optimal tube
formation as assessed by number of master junctions / segments, mesh size, peak formation time
and stability was found to be 1×106 HUVECs per ml with high concentration of VEGF-a, SDF,
and FGF-2 after 12 hours. Filtered supernatants from one-week cultures of hBMSC or hBMSC and
monocytes under normoxic or hypoxic conditions were applied to HUVEC monolayers grown on
reduced growth factor basement membrane extract. Tube forming ability was assessed after 12 hours
using the Gilles Carpentier Angiogenesis Analyzer (sic) plugin for Image J (fig. 6.10). Since the
supernatants from hBMSC alone also induced tube formation activity, the data for hBMSC-monocyte
co-cultures were normalised against the paired hBMSC alone data. The number of both master
junctions (fig. 6.10a) and master segments (fig. 6.10b) was higher in normoxic conditions than in
hypoxic conditions (p < 0.05). However, there was no difference between normoxic and hypoxic
conditions in terms of total mesh area (fig. 6.10c) or number of extremities (fig. 6.10d).
To understand the influence of monocytes on hBMSC migration, monocytes were used in the Ibidi μ
chemotaxis slides as chemotactic agents for hBMSC under both hypoxic and normoxic conditions.
When endpoints of the traces corrected to a single origin point are examined, there is a clear difference
in behaviour (fig. 6.11). hBMSC isolated and cultured under normoxia show a clear chemotactic
response to monocytes with the endpoints tightly clustered towards the chamber containing monocytes
(fig. 6.11a). On the other hand, hBMSC from the same patient isolated and cultured under hypoxic
conditions have a scattered pattern of endpoints (fig. 6.11b). The majority of cells appear to have
migrated towards the monocytes, but the clustering seen in the normoxic condition is not visible. The
hypoxic hBMSC have also travelled further than the normoxic hBMSC; there are a large number of
normoxic hBMSC clustered near the origin, while most hypoxic hBMSC have migrated away from
the origin.
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Fig. 6.10 Comparison of tube forming activity stimulated by hBMSC-monocyte co-culture
supernatants from hypoxic or normoxic culture conditions
Monocytes were isolated from PBMC using the Miltenyi MACS Pan Monocyte kit. Monocytes co-cultured
with hBMSC for 7 days under normoxic or hypoxic culture conditions. After 7 days, supernatants were
removed and filtered through a 0.22 µm filter. Supernatants were applied to HUVECs on a BME substrate and
incubated for 12 hours under normoxic conditions. Wells were imaged on a bright field microscope and
analysed using the Angiogenesis Analyzer plugin for ImageJ. Readouts of the number of master junctions
(fig. 6.10a), number of master segments (fig. 6.10b), total mesh area (fig. 6.10c), and number of extremities
(fig. 6.10d) were taken. Results were normalised to hBMSC single culture supernatant tube forming ability.
Student’s T-test p values: ∗< 0.05. Error bars show standard deviation. N = 3.
160 Examining the interactions between hBMSC and monocytes
(a) Normoxic hBMSC with monocytes (b) Hypoxic hBMSC with monocytes
Fig. 6.11 Raw traces for hBMSC migrating in response to Pan monocyte isolated subpopulations in
normoxic and hypoxic conditions
hBMSC isolated under normoxia or hypoxia were seeded into the central chamber of an Ibidi μ slide 3D. Pan
Monocyte isolated PBMC were placed into a side chamber, creating a gradient of secreted factors across the
hBMSC. Migration of 30 hBMSC was tracked for 16 hours using MTrackJ plugin for Image J and data
analysed in Ibidi Chemotaxis tool. Dots show relative end points of cell movements from a normalized start
point (0,0). Location of maximum concentration: (0,−300), minimum: (0,300).
Examining the dynamics of the population movement showed that there was no difference between the
velocity of cells in normoxic or hypoxic conditions (fig. 6.12a). However, under hypoxic conditions
cell migration was significantly more directed compared to that under normoxic conditions (fig. 6.12b).
Further examination of the cell migration showed that the Centre of mass (CoM) of the hBMSC
moved towards the monocytes under both the normoxic and hypoxic conditions (fig. 6.13a), with the
CoM of both populations moving the same distance (fig. 6.13b).
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Fig. 6.12 Velocity and directness of hBMSC migrating in response to Pan monocyte isolated
subpopulations in normoxic and hypoxic conditions
hBMSC isolated under normoxia or hypoxia were seeded into the central chamber of an Ibidi μ slide 3D. Pan
Monocyte isolated PBMC were placed into a side chamber, creating a gradient of secreted factors across the
hBMSC. Migration of 30 hBMSC was tracked for 16 hours using MTrackJ plugin for Image J and data
analysed in Ibidi Chemotaxis tool. Velocity (fig. 6.12a) and directness (fig. 6.12b) of hBMSC migration was
calculated for the hypoxic and normoxic condition. Significant difference between directness in normoxic and
hypoxic culture conditions. Error bars show standard deviation. Two-way ANOVA with Tukey’s post hoc test,
p values: ∗∗< 0.005. N = 3, 30 tracks per replicate.
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Fig. 6.13 Centre of mass plots of hBMSC migrating in response to Pan monocyte isolated
subpopulations in normoxic and hypoxic conditions
hBMSC isolated under normoxia or hypoxia were seeded into the central chamber of an Ibidi μ slide 3D. Pan
Monocyte isolated PBMC were placed into a side chamber, creating a gradient of secreted factors across the
hBMSC. Migration of 30 hBMSC was tracked for 16 hours using MTrackJ plugin for Image J and data
analysed in Ibidi Chemotaxis tool. Centre of mass direction (fig. 6.13a) and centre of mass length (fig. 6.13b)
were calculated using the Ibidi Chemotaxis tool. No statistical differences, Student’s T-test (p < 0.05). N = 3.
Error bars show standard deviation.
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6.4 Discussion
Monocytes are a common cell type in the peripheral blood and accumulate in regions of trauma.
They are known to have bi-directional interactions with hBMSC, although the consequences of these
interactions in hypoxic conditions have not been completely explored. Greater understanding of how
the interactions between monocytes and hBMSC are modified by oxygen level could aid understanding
of spatio-temporal regulation of wound healing. Furthermore, there is evidence that monocytes are
capable of modifying NK cell cytotoxicity against hBMSC (Jewett et al. 2010).
The aim of this chapter was to characterise how interactions occurring between monocytes and
hBMSC were influenced by oxygen level. Initially, the influence of the co-culture on the global
behaviour of the co-cultures was examined, followed by more detail work focused on the monocytes.
Monocyte-hBMSC co-cultures were set up under normoxic (18.9 % oxygen), and hypoxic (3 %
oxygen) conditions. The outcomes of interactions were measured through gene expression, by RT-
qPCR, flow cytometry examining cell surface markers, tube forming angiogenesis assays, and real-time
migration tracking. As a result, data presented here shows that co-cultures of monocytes and hBMSC
exhibit more pro-angiogenic and pro-inflammatory effects under normoxic conditions, compared
to hypoxic conditions. This alteration was attributed to monocyte to macrophage differentiation
and polarisation within the co-cultures: co-culturing monocytes with hBMSC is known to polarise
monocytes towards differentiation into macrophages of the M2 lineage, which are more reparative
and pro-angiogenic (Melief et al. 2013; Vasandan et al. 2016). However, this finding was unexpected,
since the wider consensus is that both monocytes and hBMSCs are more pro-angiogenic in hypoxic
as opposed to normoxic conditions (H. Ding et al. 2013; Jaipersad et al. 2014; Potier et al. 2007;
Riboldi et al. 2013). Closer consideration of these hypoxic / normoxic comparison studies shows a
critical difference: my study used hBMSC isolated and cultured under hypoxic conditions, while the
other studies used hBMSC isolated and cultured under normoxic conditions which then underwent
hypoxic preconditioning, or were placed into hypoxic conditions. As a result, the altered outcome of
the co-culture in my study is likely attributable to the fundamental difference between the hypoxic and
normoxic hBMSC strains. Throughout this thesis, the influence of sustained hypoxic culture dating
from the time of isolation on hBMSC has been emphasised, and this finding is another indication of
the importance of culture conditions from point of isolation on hBMSC phenotype and behaviour.
Supporting the gene expression data was flow cytometry and tube forming data, which also showed a
similar pattern, with the normoxic co-cultures having increased pro-angiogenic influences compared
to the hypoxic. This was particularly apparent in the tube forming assay: although the hBMSC alone
were capable of inducing tube formation, the co-cultures under normoxic conditions showed increased
tube formation relative to hBMSC alone, while no change in tube forming capacity was seen in
the hypoxic co-cultures. Both hBMSC monocultures, and hBMSC-monocyte co-cultures showed
increased tube forming ability compared to monocyte-alone cultures. This increased tube forming
ability in the normoxic co-cultures dovetails with the RT-qPCR finding of increased expression of
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FGF-2, SDF-1, and VEGF-a in said conditions. However, this finding does not indicate whether
the increased pro-angiogenic effects were a result of alterations in the monocytes, hBMSC, or both.
Further work could use a CD45 MACS isolation process to separate the hBMSC and monocytes prior
to RNA isolation, which would allow the individual contributions of cell type to FGF-2, SDF-1, and
VEGF-a expression to be quantified. In addition, the gene expression of hBMSC and monocytes
co-cultured in a paracrine system, such as Boyden chambers, under hypoxic and normoxic conditions
could also be measured and compared to the direct co-cultures. A study has demonstrated that
cell-to-cell interaction is important in polarisation of monocytes when co-cultured with hBMSC,
although this work was only done under normoxic conditions (J. Kim and Hematti 2009).
One explanation for the difference in hypoxic and normoxic co-culture RT-qPCR data could have been
that the control cultures for the RT-qPCR in hypoxic had higher baseline expression, and therefore
while the fold change in secretion was smaller, overall secretion was higher. Examination of the raw
data suggests that this was not the case — in fact, the control cultures in normoxic conditions had
higher baseline secretion than the hypoxic condition, indicating that the absolute values were even
more disparate. At face value, a stronger pro-angiogenic response in a damaged region experiencing
hypoxic conditions makes sense; a hypoxic region lacks blood flow, and so vessel formation is required
to restore circulation and permit gas and nutrient exchange. However, there are regions of the body
such as the bone marrow, where hBMSC are situated, which are hypoxic in a healthy state (Hirao
et al. 2006). A blanket pro-angiogenic response to hypoxia would therefore be problematic: further
regulatory pathways must be involved. The hBMSC cultured under normoxic conditions may be
more pro-angiogenic due to their adaptation to high oxygen levels so that, when placed into hypoxic
conditions, they may attempt to compensate by stimulating angiogenesis to restore previous levels of
oxygen. It is possible that the hBMSC in this study which were isolated and cultured under hypoxic
culture conditions were more quiescent, better adapted to hypoxia, or simply less pro-angiogenic, than
those isolated under normoxic conditions. A cross-over experiment, placing the normoxic isolated
hBMSC into co-cultures in hypoxic conditions and vice versa might indicate whether this was the
case.
Interestingly, the HIF-1α expression levels were unaltered in both the normoxic and hypoxic co-
cultures. Consideration of the expression levels, rather than the fold change, showed that the HIF-
1α expression was uniformly higher in the hypoxic condition, relative to the normoxic condition.
Therefore, although the expression level was not altered by the co-culture, the basal expression was
higher in the hypoxic condition. This indicated that the direct co-culture of the hBMSC and monocytes
was not influencing the HIF-1α expression. However, gene expression data does not necessarily track
to protein levels or activity within the cell. Further, in normoxic conditions HIF-1α degrades rapidly,
but is stabilised under hypoxic conditions (Mills et al. 2009). As a result, the higher basal expression
of HIF-1α combined with the stabilisation in the hypoxic condition may have led to a much greater
HIF-1α protein level in said condition compared to the normoxic. This could be explored through
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directly measuring the HIF-1α protein or its modification in the co-cultures via Western Blot or
Enzyme-Linked Immunosorbent Assay (ELISA). However, the fact that there was no fold change
attributable to the co-cultures in HIF-1α expression does suggest a level of regulation occurring in
both conditions.
The IL-6 and CXCL10 expression levels were significantly elevated in normoxic co-cultures, while
in the hypoxic co-culture, IL-6 was upregulated to a lesser extent than in normoxia, and CXCL10
was unaltered. Since my model considered only the expression in the cell mixtures, only global
changes, rather than changes in the individual cell types, can be examined. There is conflict in the
literature regarding how hBMSC-monocyte interactions influence the expression of IL-6 and CXCL10.
Findings range from upregulation, through no change, to decreases in gene expression in both the
monocytes and hBMSC (Anton et al. 2012; Laranjeira et al. 2015; Melief et al. 2013). However,
where changes in expression were shown in these studies, the direction of the change was the same for
both genes, which was also seen in my study. Increased IL-6 and CXCL10 secretion is associated with
a pro-inflammatory phenotype, as well as increased migration in hBMSC, and with the development
of pro-inflammatory M1 macrophage phenotype in monocytes (Anton et al. 2012; Lech and Anders
2013).
Observation of the co-cultures indicated that the monocytes were adhering to the plastic rather
than remaining in suspension, indicating that the monocytes were differentiating. Co-culturing
monocytes with hBMSC is known to induce differentiation of the monocytes into macrophages, and
the pro-angiogenic effects seen could be attributable to a macrophage polarisation (Melief et al. 2013;
Vasandan et al. 2016). The use of the macrophage polarisation model is somewhat controversial, since
it implies that macrophages lack plasticity and have rigidly, clearly defined terminal differentiation
states and, furthermore, is an in vitro model which has not necessarily been observed in vivo. Indeed,
the number of macrophage polarisation subtypes increases with greater research, demonstrating that
rather than discrete macrophage identities, there is most likely a continuum of macrophage phenotype
and behaviour, with macrophages being able to move within the spectrum (Lech and Anders 2013;
Martinez and S. Gordon 2014; Sudan et al. 2015). Despite these drawbacks, this model offers a tool to
understand macrophage behaviour at a particular point during culture and allow comparisons between
my work and that of other groups.
To further understand the influence of the co-cultures on the monocyte differentiation and macrophage
polarisation, the co-cultured monocytes were characterised through comparison of cell surface marker
expression, measured by flow cytometry, with that of monocytes differentiated into macrophage sub-
types using cytokine mixtures. The chosen subtypes were M1 classically activated, M2a alternatively
activated, and M2c immunosuppressive type macrophages (Iqbal and Kumar 2015; Lech and Anders
2013; Stöger et al. 2010; Sudan et al. 2015; L. Xie et al. 2017). The markers selected for comparison
(CD64, CD14, CD31, CD200R, TIE2, CD11b, CD80, CD163, CD16, CD209) were chosen due
to their common use in defining macrophage subtypes (table A.1). M2b Immunoregulatory-type
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Macrophage (M2b) immunoregulatory subtype was not used, since the key activating compounds for
this subtype, lipopolysaccharide and immune complexes, are more associated with pathogen responses
rather than sterile inflammation as studied in this model. The M2c immunosuppressive macrophage
subtype had the most similar pattern of expression to the co-cultures. To confirm this, monocytes
driven down the M2c lineage using a cytokine mixture were compared to monocytes co-cultured with
hBMSC under both normoxic and hypoxic conditions based on marker expression by flow cytometry.
The results showed clearly that there was no difference in cell surface marker expression between
monocytes driven to differentiate to the M2c subtype in normoxic or hypoxic culture conditions using
cytokine mixtures. However, clear differences were seen between the monocytes co-cultured with
hBMSC under normoxic and hypoxic conditions. The co-cultured monocytes were more heteroge-
neous than the M2c driven monocytes, but both the M2c driven and co-cultured monocytes showed
CD14, CD16, and CD163 expression which would seem to indicate that the co-cultured monocytes
had an M2c-like phenotype.
However, the biggest difference between the conditions was the expression of CD209 on the co-
cultured monocytes compared to the M2c-driven monocytes; CD209 was relatively highly expressed
in the co-cultured monocytes, particularly in the normoxic condition, with no expression in the M2c
driven monocytes. CD209 was co-expressed with CD16, CD14, and CD163 in over 40 % of normoxic
co-cultured monocytes, with fewer than 10 % of the hypoxic co-cultured monocytes showing the same
expression pattern. A recent study showed that co-culturing macrophages with BMSC under hypoxic
conditions inhibited M1 to M2 transition of macrophages, which supports the decreased expression of
M2-like cell surface markers in my study (Faulknor et al. 2017). CD209, along with CD163, CD16
and high CD64, is expressed on a small subset of macrophages with high phagocytic ability and T
cell modulation via antigen presentation, suggesting that the co-culture resulted in development of
an immuno-modulatory phenotype (Park et al. 2016; Schenk et al. 2014). This subtype appears to
be generated through stimulation with IL-1β, IL-15, or Toll Like Receptor 2 / 1 Ligand (TLR-2/-
1L). CD209 is also known as Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing
Non-integrin (DC-SIGN) and was originally considered to be dendritic cell specific, although it has
now been identified on multiple different macrophage types, albeit these are primarily at sites of
inflammation, or tissue resident especially lymph node macrophages (Ochoa et al. 2008; Park et al.
2016; Schenk et al. 2014). This expression of CD209 in inflammatory conditions indicates that the
co-culture in normoxic conditions might have been more stressed or pro-inflammatory than in the
hypoxic condition. CD209 expression was not previously observed in co-cultures of monocytes
and hBMSC under normoxic conditions (J. Kim and Hematti 2009). However, that particular study
used monocytes isolated from whole blood by CD14-positive MACS. While this is commonly done,
CD14 is an Lipopolysaccharide (LPS) receptor and monocytes are activated by CD14-LPS complexes
(Landmann et al. 1998). LPS itself is used to polarise macrophages in vitro (Lech and Anders 2013).
It is possible that the selection method in that study could result in pre-conditioning of the monocytes
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due to binding of the selection antibody to CD14, while the monocytes used in this study were
unlabelled, leading to the difference between the data.
Additionally, a subset of this (CD209+)(CD16+)(CD163+) population also expressed CD80. In both
normoxic and hypoxic conditions, this comprised around one third of the (CD209+)(CD16+)(CD163+)
cells. These cells were significantly more numerous in the normoxic condition and so the (CD80+)
population was proportionately larger compared to the hypoxic condition. CD80 expression is associ-
ated with classically activated M1 type macrophages, and is considered a marker of pro-inflammatory
macrophages (Lech and Anders 2013; Stöger et al. 2010). CD80, also known as B7-1, is a co-
signalling molecule with roles in antigen presentation and T cell activation, similar to CD209 (L. Chen
2004; Park et al. 2016; Schenk et al. 2014). The co-expression of CD209, and CD163 suggest at a
dendritic identity, which is further supported by the expression of CD80 by a subpopulation; CD80
expression is upregulated as DC mature (Collin et al. 2013). However, DC do not express CD16,
and only a subpopulation of DC (interstitial DC) express CD14. The fact that the proportion of the
(CD209+)(CD16+)(CD163+) population expressing CD80 was similar in normoxic and hypoxic
conditions suggests that the same interactions were occurring between the hBMSC and monocytes
in hypoxic and normoxic conditions, but this was weaker in the hypoxic condition, leading to lower
levels of differentiation. Although the CD14/CD16 expression data would suggest at a macrophage
identity, further work could use other more specific markers such as CD11c or CD103 for DCs to
definitively identify the cell type derived from co-cultured monocytes (Merad et al. 2013).
The migration induced in hBMSC by monocytes was examined under normoxic and hypoxic con-
ditions, to understand whether the populations would have the potential co-localise in vivo. This
showed that while both monocytes induced migration in hBMSC under both hypoxic and normoxic
conditions, the normoxic condition had a stronger chemotactic effect, with the hypoxic condition
inducing more chemokinesis, as seen by the greater spread in the migration traces. That being said, the
hypoxic traces showed greater directness than the normoxic traces. hBMSC migration has previously
been shown to be reduced under hypoxic conditions (Raheja et al. 2011). However, this study used
hBMSC which had been isolated from a juvenile donor under normoxic conditions, which were then
placed into hypoxic conditions. As discussed previously, this may result in differences in the hBMSC
population and correspondingly different behaviours during co-culture.
6.4.1 Limitations
Many of the limitations of this study have already been discussed in previous chapters: the use of
allogenic cell sources, the use of elderly hBMSC, and the use of LRS cones have all been covered. In
addition, the use of the mixed co-culture for RT-qPCR and lack of protein expression data have been
previously discussed.
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Like many studies, the tube forming assay was used to provide functional assessment of pro-angiogenic
potential. This assay uses HUVECs which have high angiogenic potential and, if treated with pro-
angiogenic factors when grown on a gel substrate, will form pseudocapillaries (W. Chen et al. 2018).
This assay is widely used, provides quantifiable outputs, and is relatively simple, being a short
assay and not requiring animal usage and, as a result, is often used to screen compounds for effects
on angiogenesis. This method does have drawbacks: the capillaries formed are non-functional
pseudocapillaries, the matrix is only formed in 2 dimensions, and the results may not represent in vivo
processes. In vivo angiogenic assays, such as the chick chorioallantoic membrane assay or the mouse
Matrigel plug angiogenesis assay provide more potentially biologically relevant data, but are more
complex and less suited for screening or preliminary investigations (D. Xie et al. 2016). Furthermore,
the assay used only supernatants from the co-cultures, rather than the cells themselves. Monocytes,
for example, are known to support the formation of capillary networks (Dalton et al. 2014; Sidibe et al.
2018). As a result, some elements of the biology of the system have been neglected through the use of
supernatants. However, three-cell tube forming systems are extremely rare in the literature due to the
challenge in creating and interpreting them. This would be an ideal opportunity for a future study.
6.4.2 Future directions
Some future directions have already been suggested previously within this discussion, albeit mainly
adding extra details to the existing work. The aforementioned extension of the tube forming assay work
would be a key initial point for development of further work. In addition, performing the assays within
a simulated pro-inflammatory environment through the addition of cytokines such as IFNγ, TNFα, or
IL-1β, or through the addition of haematoma supernatant could indicate how these interactions were
influenced not only by the oxygen level, but also the biochemical environment of the repair. Further,
greater in-depth analysis of the hBMSC-monocyte interactions could be performed, perhaps tracking
the exchange of microvesicles, mitochondria, or other cellular material, to demonstrate the vector by
which the cells communicate when in direct co-culture.
Greater understanding of how monocytes and hBMSC interact within the haematoma following
bone marrow stimulation could be obtained by extending the co-culture model. This could be done
through addition of pro-inflammatory stimuli, as mentioned within chapter 5, which could include
administration of cytokines such as IL-1β, IL-8, or TNFα, or haematoma supernatants (Gerstenfeld
et al. 2003). In addition, a greater number of oxygen levels ranging from 1 to 18.9 % oxygen could be
used to demonstrate the temporal changes in the oxygen content of a haematoma during the switch
from the inflammatory to the re-vascularisation phase. This work could also be used as a prelude to
development of a three-cell system to allow development of a more detailed in vitro model of trauma
induced repair following bone marrow stimulation.
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6.4.3 Summary
This study has shown that co-cultures of hBMSC and monocytes develop a pro-angiogenic, immuno-
modulatory phenotype under normoxic conditions. However, this is inhibited in hypoxia, likely due
to the hBMSC which had been isolated and cultured under hypoxic conditions. In this respect, this
study is differentiated from other studies, which used hBMSC isolated under normoxic conditions
and then exposed to hypoxia. This difference between the normoxic and hypoxic conditions could
represent the temporal influence of oxygen on hBMSC-monocyte interactions during repair; in the
early stages of repair, the haematoma lacks a blood supply and is profoundly hypoxic. As repair
progresses, the damaged tissue surrounding the haematoma is re-vascularised and the oxygen level
at the periphery increases, gradually invading the haematoma and creating an oxygen gradient. The
inhibition of the pro-angiogenic, immuno-modulatory phenotype in the hypoxic conditions could
represent a mechanism to ensure a controlled repair, by preventing suppression of the inflammatory
response and angiogenesis until appropriate clearance and stabilisation of the wound had occurred,





The aim of this body of work was to extend the present understanding of the consequences of
interactions occurring between hBMSCs and PBMCs within the haematoma formed by surgical
bone marrow stimulation techniques, as opposed to pharmacological stimulation, for example by
Granulocyte Colony Stimulating Factor (G-CSF). To do this, hBMSC which had been isolated and
cultured under normoxic and hypoxic conditions were characterised, with the normoxic strains
representing the cell populations commonly used in other studies or therapeutically, and the hypoxic
strains representing the endogenous hBMSC population. These cells were then used in parallel
migration assays with subpopulations of PBMC isolated using sequential magnetic activated cell
sorting to identify a population resulting in hBMSC migration. Characterisation of this population
showed that it comprised a NK cell population. Co-cultures of NK cells and hBMSC under hypoxic
and normoxic conditions showed that under hypoxic conditions, hBMSC were able to modulate the
activity of NK cells to a greater degree than the same system under normoxic conditions. Co-cultures
of hBMSC and monocytes showed that co-cultures exhibited pro-angiogenic and pro-inflammatory
behaviour, attributed in part to monocyte-to-macrophage differentiation under normoxic conditions.
This behaviour was significantly reduced under hypoxic conditions. hBMSC recruitment by monocytes
was also influenced, with greater chemotaxis seen in the hBMSC under normoxic conditions. As a
result, this work has explored some facets of PBMC-hBMSC interactions which are likely to occur
within the haematoma formed following bone marrow stimulation techniques and has made novel
contributions to the current understanding. This final discussion will summarise the key findings and
outlooks for this work.
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Table 7.1 Comparison of donor characteristics between this study and a sample of those in the wider
literature. (*one study)
My Work Wider Literature
Donor Age 64 to 87 years Paediatric* – 45 years
Donor Health Status Advanced OA, unknown co-morbidity
Paediatric Spinal Scoliosis*
Other: Healthy




7.2.1 Donor characteristics and donation site alter hBMSC behaviour in vitro
Throughout this thesis, comparisons have been made between my work and that in the wider literature.
A constant theme has been the differences seen between the results obtained using hBMSC isolated
under normoxic conditions in this work and those in other studies. The key differences between the
hBMSC used in the wider literature, and those used in my study, were the age, health status, and site
of donation as outlined in table 7.1.
The normoxic hBMSC isolated in my study did show characteristics of hBMSC populations, including
osteogenic, adipogenic, and chondrogenic differentiation, the ability to form colonies, and cell surface
markers at abundances close to those specified by the ISCT (Dominici et al. 2006). However, the
behaviour of the cells did show differences from those reported in the literature. Examples of this
include the observation that the colony forming unit activity was significantly lower in the aged
hBMSC compared to those from younger donors. Another example is the decreased ability of aged
normoxic hBMSC to modulate killing by NK cells, either with or without activation, leading to greater
hBMSC death. The immuno-modulatory ability of hBMSC reported in the literature was significantly
higher than that seen in my studies (Poggi et al. 2005; Sotiropoulou et al. 2006; Spaggiari et al. 2006).
As a result, this work has shown that while hBMSC can be isolated from the tibia and femur of elderly
donors with advanced OA, the hBMSC obtained have decreased proliferative and immuno-modulatory
function (in terms of modulating NK cell activity). In addition, far fewer hBMSC were present in
the marrow samples received due to the greater reversion of red marrow to yellow marrow in the
appendicular compared to the axial skeleton. Although the number of variables present prevents
identification of donor site, disease stage, or age as the principle cause of this shift, my work has shown
that the hBMSC found within the osteoarthritic knee of elderly patients have lower proliferative and
immuno-modulatory potential compared to those from the axial skeleton of younger, healthy donors.
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This may provide some insight as to why bone marrow stimulation techniques lose effectiveness in
elderly patients.
7.2.2 Isolation and culture of hBMSC under hypoxic conditions results in altered
hBMSC phenotype and behaviour, and is different from hypoxic pre-exposure
The use of hypoxic-preconditioning, rather than permanent hypoxic culture, is widespread throughout
the current literature. My work has shown that, in terms of hBMSC phenotype and behaviour, the
two are not the same. The first indication of this was that hypoxic hBMSC did not shows osteogenic
ability, and a preliminary study suggested that moving the cultures to normoxic conditions did not
restore osteogenic ability. The colony formation ability of hBMSC was not higher in the hypoxic
condition than the normoxic condition, although proliferation was higher in my study, contrasting
with the literature which showed increased colony formation in hypoxic preconditioned hBMSC
(Ang et al. 2010). In addition, studies using hypoxic preconditioned hBMSC showed that CD90
expression was decreased by hypoxic culture: my study showed the reverse, with CD90 expression
higher in the hypoxic hBMSC compared to the normoxic (Adesida et al. 2012). Sustained hypoxic
culture and hypoxic preconditioning appeared to result in different hBMSC populations, which
may not be functionally equivalent. My work has shown that sustained hypoxic culture results
in hBMSC with different phenotypes and behaviours compared to those exposed cells grown in
normoxia and then moved to hypoxic conditions. One possibility for the observed variation between
the populations may be due to different selection pressures placed upon the hBMSC during the initial
adhesion and expansion phase. These observations also hold true for the hBMSC-PBMC co-cultures:
as in the published studies discussed in chapter 4, chapter 5, chapter 6, PBMC were used fresh
and isolated using similar methods, hence the differences between my work and the studies in the
literature were unlikely to have arisen due to the PBMC. The hBMSC niche within the bone marrow
is profoundly hypoxic, and so isolation under normoxic conditions would place oxidative stress on
the cell population, selecting for a subpopulation with the greatest tolerance to stress. To contrast,
hypoxic isolation conditions may more closely recreate niche conditions, which may range from 0.6
to 2.8 % oxygen, leading to a heterogenous population more like the resting, quiescent population
(Spencer et al. 2014). This hypothesis is supported by the potent immuno-modulatory influence seen
in direct co-cultures of hypoxic hBMSC and non-activated NK cells: no killing was seen, in contrast
with normoxic hBMSC and non-activated NK cells where hBMSC death occurred. In fact, this finding
would suggest that hBMSC should be isolated and cultured under hypoxic conditions and may have a
distinctly different influence in regenerative therapies.
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7.2.3 Isolation and culture of hBMSC under hypoxic conditions influences interac-
tions with PBMC
Both direct and paracrine interactions between hBMSC and PBMC were modulated by the oxygen
level of the system in a way consistent with events occurring during repair. The lack of non-activated
NK cell killing of hBMSC under hypoxic conditions has already been attributed to the immuno-
modulatory abilities of resting hBMSC within their intact niche. The fact that increased oxygen levels
or NK cell activation resulted in hBMSC lysis supports the niche hypothesis: these conditions would
not be found within healthy, undamaged bone marrow and so are consistent with conditions and events
occurring after trauma, where oxygen levels have been shown to increase from the physoxic 0.6 to
2.8 % as a result of bleeding from ruptured blood vessels (Spencer et al. 2014). In terms of recruitment
by NK cells, hBMSC migrated more rapidly, but less directly in response to NK cells under hypoxic
conditions compared to normoxic, meaning that a level of co-localisation would occur, and hence
only a subpopulation of the hBMSC could co-localise with the NK cells. This partitioning of hBMSC
and NK cells in the hypoxic environment may represent regulation of hBMSC immuno-modulatory
activity, on the one hand providing a counter-regulatory mechanism to prevent over-suppression of
the early inflammatory response by killing hBMSC, and on the other by enhancing expression of
immuno-modulatory genes by hBMSC. Moreover, this reduction in hBMSC numbers could represent
an anti-tumour-like response or indeed an anti-fibrotic mechanism to prevent excessive accumulation
of hBMSC prior to establishment of the repair framework, which otherwise could have negative
consequences for restoration of tissue structure and function. The response in normoxic conditions
could represent the events occurring during haemostasis, but is more likely to show how NK cells
respond to hBMSC under increased metabolic stress, supported by the increased expression of IDO,
a cytokine associated with immune evasion, by the co-cultured hBMSC. This NK cell response in
normoxic conditions is likely to be strongly related to their anti-tumour role, whereby NK cells
preferentially target poorly differentiated or stressed progenitor cells (Tseng et al. 2010).
The monocyte-hBMSC co-cultures showed a similar difference between normoxic and hypoxic condi-
tions. Under normoxic conditions, co-cultures had stronger pro-angiogenic ability and the monocytes
within said co-cultures developed a pro-angiogenic, pro-inflammatory, and pro-migratory macrophage-
like phenotype. Here again is a point where my research diverged from the literature: my studies found
that the hypoxic co-cultures showed less pro-angiogenic ability and the monocyte-to-macrophage dif-
ferentiation was significantly reduced, while other studies have shown that angiogenesis was enhanced
in hBMSC-monocyte co-cultures in hypoxia. However, harking back to the hypoxic isolation versus
pre-conditioning point, the difference is likely to be due to the isolation condition of the hBMSC.
The hBMSC selected by normoxic isolation may have intrinsically higher pro-angiogenic potential,
which was stimulated in the other studies by immediate introduction to an hypoxic environment. In
my study, the hBMSC were isolated under an hypoxic environment and so lacked the stimulus of
rapid introduction to hypoxia. The lack of HIF-1α upregulation in the hypoxic cultures does support
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this fact. In vivo, the inhibition of angiogenesis stimulated by hBMSC – monocyte interactions under
hypoxic conditions is logical: once again, the hBMSC niche in the bone marrow is hypoxic and
so induction of angiogenesis under hypoxic conditions without further stimulation is undesirable.
Perturbation of the system by damage would lead to stress, indicating the need for repair and hence
stimulating angiogenesis. Moreover, oxygen levels rise as healing progresses as the haematoma /
callus is connected to, and invaded by, the vasculature. The induction of a pro-angiogenic response
by the rising oxygen level may stimulate monocytes / macrophages and hBMSC embedded within
the haematoma to enable vascularisation in a controlled manner. Examination of osteochondral
repair shows that repair occurs from the periphery towards the centre of the defect, supporting this
hypothesis (Lydon et al. 2017). The stronger chemotaxis in hBMSC responding to monocytes seen
under normoxic conditions may indicate a part of this response, as the two cell types co-localise to
enable angiogenesis.
7.2.4 Oxygen level during isolation and culture of hBMSC may be a key regula-
tor of immuno-modulatory behaviour and represent a mechanism for spatio-
temporal control of healing.
The oxygen level that hBMSC are isolated, established and cultured under makes a significant
difference to their interactions with PBMC. As discussed, my studies show multiple divergences with
the literature in terms of said interactions, both when compared to those occurring under normoxic
conditions and under hypoxic preconditioning. The use of continuous, sustained hypoxic conditions
was the critical difference between my studies and those in the literature, and these findings represent
a novel contribution to the literature. The paradigm suggested by these findings is as follows: co-
cultures of hBMSC and PBMC under hypoxic conditions represent the early phase of healing, covering
haemostasis and the initiation of the inflammatory and clearance phase. At this point, recruitment
of immune populations is important, as is clearance of debris caused by trauma and the deposition
of matrix to stabilise the region and provide a scaffold for later repair. During this phase, balanced
immuno-modulation is required to ensure that the inflammatory response is proportionate to the
injury. Additionally, uncoordinated osteogenesis and angiogenic activity are detrimental at this
stage, due to the debris clearance and lack of structure in the wound. Therefore, under hypoxic
conditions, angiogenic and osteogenic activity are curtailed, while interactions between hBMSC and
NK cells result in increased hBMSC immuno-modulatory activity and death, and between hBMSC
and monocytes significantly decrease the pro-angiogenic activity. Moreover, the hypoxic condition
could also represent the endogenous bone marrow niche of the hBMSC, hence the greater immuno-
modulatory behaviour particularly seen in the dramatic inhibition of NK cell mediated hBMSC death
in the unactivated NK cell-hBMSC co-cultures.
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On the other hand, the in vitro normoxic condition could represent a less metabolically restricted, more
dynamic, later phase of healing such as vascularisation or remodelling of the haematoma, perhaps
even extending into hard callus formation. In these conditions, osteogenesis and angiogenesis are
enhanced and desirable to progress towards resolution, since initial debris clearance is complete and
the provisional matrix laid down in the earlier repair phases is remodelled to provide a scaffold for the
repair. In this environment, interactions between hBMSC and monocytes to produce a pro-angiogenic
phenotype are upregulated. The increased NK cell mediated hBMSC death in the normoxic condition
is likely to be related: while NK cell numbers decrease in the latter phases of repair, their role as
anti-tumour cells means that they are likely to target poorly differentiated or stressed hBMSC to
protect against adverse events.
Since a region of damage has an oxygen gradient, from profound hypoxia in the centre to increasing
oxygen towards the periphery, it is reasonable to assume that the events outlined above will be
occurring simultaneously in different regions of the repair. The oxygen gradient may well play a role
in co-ordinating the different stages of repair occurring in each specific micro-environment, ensuring
an orderly progression through the stages. Moreover, these hypoxic hBMSC appear to have greater
immuno-modulatory potential, making them more suitable for regenerative therapies.
7.2.5 Use of hypoxic conditions may improve chondrogenic outcomes
With regards to the specific aim of MF/MD therapies, namely stimulating defect infill with hyaline
cartilage via chondrogenesis, maintenance of the hBMSC under hypoxic conditions appears to
be preferable to normoxic conditions, either within the wound or during ex-vivo culture for later
exogenous administration of autologous hBMSC. The hBMSC isolated and cultured under hypoxic
conditions appear to generate a more homogeneous cartilage matrix when stimulated down the
chondrogenic pathway compared to those in normoxic conditions. Increased matrix homogeneity
could indicate improved biomechanical properties and increase the longevity of the the regenerated
cartilage. Furthermore, the hypoxic hBMSC show decreased osteogenesis when stimulated, which
could mean a reduced risk of mineralisation occurring within the repair tissue.
In addition, the improved immuno-modulatory properties of the hypoxic hBMSC could be beneficial
for chondrogenesis. To start with, the hypoxic hBMSC appear to be less susceptible to NK cell-
mediated killing, and to stimulate a more immuno-modulatory, less pro-angiogenic phenotype in
monocytes. If the ’cell replacement’ paradigm of repair is considered, this could mean that the hypoxic
hBMSC are less likely to be lost to the action of cytotoxic cell types, and therefore more are present
to differentiate into chondrocytes and contribute to repair than the normoxic hBMSC. Alongside
direct contribution through differentiation, the immuno-modulatory properties of the hBMSC could
be important indirectly; excessive and uncontrolled pro-inflammatory response following trauma is
associated with increased scarring. In the case of hyaline cartilage repair, this could take the form of a
7.3 Barriers to translation 177
repair tissue with a higher proportion of fibrocartilage as opposed to hyaline cartilage. The presence
of a more immuno-modulatory cell type, such as hypoxic hBMSC, could increase the regulation of
the immune response following surgery, thereby enabling and supporting chondrogenesis and leading
to repair tissue which could be primarily hyaline cartilage rather than fibrocartilage scar tissue.
7.3 Barriers to translation
Although this work provides indications that use of hypoxic conditions may be beneficial, significant
barriers to translation remain. These can be broken down into three main categories: regulatory,
system or organisational, and individual.
7.3.1 Regulatory barriers
Use of hBMSC for regenerative medicine in the UK is regulated by the Medicines and Health Products
Regulatory Authority (MHRA), and by other agencies elsewhere (MHRA 2015). As such, the data
presented here are insufficient to support immediate clinical translation, for example the isolation
and expansion of exogenous hBMSC under hypoxic as opposed to normoxic conditions. While the
exact regulatory requirements to introduce such a claim are beyond the scope of this discussion, it is
reasonable to believe that at minimum, greater safety and efficacy data would be requested, probably
requiring further in-vitro and in-vivo testing. Should this be deemed satisfactory, clinical trials would
be required prior to licensing, necessitating funding and organisation.
7.3.2 System or organisational barriers
Working under hypoxic conditions presents a range of logistical and safety challenges due to the very
nature of hypoxia; the extreme reduction of oxygen levels. This requires specialist equipment, such as
incubators and laminar flow hoods capable of maintaining an hypoxic environment, as well as gas
supplies to provide the nitrogen used to generate the hypoxic environment. This may also necessitate
expansion of laboratory space to provide room for the hypoxic equipment. In addition, hypoxic culture
work presents health and safety challenges requiring specialist training and safety equipment, such as
oxygen monitors. Although these challenges are surmountable, there is a significant up-front cost
in terms of both time and resources related to the installation of facilities, as well as on-going costs
related to gas supply, maintenance and safety inspections. Particularly with regards to the National
Health Service (NHS), a cost-benefit analysis would have to demonstrate significant advantages to the
use of these techniques prior to their adoption.
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7.3.3 Individual barriers
Should the preceding barriers be cleared, specialist training and ways of working are required to
ensure that the hypoxic conditions are maintained correctly during culture and processing. This would
affect both the surgical team and any supporting laboratory staff, requiring changes in practice in both
the theatre and the tissue culture facility. Adequate training and access to appropriate facilities would
be crucial to enabling adoption of these techniques.
7.4 Overall conclusion
This work has shown that the oxygen level used to isolate and culture hBMSC is critical to their
behaviour, in particular their immuno-modulatory properties. This suggests that oxygen is a key
regulator of the contributions of hBMSC to repair, as outlined in the figure below (fig. 7.1). In
addition, this work has shown that hBMSC isolated from elderly donors with OA retain a level of
immuno-modulation, albeit lower than that found in younger donors as described previously, which
may provide some insight into the decreased efficacy of bone marrow stimulation with increasing age
(Muschler et al. 2001; Stiehler et al. 2016). In terms of regenerative therapy, my findings indicate
that hBMSC isolated and cultured under hypoxic conditions may have distinct therapeutic effects
compared to cells grown under normoxic conditions, with applicability to both surgical bone marrow
stimulation techniques and fracture healing in general.
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Fig. 7.1 Outline of oxygen-dependent contributions of hBMSC within the clot formed following bone
marrow stimulation
hBMSC may contribute differently to repair, depending on the level of oxygen available. At the periphery, the
proximity to vasculature results in a higher oxygen level while the centre of the clot remains hypoxic. hBMSC
within the lower oxygen regions have a more immunomodulatory phenotype, while those within the higher
oxygen regions have a more pro-inflammatory phenotype.
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7.5 Further work
Throughout this thesis, various opportunities for developing the research further have been identified.
In the short term, the three experiments which should be done next are:
1. Crossing over the hypoxic hBMSC to normoxic conditions and vice versa for characterisation
work. This would include the adipogenic, chondrogenic, and osteogenic differentiation, CFU
assay and assessment of surface marker expression and cellular stress markers, such as HIF-1α
and senescence. In addition, performing transcriptome and epigenome analysis on the hypoxic
and normoxic strains in situ, with particular attention paid to genes relating to metabolism and
immuno-modulation could indicate whether the population differences were transient and due
to adaptation, or more permanent and due to population selection.
2. Performing the NK cell-hBMSC co-cultures using hBMSC isolated under hypoxic and normoxic
conditions from the iliac crests of young (under 45 years) donors, using the same ratios to
determine whether donor age influences the immuno-modulatory ability of hBMSC towards
NK cells.
3. Examining the hBMSC-monocyte interactions in greater detail. This would comprise per-
forming the co-cultures and analysing changes in gene expression and cell surface marker
expression in separated populations following the co-culture. This could in particular examine
genes related to angiogenesis and immuno-modulation to determine the cell type responsible
for the observed phenotype. In addition, the tube forming assay could be extended to use the
hBMSC-monocyte mixture, labelled with fluorescent markers, with the HUVECs to identify
how the physical contribution of the hBMSC or monocytes to the pseudocapillary network is
altered by oxygen level.
In the long term, the following strands could be followed to extend this work further:
1. The model could be refined further to more closely adhere to the conditions within a repair
to examine how this influences the hBMSC behaviour and interactions with PBMC, using
experiments similar to those laid out within this work. The refinements to the model could
include addition of inflammatory stimuli, such as TNFα, IL-1β, or IL-6 to the culture media.
Another refinement would be use of a greater range of oxygen levels, based more closely on the
oxygen level found within a haematoma during various phases of repair. A final option would
be introduction of a 3D environment, perhaps through embedding cells within a fibrin gel and
examining how this influences differentiation, gene expression, migration and protein secretion.
Use of an explant culture bioreactor, such as that developed by Rocky Tuan (Hang Lin et al.
2014) would be the ultimate goal of the model refinements, allowing interrogation of more
complex interactions.
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2. Having refined the model, a more complex cell-mixture could be added. Some studies have
examined the interactions between hBMSC, monocytes and NK cells, finding that, for example,
monocytes reduce NK cell mediated hBMSC death (Jewett et al. 2010). Once again, this work
focusses solely on the normoxic environment: use of the three-cell system in the model outlined
above would demonstrate greater biological relevance.
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A.1 Markers Used For Flow Cytometry
Table A.1 Markers used for flow cytometry
Marker
used
Other names Function Reference
CD3 T3 complex T cell activation Kuhns et al. 2006




CD8 T8, Leu2, Ly2/Ly3 Differentiation, activation and
mediation of direct cytotoxicity
by cytotoxic T-cells
N. Zhang and Be-
van 2011
















Other names Function Reference
CD16 Type III Fc-gamma receptor
(FcγRIII)
Low affinity antibody Fc re-
ceptor. Activation and con-




Required for NK cell ADCC.
Yeap et al. 2016
CD19 B-lymphocyte antigen Control and mediation of B-cell
signalling and activity
K. Wang et al.
2012





Unknown role, possibly related
to adhesion. Associated with pro-
genitor cells, particularly HSPCs
Sidney et al.
2014
CD44 Multiple including: Chon-
droitin, Sulphate Proteogly-




Diverse functions related to cel-
lular adhesion including angio-
genesis, cytokine release, and
cellular homing to lymph nodes
Sneath and
Mangham 1998
CD45 Leukocyte common anti-
gen, Protein tyrosine phos-
phatase, receptor type C
Diverse roles in lymphocyte
function and development
Dawes et al. 2006
CD49alpha Very late antigen-1 (VLA-
1), alpha-1 beta-1 integrin
Extracellular matrix receptor
with roles in ahdesion and activa-
tion of T cells
Bank et al. 1994
CD56 Neural cell adhesion
molecule (NCAM)
Activation of signalling path-
ways leading to immunostimula-
tion. Natural Killer cell marker.
Van Acker et al.
2017
CD64 Type I Fc-gamma receptor
(FcγRI)
High affinity antibody Fc recep-
tor. Activation and control of
ADCC and ADCP
Herter et al. 2014
CD68 Macrosialin Putative scavenger receptor, pos-
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Marker
used





Diverse roles including ion and
fluid transport, cell-cell, and cell-
matrix interactions
B. Zhang 2010
CD80 B7-1 Co-signalling molecule with






Diverse roles including cell-cell
and cell-matrix interactions, and




CD105 Endoglin Support of early haematopoiesis
and angiogenesis
Cho et al. 2001
CD133 Prominin-1 Unknown role, possible involve-
ment with proliferation. Strongly
associated with stem and tumour
cells
Z. Li 2013
CD146 Melanoma cell adhesion
molecule (MCAM)
Diverse functions, most com-
monly associated with adhesion,
but also including angiogenesis,
migration and differentiation of
MSCs
Z. Wang and Yan
2013
CD163 Scavenger receptor








CD166 Activated leukocyte cell ad-
hesion molecule (ALCAM)
Diverse roles related to adhesion Uniprot 2019
CD200R Cell surface glycoprotein
CD200 receptor 1
Negative regulation of myeloid








Pattern recognition receptor with







Other names Function Reference
CD271 Nerve growth factor recep-









Binds and mediates downstream




CD317 Tetherin, Bone marrow stro-
mal antigen 2
Diverse roles in cell membrane,
including lipid raft organisation
and inhibition of viral release
Billcliff et al.
2013
HLA-DR MHC Class II receptor Antigen presentation and im-
mune cell activation
NCBI 2019
Tie2 Angiopoietin receptor Regulation of angiogenesis, and
vascular remodelling and stabil-
ity
Jeltsch et al. 2013
A.2 Equipment Used
Table A.2 Table of equipment used
Equipment Details
Category 2 certified biological safety cabinet Thermo Scientific MSC Advantage
Water bath Grant OLS 200
Tissue culture Centrifuge Thermo Scientific Sorvall ST16R
Normoxic incubator Sanyo CO2 incubator
Hypoxic incubator Thermo Scientific Heracell Vios 160i
Pipettes Various Eppendorf
Pipetboy Integra Biosciences pipetboy
Multi-dispense pipette Eppendorf Multipette E3X
Light microscope Leica DMIRB
Camera Q Imaging micropublisher 3.3RTV
Fluorescent microscope Nikon Eclipse TDI
Camera Hamamatsu ORCA-05G
Stage and control Nikon TI-S-EJOY and Nikon TI-SH-U
Automated shutter Nikon NI-SH-CON
Temperature control OKO Lab Control Unit
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Equipment Details
Light Nikon Intensilight C-HGFI
Xcelligence ACEA Biosciences Xcelligence RTCA DP
Vortex mixer Various
Quadromacs Miltenyi Quadromacs
RNA centrifuge Eppendorf Centrifuge 5471R
DNA centrifuge Eppendorf MiniSpin Plus
Ice machine Scotsman AF-80
qPCR reader Applied Biosystems StepOnePlus Real-time
PCR analyser
Heat blocks VWR digital heatblock / Techne
Fume cabinet Mach-Aire
Fluorescent platereader BMG Labtech Fluostar Optima
Densitometer Thermo Scientific GS-800 Calibrated Densito-
meter
RNA quantification Thermo Scientific Nanodrop 2000
Fridge 2 to 8 ◦C Various
Freezer −20 ◦C Various
−70 ◦C Freezer New Brunswick U725-G Innova Freezer
Liquid nitrogen storage system Arpege 110
Distilled water dispenser Millipore ELIX / Synergy UV
Digital Scale Sartorius CPA224S
Rocking stage VWR Stage Rocker
Magnetic stirring platform Stuart Heat Stir CB162
Flow cytometer Becton Dickenson LSR Fortessa Analyser and
Sampler
X-ray developing cassette Hypercassette Amersham Pharmacia Biotech
Automatic X-ray film processing machine MSL MSLXF01
A.3 Reagents Used
Table A.3 Table of reagents used
Reagent Catalogue number Company
Alcian Blue 8GX A5268 Sigma Aldrich Company Ltd
Alizarin red, 2 % solution 42746 Alfa Aesar
Amphotericin B A9528 Sigma Aldrich Company Ltd
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autoMACS rinsing solution 130-091-222 Miltenyi Biotec Ltd.
B Cell Isolation Kit II, human 130-091-151 Miltenyi Biotec Ltd.
Beta-mercaptoethanol M6250 Sigma Aldrich Company Ltd
BGP, TC grade G9422-50G Sigma Aldrich Company Ltd
Bovine Serum Albumin 130-091-376 Miltenyi Biotec Ltd.
Calcein-AM 425201 Biolegend
CD146 microbeads, human 130-093-593 Miltenyi Biotec Ltd.
CD31 microbead kit, human 130-091-935 Miltenyi Biotec Ltd.
CD34 microbeads, human 130-046-702 Miltenyi Biotec Ltd.
CD45 microbeads, human 130-045-801 Miltenyi Biotec Ltd.
CellTox Green G8742 Promega




Custom primers (as listed) Custom order Integrated DNA Technologies
DAPI D9542 Sigma Aldrich Company Ltd
Dexamethasone D4902 Sigma Aldrich Company Ltd
Dimethyl sulphoxide D8418 Sigma Aldrich Company Ltd
Direct-zol RNA MiniPrep Plus
kit
R2061 Zymo Research




DMEM with Glutamax 21885108 Gibco Laboratories
DMEM with high glucose and
GlutaMAX
10566016 Gibco Laboratories
EDTA 15575-020 Life Technologies
Endothelial Cell Growth Sup-
plement
E2759-15MG Sigma Aldrich Company Ltd
Ethanol Absolute 32221-2.5L Sigma Aldrich Company Ltd
Ethanol, BioUltra, for molecu-
lar biology, ≥99.8 %
51976 Sigma Aldrich Company Ltd
FcR block 130-059-901 Miltenyi Biotec Ltd.
Fetal Bovine Serum 02-00-850 First Link (UK) Ltd.
Fibroblast Growth Factor 2 100-18C Peprotech
Formalin solution 10 % neutral
buffered
HT501320 Sigma Aldrich Company Ltd
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Gelatin 2 % solution for tissue
culture
G1393-20ML Sigma Aldrich Company Ltd
Gentamicin solution G1272 Sigma Aldrich Company Ltd











cells, EGM-2, cryo amp
C2519A Lonza
Hydrocholoric acid H1758-500mL Sigma Aldrich Company Ltd
Isopropyl alcohol W292907 Sigma Aldrich Company Ltd





A8960 Sigma Aldrich Company Ltd
Leukocyte Cone NC24 National Blood & Transplant
L-GlutaMAX 35050038 Life Technologies
Lymphoprep 11114544 Axis Shield POC AS
Medium 199 with HEPES M7528-500ml Sigma Aldrich Company Ltd
NK Cell Isolation Kit, human 130-092-657 Miltenyi Biotec Ltd.
OneComp eBeads 01-1111-42 eBioscience
Pan Monocyte Isolation Kit,
human
130-096-537 Miltenyi Biotec Ltd.
PBS 10010056 Gibco Laboratories







Recombinant human GM-CSF 300-03 Peprotech
Recombinant human IL-10 200-10b Peprotech
Recombinant Human IL4 200-04 Peprotech
Recombinant human M-CSF 300-25 Peprotech
Recombinant human SDF1 300-28B Peprotech
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Recombinant Human TGFβ1 100-21-50 Peprotech
Recombinant Human TNF-α 300-01a Peprotech
Recombinant human VEGF 100-20B Peprotech
RPMI-1640 31870-025 Life Technologies
Sodium Pyruvate, 1 mmol S8636 Sigma Aldrich Company Ltd




Sterile mineral oil M5310-100ml Sigma Aldrich Company Ltd
Triton x100 T8787-50ML Sigma Aldrich Company Ltd
TRIzol reagent 15596026 ThermoFisher Scientific
TryplE Express (No Phenol
Red)
12604021 Invitrogen
Trypsin EDTA T3924 Sigma Aldrich Company Ltd
αMEM without nucleosides 22561054 Gibco Laboratories
